Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3022250	p-ld	u/l (u/l)	42320	178184	0.05%
3022250	p-ld	— (—)	4586	8185	100.00%	Distribution not available
3022250	p-laktaattidehydrogenaasi	u/l (u/l)	160	289	0.00%
3022250	laktaattidehydrogenaasi	u/l (u/l)	14	21	0.00%
3022250	s-laktaattidehydrogenaasi,pitoisuus(s-ld-is)	u/l (u/l)	5	5	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Malignant melanoma

1612

6100

3.28

323.01

7.6

4.1

238.93

243.84

u/l

0.38

1566

5744

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

1937

6465

2.88

322.70

4.2

2.5

255.96

243.63

u/l

2.16

1881

5953

Continuous positive airway pressure

1738

5685

2.99

320.42

4.2

5.3

249.78

246.17

u/l

0.40

1617

5442

Finngen Rheumatological endpoints

7539

26727

1.69

320.34

4.1

4.3

238.24

242.07

u/l

1.13

7112

25336

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

502

876

12.44

317.84

13.3

3.5

226.78

256.48

u/l

2.27

490

823

Multiple myeloma

502

876

12.44

317.84

13.3

3.5

226.78

256.48

u/l

2.27

490

823

Ulcer of lower limb, not elsewhere classified

1524

5668

3.34

315.25

3.6

4.1

249.85

244.89

u/l

0.70

1435

5323

Nausea and vomiting

2343

10259

2.51

314.68

4.8

4.1

239.19

247.76

u/l

2.04

2220

9608

Diseases of the digestive system

3968

21462

2.02

314.24

4.1

241.11

247.11

u/l

1.59

3735

20181

Symptoms and signs involving the urinary system

6251

29419

1.75

312.77

3.9

4.3

241.16

244.94

u/l

0.82

5842

27827

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

1478

5021

3.28

311.57

4.4

2.5

243.07

242.13

u/l

0.09

1442

4609

Osteopathies and chondropathies

4425

23489

1.93

310.81

4.3

4.2

240.12

244.34

u/l

1.27

4169

22135

Deposits [accretions] on teeth

848

2116

5.04

310.28

8.9

4.0

262.78

252.20

u/l

0.64

828

2007

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

343

403

26.16

310.21

9.8

2.6

242.82

243.22

u/l

0.02

333

378

Anaemia in chronic diseases classified elsewhere

454

721

12.56

309.70

4.5

4.4

250.27

238.57

u/l

0.69

435

685

Diseases of the skin and subcutaneous tissue

8187

26075

1.65

309.48

4.5

4.0

240.90

242.96

u/l

0.49

7712

24660

Asthma (only as main-diagnosis)

5053

17174

1.87

309.02

3.5

3.9

237.24

240.98

u/l

0.90

4773

16207

ILD medications: azathioprine

1333

4556

3.38

308.66

3.9

3.8

246.07

236.29

u/l

1.32

1284

4305

Other special examinations and investigations of persons without complaint or reported diagnosis

5428

15647

1.85

307.89

4.5

3.9

239.80

245.40

u/l

1.51

5156

14867

ILD medications: immunosuppressive drugs

6635

23207

3.15

307.65

5.6

3.8

244.13

240.53

u/l

1.11

6380

21930

Heart failure, not strict

9098

22600

3.31

307.65

4.7

4.4

257.16

240.17

u/l

11.64

8660

21366

Explicit Sepsis

5122

17720

3.33

307.65

5.7

3.9

255.92

244.20

u/l

4.97

4895

16657

Asthma, excluding more controls

5655

15405

2.08

307.65

3.7

3.9

236.32

238.12

u/l

0.34

5361

14547

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

699

797

28.89

307.65

16.1

2.7

230.12

241.78

u/l

1.95

679

743

Codeine or tramadol medication

9385

32378

1.69

307.65

3.9

4.2

235.59

243.14

u/l

5.26

8817

30674

Calcific aortic valvular stenosis, diagnosis (helper)

3162

13763

2.66

307.65

3.1

3.9

271.88

247.26

u/l

15.28

2982

12845

Intestinal infectious diseases

7354

35640

1.69

307.65

4.7

4.1

239.55

243.32

u/l

1.32

6929

33720

Myeloid leukaemia

538

688

17.37

307.65

18.6

2.9

299.90

234.31

u/l

4.73

528

645

Systemic connective tissue disorders

3160

14938

2.38

307.65

3.5

4.1

239.90

244.57

u/l

1.14

2976

14039

Diseases of liver

3066

14408

2.40

307.65

3.8

4.4

251.36

242.95

u/l

1.46

2885

13613

Calcific aortic valvular stenosis, operated

3168

13779

2.66

307.65

3.2

3.9

271.91

247.74

u/l

14.50

2988

12861

Renal tubulo-interstitial diseases

10129

29406

3.06

307.65

4.4

4.2

248.21

241.27

u/l

3.50

9631

27741

Other soft tissue disorders, not elsewhere classified

7567

27784

1.78

307.65

4.0

4.3

238.43

244.26

u/l

2.14

7143

26327

Bacterial Sepsis

5421

17834

3.26

307.65

4.8

3.9

253.18

244.43

u/l

3.28

5116

16766

Persons encountering health services in other circumstances, wide

10070

32180

1.71

307.65

4.4

4.1

243.10

242.94

u/l

0.03

9615

30322

Other septicaemia

4464

14870

3.60

307.65

5.7

3.6

258.11

244.81

u/l

5.19

4264

13907

Hypertension

6440

18603

2.10

307.65

4.4

4.5

239.17

244.21

u/l

1.58

6130

17616

Codeine

7903

23586

1.96

307.65

3.8

4.0

234.43

239.51

u/l

2.22

7422

22337

Acute tubulo-interstitial nephritis

5290

23822

2.15

307.65

3.8

4.0

240.63

242.54

u/l

0.42

4972

22407

Operations 2 for CAVS

3162

13763

2.66

307.65

3.1

3.9

271.88

247.26

u/l

15.28

2982

12845

ILD differential diagnosis

6549

17324

2.01

307.65

4.5

3.9

241.32

240.72

u/l

0.09

6222

16347

COPD/asthma/ILD related infections

9037

24663

1.96

307.65

4.8

3.8

243.05

240.23

u/l

0.80

8570

23282

Insulin medication

5143

24586

1.93

307.65

3.7

4.5

239.57

247.67

u/l

3.61

4861

23253

Calcific aortic valvular stenosis, including rheumatic fever

3169

13809

2.65

307.65

3.1

3.9

272.77

246.99

u/l

16.09

2989

12889

Inflammatory bowel disease treatment related agents

11215

30793

2.26

307.65

4.7

3.9

244.39

240.84

u/l

1.21

10656

29080

ILD medications: prednisolone, methylprednisolone, prednisone

11470

27834

2.58

307.65

5.0

3.6

245.95

240.40

u/l

2.36

10919

26247

Iron deficiency anaemia secondary to blood loss (chronic)

1778

5979

3.66

307.65

5.2

4.0

247.19

248.96

u/l

0.14

1672

5614

Non-follicular lymphoma

2365

3781

16.29

307.65

8.3

4.0

279.69

239.49

u/l

7.10

2309

3561

Calcific aortic valvular stenosis

3168

13779

2.66

307.65

3.2

3.9

271.91

247.74

u/l

14.50

2988

12861

ILD medications

11751

28200

2.52

307.65

5.2

3.6

244.45

240.48

u/l

1.45

11207

26600

Septicaemia

4998

16467

3.56

307.65

5.7

3.6

256.60

244.06

u/l

5.40

4776

15428

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

3311

8904

2.54

307.65

4.6

4.5

240.56

232.37

u/l

2.37

3159

8430

Dialysis, with operation codes

2506

4633

9.64

307.65

6.3

4.4

260.44

242.62

u/l

4.05

2476

4382

Cardiovascular diseases

4500

10647

2.45

307.65

4.8

4.2

237.61

231.56

u/l

1.11

4296

10144

Pneumonias (Asthma/COPD co-morbidities)

10287

30945

2.57

307.65

5.1

3.9

249.97

239.77

u/l

7.15

9824

29204

Implicit bacterial Sepsis

4745

16021

3.29

307.65

4.7

3.9

254.87

245.24

u/l

3.36

4471

15043

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

9504

24637

2.71

307.65

5.1

3.8

249.51

240.24

u/l

5.34

9078

23256

Second line medication for Crohn's disease

4913

24426

2.21

307.65

4.6

4.3

242.45

242.33

u/l

0.02

4698

23124

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

639

828

16.98

307.65

13.3

2.9

263.58

239.74

u/l

1.43

623

785

Other heart diseases, wide

8164

23856

2.31

307.65

4.8

4.3

250.60

236.02

u/l

11.78

7774

22592

Lymphoid leukaemia

1279

1631

19.32

307.65

14.7

2.8

239.58

235.89

u/l

0.27

1242

1519

Hypothyroidism, levothyroxine purchases

1746

2492

4.35

307.65

4.9

2.5

227.98

218.97

u/l

2.46

1658

2369

Hypertensive diseases (excluding secondary)

4290

9453

2.88

307.65

4.5

237.16

234.89

u/l

0.39

4095

8956

Valvular operations

1972

5347

4.92

307.65

3.3

4.3

294.76

243.35

u/l

23.12

1890

5026

Glomerular diseases

2326

7334

4.11

307.65

4.0

4.4

240.84

243.23

u/l

0.34

2255

6926

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

6362

28073

2.37

307.65

4.6

4.1

242.53

245.85

u/l

0.92

6054

26399

Pain in limb

6398

26866

1.84

307.65

4.1

4.3

239.36

244.29

u/l

1.52

6042

25445

Other pleural conditions

1300

4132

4.15

307.65

3.9

243.66

246.53

u/l

0.26

1254

3858

Hypothyroidism (congenital or acquired)

1774

2499

4.40

307.65

4.9

2.4

228.13

219.09

u/l

2.49

1686

2376

Autoimmune diseases related-to ILD

6664

35792

1.73

307.65

3.6

4.3

234.82

242.72

u/l

4.84

6312

33845

Viral Sepsis

2174

7221

3.70

307.65

5.5

3.9

251.59

241.71

u/l

2.24

2056

6767

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2767

5568

2.64

307.65

4.5

3.8

241.12

241.07

u/l

0.00

2620

5275

Polyarthropathies

6793

20983

2.38

307.65

4.3

4.5

245.73

244.54

u/l

0.20

6450

19879

Influenza and pneumonia

10685

30952

2.52

307.65

5.1

3.9

249.31

239.12

u/l

7.51

10197

29223

Anaemias

3965

2223

16.00

307.65

5.9

2.5

245.04

220.62

u/l

12.16

3790

2109

Pain in throat and chest

6783

23205

1.90

307.65

3.9

4.2

240.26

241.30

u/l

0.17

6408

21967

Acquired haemolytic anaemia

507

765

15.25

307.65

17.2

3.5

378.22

257.02

u/l

8.81

486

724

Haemorrhage from respiratory passages

3125

14123

2.28

307.65

4.5

4.1

257.27

244.81

u/l

3.19

2935

13297

L04AA Selective immunosuppressants

2401

7986

3.68

307.65

5.3

4.4

248.45

241.35

u/l

1.54

2334

7559

Non-ischemic cardiomyopathy

3181

10635

2.91

307.65

4.6

4.3

261.63

243.70

u/l

6.07

3002

9972

Fever of other and unknown origin

7101

19411

4.09

307.65

6.6

3.7

251.65

241.69

u/l

4.14

6852

18282

Abnormalities of breathing

7856

24117

2.08

307.65

4.1

4.2

243.45

241.03

u/l

0.67

7429

22847

L04AX Other immunosuppressants

4807

23811

2.23

307.65

4.6

4.3

242.85

242.34

u/l

0.08

4595

22540

Bleeding

7337

29674

1.95

307.65

4.5

4.2

251.78

243.33

u/l

3.54

6919

28018

Oedema, not elsewhere classified

2898

11253

2.93

307.65

4.2

3.6

243.37

244.12

u/l

0.10

2736

10547

L01XX Other antineoplastic agents

1441

2134

21.88

307.65

12.9

3.6

286.93

248.30

u/l

8.89

1400

2005

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

9343

20199

3.10

307.65

6.4

2.8

250.32

237.81

u/l

6.06

9027

18836

Dyspnoea

8224

32371

2.13

307.65

4.1

4.2

247.23

241.96

u/l

2.40

7752

30593

Oxycodone

4500

14543

3.69

307.65

5.8

4.0

267.63

246.69

u/l

8.18

4288

13731

L01XE Protein kinase inhibitors

887

2180

6.51

307.65

12.2

4.3

285.59

247.14

u/l

5.25

869

2057

COPD/asthma related infections

9037

24663

1.96

307.65

4.8

3.8

243.05

240.23

u/l

0.80

8570

23282

Abnormal findings on diagnostic imaging of lung

4815

22187

2.41

307.65

4.7

4.1

244.15

246.94

u/l

0.60

4601

20851

Non-invasive ventilation

1862

6522

3.01

307.65

3.9

5.1

247.53

243.42

u/l

0.52

1728

6255

Aplastic and other anaemias

7758

18121

5.78

307.65

4.7

3.9

248.71

247.89

u/l

0.13

7294

16992

Polycythaemia vera

817

958

23.21

307.65

10.1

2.6

292.95

237.41

u/l

16.21

805

899

Myeloid leukaemia

538

876

13.35

307.65

18.6

4.0

299.90

252.03

u/l

2.08

528

821

Headache

4479

20201

1.96

307.65

4.0

3.6

234.78

239.00

u/l

0.79

4210

19054

Viral pneumonia

1391

4233

4.07

307.65

5.6

3.9

259.02

239.43

u/l

4.71

1340

3977

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

376

404

29.33

307.65

7.1

2.9

234.31

238.93

u/l

0.30

370

381

Non-rheumatic valve diseases

5324

14440

3.17

307.65

3.9

4.5

268.53

239.26

u/l

26.42

5053

13614

Unspecified kidney failure

1289

3635

4.81

307.65

4.4

3.8

247.09

246.42

u/l

0.05

1239

3388

Non-follicular lymphoma, hilmo, excluding all cancers

2365

2888

21.91

307.65

8.3

2.9

279.69

239.03

u/l

7.22

2309

2686

Other diseases of pleura

4873

19352

2.60

307.65

3.9

4.1

248.33

247.34

u/l

0.16

4657

18163

Diseases of arteries, arterioles and capillaries (FINNGEN)

2613

5370

4.02

307.65

3.9

5.0

251.92

236.58

u/l

3.89

2497

5089

Neoplasms

6857

14139

2.83

307.65

5.7

2.5

241.86

233.74

u/l

2.39

6584

13231

Other pulmonary diagnosis

6559

17332

2.01

307.65

4.6

3.9

241.05

241.14

u/l

0.01

6229

16353

Lymphoid leukaemia

1279

2128

14.42

307.65

14.7

3.8

239.58

250.51

u/l

0.84

1242

2012

General symptoms and signs

11037

23492

2.58

307.65

5.0

3.7

242.77

240.44

u/l

0.57

10483

22164

Pleural effusion

2222

6470

4.75

307.65

3.8

4.0

237.73

246.21

u/l

1.59

2164

6047

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

1754

2540

14.90

307.65

9.1

2.8

231.32

240.57

u/l

2.08

1699

2342

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

1079

1294

25.59

307.65

8.1

2.8

304.41

237.78

u/l

9.23

1049

1204

Autoimmune diseases excluding thyroid diseases, strict definition

9048

27634

1.95

307.65

4.0

4.2

241.80

242.71

u/l

0.18

8617

26084

Multiple myeloma, excluding all cancers (controls excluding all cancers)

1030

1399

17.75

307.65

12.1

2.6

230.36

236.82

u/l

0.80

1011

1291

Asthma, unspecified (mode)

4235

15681

2.32

307.65

3.6

3.9

238.13

241.58

u/l

0.76

4005

14772

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

4546

14315

2.40

307.65

5.6

2.7

242.37

241.11

u/l

0.19

4342

13266

Infections, IBD-co-morbidities

1972

3699

4.67

307.65

6.7

4.9

252.02

250.71

u/l

0.08

1871

3546

Implicit viral Sepsis

2172

7206

3.71

307.65

5.5

3.9

251.50

241.76

u/l

2.18

2054

6752

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

3497

4247

21.55

307.65

8.1

2.7

267.09

239.59

u/l

6.39

3413

3916

Dental caries

3098

9694

3.85

307.65

7.0

4.1

244.96

243.89

u/l

0.12

2977

9181

Benign neoplasm of colon, rectum, anus and anal canal

4690

13677

2.74

307.65

4.0

2.8

239.16

240.88

u/l

0.21

4411

12716

Diffuse large B-cell lymphoma, helper endpoint

1079

1294

25.59

307.65

8.1

2.8

304.41

237.78

u/l

9.23

1049

1204

Any gastric operation

7699

13436

3.15

307.65

4.9

3.0

241.67

237.64

u/l

0.84

7296

12627

Other anaemias

7233

17021

5.88

307.65

4.6

3.9

247.90

248.23

u/l

0.05

6795

15963

Chronic lymphocytic leukaemia, helper endpoint

699

797

28.89

307.65

16.1

2.7

230.12

241.78

u/l

1.95

679

743

Malignant melanoma, excluding all cancers (controls excluding all cancers)

1887

5599

4.23

307.65

7.4

2.7

240.57

240.23

u/l

0.02

1829

5170

Type 2 diabetes, wide definition

7045

25220

1.97

307.65

3.6

4.5

237.67

247.95

u/l

6.40

6620

23875

Other heart diseases

4624

9693

3.55

307.65

5.2

4.5

255.45

234.66

u/l

10.84

4444

9187

Follicular lymphoma

1007

1218

23.48

307.65

7.4

3.3

236.10

235.30

u/l

0.06

982

1141

Pure hypercholesterolaemia

6118

23255

1.90

307.65

3.8

4.4

245.22

244.96

u/l

0.04

5738

21989

Antihypertensive medication - note that there are other indications

4283

11657

2.12

307.65

4.3

4.5

235.78

233.82

u/l

0.30

4066

11112

Renal failure

6726

18129

4.55

307.65

4.4

4.0

252.86

247.21

u/l

1.60

6428

16978

Heart failure, strict

6572

20248

2.75

307.65

4.7

4.2

262.72

243.74

u/l

14.67

6227

19072

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

9885

31266

2.47

307.65

5.0

4.0

249.26

240.55

u/l

5.22

9428

29528

Persons encountering health services for specific procedures and health care

10917

30152

2.48

307.65

4.9

4.0

257.40

236.46

u/l

18.18

10444

28381

GASTRO-related operations

7699

13436

3.15

307.65

4.9

3.0

241.67

237.64

u/l

0.84

7296

12627

Excluding asthma or asthma-COPD overlap

6621

17332

2.03

307.65

4.5

3.9

241.04

241.14

u/l

0.01

6285

16353

Diseases of pulp and periapical tissues

3373

14245

2.68

307.65

5.9

4.1

243.62

245.47

u/l

0.24

3207

13506

Asthma (mode)

5675

17324

1.90

307.65

3.6

3.9

237.53

240.72

u/l

0.75

5370

16347

Any event in cancer register

9227

22390

2.72

307.65

6.5

2.9

251.20

235.69

u/l

9.23

8878

20979

Cardiac arrhythmias

4778

14898

2.28

307.65

4.7

4.6

246.37

236.09

u/l

4.26

4533

14175

Primary_lymphoid and hematopoietic malignant neoplasms

6480

8074

19.84

307.65

10.2

2.7

255.65

241.54

u/l

4.08

6323

7476

Tramadol

7159

21855

2.30

307.65

4.0

4.1

238.72

241.68

u/l

0.78

6767

20672

Disorders of lipoprotein metabolism and other lipidaemias

7016

24617

1.93

307.65

3.7

4.4

243.97

244.87

u/l

0.16

6615

23292

Any reimbursement code in KELA

4375

8248

2.84

307.65

5.2

2.5

241.05

224.46

u/l

5.63

4170

7737

Lung cancer and mesothelioma

2025

6469

3.17

307.65

4.2

3.8

253.26

249.38

u/l

0.35

1972

6052

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

716

1013

14.31

307.65

14.5

2.5

284.95

239.17

u/l

3.85

689

932

Medical observation and evaluation for suspected diseases and conditions

6129

15643

2.15

307.65

4.8

3.9

237.56

245.39

u/l

2.93

5726

14865

Chronic kidney disease

4766

12555

5.35

307.65

4.1

3.9

243.87

248.22

u/l

1.00

4576

11705

Other diseases of blood and blood-forming organs, wide

3714

8554

6.51

307.65

8.2

3.9

258.17

240.89

u/l

6.57

3576

8048

Other and unspecified iron deficiency

4269

12984

4.18

307.65

3.3

4.0

233.34

247.32

u/l

6.75

3972

12185

Other and unspecified anaemias

7190

16891

5.92

307.65

4.6

3.9

247.74

248.21

u/l

0.07

6755

15837

Myeloproliferative diseases (CML excluded)

1874

2861

17.09

307.65

9.7

3.8

286.19

245.11

u/l

13.90

1820

2689

Presence of cardiac and vascular implants and grafts

4616

16830

2.36

307.65

4.7

4.0

266.96

244.53

u/l

16.88

4341

15851

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

576

790

15.49

307.65

12.6

2.5

257.89

240.30

u/l

2.13

550

725

Persons encountering health services for other counselling and medical advice, not elsewhere classified

8800

31948

1.65

307.65

4.4

4.2

241.70

242.91

u/l

0.25

8424

30125

Rare circulating lymphoid malignancy

639

1099

12.46

307.65

13.3

3.9

263.58

252.38

u/l

0.38

623

1038

Other medical care

4766

17056

3.28

307.65

6.1

3.9

284.75

240.49

u/l

22.29

4598

15946

Extracorporeal dialysis

1177

2177

10.52

307.65

4.6

4.3

247.82

245.50

u/l

0.17

1164

2066

First line medication for Crohn's disease

11681

26628

2.65

307.65

5.2

3.6

245.95

238.77

u/l

3.67

11156

25068

Autoimmune diseases

9266

28457

1.75

307.65

4.2

4.3

238.95

242.49

u/l

1.18

8812

26872

Agranulocytosis

1462

3886

5.15

307.65

9.1

3.8

250.32

244.06

u/l

0.66

1419

3667

Follicular lymphoma, hilmo

1007

1588

17.52

307.65

7.4

4.1

236.10

247.69

u/l

0.98

982

1495

Examination and observation for other reasons

5389

15463

2.30

307.65

4.8

3.9

238.85

245.31

u/l

1.61

5128

14715

Enlarged lymph nodes

2777

5071

8.13

307.65

6.8

3.9

242.18

239.05

u/l

0.35

2705

4775

Other disorders of skin and subcutaneous tissue

5650

29939

1.86

307.65

4.3

4.1

241.99

243.93

u/l

0.39

5312

28265

Myeloproliferative diseases

2099

3156

17.64

307.65

10.0

3.8

282.54

243.44

u/l

14.67

2042

2955

Diseases of oesophagus, stomach and duodenum

9170

31560

1.89

307.65

3.8

4.3

238.15

244.40

u/l

2.34

8584

29949

Secondary and unspecified malignant neoplasm of lymph nodes

1985

3154

14.97

307.65

8.0

4.1

257.14

243.07

u/l

2.24

1927

2976

Cerebrovascular diseases (FINNGEN)

2478

6860

2.84

307.65

4.8

249.18

237.46

u/l

2.25

2355

6498

Metabolic disorders

8894

27247

2.22

307.65

4.3

243.87

243.69

u/l

0.03

8393

25785

Erysipelas

4807

21783

2.22

307.65

4.0

3.8

249.00

241.64

u/l

2.62

4541

20465

Benign neoplasm: Colon

4151

13041

2.74

307.65

4.0

2.8

239.03

241.79

u/l

0.33

3902

12098

Non-Hodgkin lymphoma, all

792

1488

10.64

307.65

9.6

3.8

316.66

244.44

u/l

6.59

771

1397

Care involving dialysis

1658

2681

12.29

307.65

4.2

4.4

246.23

234.06

u/l

3.08

1643

2540

Acute renal failure

2941

8296

4.86

307.65

5.1

4.1

267.35

247.07

u/l

4.94

2804

7751

Other and unspecified types of non-Hodgkin lymphoma, hilmo

853

1522

11.72

307.65

8.2

4.2

270.05

251.06

u/l

1.41

830

1431

Atrial fibrillation and flutter with reimbursement

2400

5460

3.19

307.65

4.5

5.0

247.77

238.40

u/l

1.94

2289

5171

Benign neoplasms

5582

15790

2.12

307.65

4.6

2.8

232.82

235.86

u/l

0.81

5290

14819

Other diseases of blood and blood-forming organs

1256

2353

9.44

307.65

7.4

4.0

262.58

245.09

u/l

2.43

1196

2224

Malignant neoplasm, wide definition for exclusion

9343

20201

3.10

307.65

6.4

2.8

250.32

237.81

u/l

6.07

9027

18838

Primary_lymphoid and hematopoietic malignant neoplasms

6480

9503

16.61

307.65

10.2

3.1

255.65

242.20

u/l

3.82

6323

8872

Glomerular disorders in diseases classified elsewhere

1694

4467

5.40

307.65

3.9

4.4

243.37

242.68

u/l

0.06

1649

4227

Other bacterial diseases

11437

28403

3.25

307.65

5.5

3.8

254.00

240.54

u/l

10.70

10921

26740

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

933

1427

13.39

307.65

6.0

2.6

228.22

239.32

u/l

2.00

893

1323

Complications of medical and surgical care

6136

32717

1.93

307.65

4.9

4.1

248.07

242.52

u/l

1.62

5801

30896

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

853

1163

15.75

307.65

8.2

3.2

270.05

237.14

u/l

5.11

830

1076

Provisional assignment of new diseases of uncertain etiology

4540

18145

2.87

307.65

4.7

4.0

247.10

240.96

u/l

1.76

4400

17092

Abnormal findings on examination of blood, without diagnosis

4419

21291

2.18

307.65

4.4

4.2

245.49

244.53

u/l

0.12

4208

20082

Heart failure,strict

6162

16837

3.17

307.65

4.8

4.3

262.59

241.80

u/l

16.64

5841

15878

All-cause Heart Failure

6429

19964

2.72

307.65

4.5

4.2

262.59

243.82

u/l

14.05

6090

18805

Gout, FINNGEN

3155

13595

2.76

307.65

5.6

4.0

249.53

246.76

u/l

0.42

3000

12772

Transplanted organ and tissue status

1899

3165

10.84

307.65

11.3

4.2

248.19

242.56

u/l

0.59

1880

3003

Gout

3155

11619

2.96

307.65

5.6

4.4

249.53

248.08

u/l

0.18

3000

10954

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

3368

12859

2.24

307.65

3.6

2.7

249.18

241.75

u/l

1.41

3209

11905

Hypertensive diseases

6451

18608

2.11

307.65

4.4

4.5

239.16

244.21

u/l

1.59

6141

17621

Other disorders of fluid, electrolyte and acid-base balance

3163

12064

2.98

307.65

3.7

4.2

248.90

247.36

u/l

0.16

2941

11338

Used for control exclusion in common control thyroid runs

8727

26702

1.75

307.65

4.2

238.66

242.87

u/l

1.43

8286

25211

Secondary hypertension

1084

1994

7.34

307.65

3.3

4.5

234.27

244.05

u/l

0.91

1050

1886

Heart failure and antihypertensive medication

3255

5444

4.94

307.65

6.0

5.3

267.12

244.61

u/l

6.75

3119

5168

Diverticular disease of intestine

5983

22861

1.87

307.65

4.1

4.3

237.38

248.23

u/l

5.73

5608

21639

Multiple myeloma and malignant plasma cell neoplasms

1021

1392

17.68

307.65

12.1

2.6

229.98

237.03

u/l

0.90

1002

1284

Hodgkin lymphoma, hilmo

611

882

14.84

307.65

7.1

4.2

232.15

244.44

u/l

1.09

593

838

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

2796

4718

10.19

307.65

7.3

2.8

260.80

236.84

u/l

8.85

2715

4368

Nephropathy related operations

2354

4759

8.67

307.65

6.4

4.5

258.76

242.84

u/l

3.54

2325

4521

Bacterial infection, other or unspecified

7410

20168

4.22

307.65

6.2

3.7

254.72

242.58

u/l

5.74

7085

18919

Diffuse large B-cell lymphoma

1079

1674

19.25

307.65

8.1

4.1

304.41

246.16

u/l

6.49

1049

1581

Malignant neoplasm

9529

21083

3.04

307.65

6.6

2.8

251.33

237.87

u/l

7.08

9197

19684

Heart failure and bmi 25plus

3649

10616

2.78

307.65

4.4

4.0

257.01

242.08

u/l

6.41

3435

9940

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

9341

20202

3.10

307.65

6.4

2.8

250.32

237.81

u/l

6.06

9024

18840

Autoimmune diseases excluding thyroid diseases

9338

28350

1.96

307.65

4.0

4.3

241.37

242.53

u/l

0.24

8887

26767

Opioids

8491

23889

1.99

307.65

4.3

4.0

239.94

239.24

u/l

0.13

8034

22618

Asthma, unspecified (mode), excluding more controls

4134

14061

2.51

307.65

3.6

3.9

238.34

238.88

u/l

0.08

3914

13257

L04AD Calcineurin inhibitors

1749

3519

7.74

307.65

8.6

4.4

251.06

245.28

u/l

0.62

1725

3352

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

2334

7494

3.05

307.65

4.3

2.6

252.95

243.15

u/l

1.87

2269

6927

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

1536

4625

4.14

307.65

7.9

2.7

241.53

239.78

u/l

0.10

1492

4265

Hernia of abdominal wall, postoperative

1431

4617

3.53

307.65

4.0

3.1

237.15

246.52

u/l

1.12

1349

4346

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

1711

5730

3.62

307.65

4.6

2.6

273.61

240.15

u/l

6.36

1668

5297

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

9034

29601

2.27

307.65

5.6

3.9

250.47

239.80

u/l

5.38

8577

28006

Haemolytic anaemias

663

1092

11.69

307.65

15.1

3.6

344.47

252.54

u/l

8.42

638

1033

Hodgkin lymphoma

611

675

19.79

307.65

7.1

2.9

232.15

235.32

u/l

0.22

593

640

Valvular heart disease excluding rheumatic fever

5371

14526

3.18

307.65

3.9

4.5

269.00

239.74

u/l

25.93

5099

13697

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

2773

7860

4.58

307.65

6.0

2.7

284.31

241.04

u/l

16.40

2705

7290

Secondary uncertain malignant neoplasm

2376

5086

7.83

307.65

7.4

3.9

265.43

243.62

u/l

4.61

2298

4776

Chronic lymphocytic leukaemia

699

1064

20.99

307.65

16.1

3.9

230.12

253.13

u/l

1.93

679

999

Hypothyroidism and >3 levothyroxin purchases

1746

2492

4.35

307.65

4.9

2.5

227.98

218.97

u/l

2.46

1658

2369

Asthma (only as main-diagnosis), excluding more controls

4918

15405

2.01

307.65

3.6

3.9

237.04

238.12

u/l

0.17

4656

14547

9504

24637

2.71

307.65

5.1

3.8

249.51

240.24

u/l

5.34

9078

23256

Pneumonia, organism unspecified

9315

29055

2.60

307.65

5.1

3.9

249.53

240.50

u/l

5.13

8885

27418

COPD differential diagnosis

6553

17326

2.01

307.65

4.5

3.9

241.29

240.73

u/l

0.09

6226

16348

Depression medications

1809

2637

3.66

307.65

3.5

2.4

226.07

218.10

u/l

1.81

1707

2509

Malaise and fatigue

4955

16010

2.93

307.65

3.9

3.6

243.20

243.53

u/l

0.04

4657

15031

Hypertension, essential

6466

18180

2.19

307.65

4.0

4.5

239.45

243.19

u/l

1.02

6152

17208

Chronic periapical parodontitis

2326

7938

3.55

307.65

6.9

4.1

245.38

245.08

u/l

0.03

2229

7510

Diseases of arteries, arterioles and capillaries

6108

25100

1.99

307.65

3.6

4.3

250.23

245.17

u/l

1.54

5773

23648

Other diseases of intestines

8509

29735

1.76

307.65

4.3

4.2

235.82

244.74

u/l

5.12

8013

28214

Complications of surgical and medical care, not elsewhere classified

8621

33866

1.97

307.65

4.7

4.0

246.81

241.73

u/l

1.89

8150

31989

Coagulation defects, purpura and other haemorrhagic conditions

2443

7257

4.34

307.65

6.6

4.1

261.65

239.91

u/l

5.07

2355

6846

Cardiovascular diseases (excluding rheumatic etc)

5033

11954

2.62

307.65

4.7

4.3

240.11

232.21

u/l

1.89

4820

11351

Multiple myeloma and malignant plasma cell neoplasms

1021

1810

13.22

307.65

12.1

3.6

229.98

248.59

u/l

2.37

1002

1703

Thrombocytopenia, unspecified

1168

2482

7.60

307.65

7.6

3.9

275.65

245.80

u/l

3.11

1125

2346

Other disorders of white blood cells

857

1864

7.15

307.65

8.4

3.8

250.06

247.19

u/l

0.12

822

1768

Complications of procedures, not elsewhere classified

6591

32726

1.87

307.65

4.2

4.0

248.04

241.76

u/l

2.04

6247

30928

Certain infectious and parasitic diseases

8810

22268

2.12

307.65

4.9

3.6

243.04

239.88

u/l

0.85

8355

21014

Oral corticosteroids

10674

30037

2.37

307.65

4.8

3.9

246.25

241.19

u/l

2.00

10132

28355

All pneumoniae

10308

31108

2.55

307.65

5.1

3.9

249.85

239.80

u/l

6.99

9844

29363

Codes for special purposes

4549

18167

2.88

307.65

4.7

4.0

247.07

240.92

u/l

1.77

4409

17111

Condition for Implicit Sepsis (Organ dysfunction codes)

8277

27895

2.39

307.65

4.4

4.0

251.69

240.09

u/l

6.81

7791

26357

Covid-19 confirmed case

3527

11424

3.85

307.65

4.7

4.1

250.54

243.75

u/l

1.53

3423

10718

Kidney transplant status

934

1656

10.00

307.65

3.8

4.8

243.60

251.94

u/l

0.54

928

1576

Nutritional anaemias

5958

20644

3.40

307.65

4.0

242.27

247.28

u/l

1.16

5557

19389

Asthma

5881

17174

1.94

307.65

3.6

3.9

237.14

240.98

u/l

0.99

5565

16207

Chronic periodontitis

1730

5696

3.80

307.65

6.1

4.1

247.28

245.74

u/l

0.12

1669

5391

Essential (haemorrhagic) thrombocythaemia

971

992

33.17

307.65

9.6

2.5

281.94

235.41

u/l

14.18

939

923

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

6197

13188

5.57

307.65

6.3

2.7

271.02

240.95

u/l

19.75

6017

12222

Parasetamol

6604

17884

2.00

307.65

4.2

234.83

243.52

u/l

3.48

6251

16994

Endocrine, nutritional and metabolic diseases

6283

18164

1.85

307.65

4.4

235.20

242.61

u/l

2.34

5931

17293

Symptoms and signs involving the circulatory and respiratory systems

8057

24193

1.75

307.65

4.2

240.27

240.96

u/l

0.12

7635

22920

Atrial fibrillation and flutter

2934

6504

3.32

307.65

5.0

4.9

256.90

236.66

u/l

6.84

2801

6162

Dentinal caries

2758

8498

3.97

307.65

6.9

4.0

243.63

244.45

u/l

0.08

2644

8055

Purpura and other haemorrhagic conditions

1866

4987

5.13

307.65

7.2

4.1

268.00

241.56

u/l

4.73

1802

4709

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

15634

26437

5.44

307.65

5.2

3.7

249.10

239.65

u/l

6.48

14800

24990

Implicit Sepsis

7779

25840

2.66

307.65

4.4

4.0

251.33

241.66

u/l

4.77

7323

24376

Iron deficiency anaemia

5302

17286

3.77

307.65

3.9

4.0

238.51

246.64

u/l

2.92

4941

16239

Other and unspecified disorders of white blood cells

677

1321

8.56

307.65

9.3

3.8

247.77

248.28

u/l

0.02

647

1240

Diabetes mellitus

7871

29909

1.65

307.33

3.8

4.4

237.33

244.55

u/l

4.23

7415

28329

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

7449

28654

1.67

306.79

3.6

4.5

237.27

245.83

u/l

4.92

7015

27121

Venous thromboembolism

4581

25332

1.91

306.72

4.8

4.0

252.95

244.57

u/l

2.83

4367

23794

Pulmonary heart disease, diseases of pulmonary circulation

2893

14259

2.29

306.65

5.0

4.0

258.98

245.30

u/l

4.32

2775

13332

Diabetes, varying definitions

7841

29835

1.65

306.19

3.8

4.4

237.57

244.64

u/l

4.06

7388

28260

Hypo-osmolality and hyponatraemia

1668

6504

3.02

305.67

3.6

4.2

246.14

u/l

0.00

1551

6100

8969

30991

1.60

302.72

4.8

3.9

238.83

243.46

u/l

2.07

8473

29276

Gastrointestinal diseases

4456

11973

1.96

302.16

4.6

3.8

239.20

242.19

u/l

0.41

4214

11406

Diabetic nephropathy, excluding more controls

1574

4993

3.25

300.92

3.1

3.9

238.66

237.38

u/l

0.18

1510

4671

Diarrhoea and gastroenteritis of presumed infectious origin

5424

29317

1.78

300.44

4.4

4.0

239.32

243.18

u/l

1.19

5120

27722

Hypothyroidism, drug reimbursement

854

1437

4.60

299.49

4.4

2.6

235.57

218.85

u/l

3.97

804

1349

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

1008

3070

4.38

298.34

4.0

3.8

228.63

245.61

u/l

2.92

939

2876

Other and unspecified diseases of blood and blood-forming organs

462

775

11.32

297.87

8.2

3.7

256.97

247.52

u/l

0.34

454

737

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4886

28448

1.84

297.43

5.1

4.0

247.47

242.62

u/l

1.17

4609

26843

Disorders resulting from impaired renal tubular function

578

1199

8.13

295.63

3.3

4.5

236.18

257.25

u/l

1.41

567

1137

Bronchitis

8252

35320

1.61

294.93

5.0

3.9

239.34

242.65

u/l

1.22

7815

33360

Symptoms and signs involving the skin and subcutaneous tissue

5326

31762

1.78

293.65

4.8

4.1

233.52

243.83

u/l

6.71

5041

30052

Other disorders of teeth and supporting structures

1930

8198

2.68

292.77

5.4

4.0

239.63

244.94

u/l

0.74

1817

7736

Symptoms and signs involving the digestive system and abdomen

8142

26231

1.63

292.39

4.4

4.2

239.64

244.83

u/l

1.77

7697

24816

Certain disorders involving the immune mechanism

1786

7368

2.81

291.54

5.6

4.3

239.39

240.74

u/l

0.14

1715

6989

Pain, not elsewhere classified

2051

8877

2.54

291.31

4.0

3.7

237.41

240.99

u/l

0.47

1934

8352

Insulin, combination of fast acting with intermediate-acting or long-acting

5147

28267

1.80

289.17

3.7

4.2

239.62

245.20

u/l

2.05

4865

26669

Syncope and collapse

3420

15891

2.05

287.97

3.8

3.6

240.18

243.11

u/l

0.53

3173

14927

Conduction disorders

2496

9729

2.37

286.91

3.6

4.3

254.26

242.95

u/l

3.45

2356

9135

Insulin, intermediate and long-acting

4625

26411

1.86

286.80

3.5

4.3

238.64

245.35

u/l

2.58

4367

24946

DVT of lower extremities and pulmonary embolism

3598

19443

2.03

286.50

4.7

4.0

253.21

245.69

u/l

2.02

3426

18235

Glucagon-like peptide-1 (GLP-1) analogues

4726

22670

1.87

285.99

3.5

4.5

236.82

249.99

u/l

7.17

4398

21442

COPD (mode)

2635

9995

2.32

285.71

3.3

4.0

237.48

246.13

u/l

2.05

2465

9354

Diabetes, insulin treatment (Kela reimbursement)

7802

30945

1.62

284.17

3.6

4.5

237.25

245.94

u/l

5.35

7341

29271

Other arrhythmias

4562

19926

1.86

283.78

4.1

4.4

242.06

236.38

u/l

1.80

4293

18834

Type 2 diabetes

7501

28606

1.64

282.51

3.7

4.4

237.40

245.18

u/l

4.52

7053

27077

Hypertensive heart and/or renal disease

2369

8494

2.43

280.02

3.4

4.4

247.10

250.07

u/l

0.39

2227

7976

Azathioprine

1333

4830

3.17

278.01

3.9

4.3

246.07

235.94

u/l

1.42

1284

4571

Diabetes medication

7807

30940

1.61

276.00

3.6

4.4

236.02

245.12

u/l

6.25

7339

29308

Direct fill therapy

1303

4729

3.28

275.60

7.1

4.3

241.33

244.04

u/l

0.27

1252

4477

Other diseases of the digestive system

2877

14707

2.18

274.86

4.3

4.0

245.60

247.89

u/l

0.30

2698

13788

Viral pneumonia (unknown virus, not influenza)

788

2127

4.84

274.81

5.3

4.3

264.63

242.20

u/l

3.53

774

2013

Benign neoplasm of colon, rectum, anus and anal canal

5073

27609

1.79

274.11

3.9

4.2

238.89

247.02

u/l

1.93

4765

26032

Bacterial pneumoniae

3341

15749

2.04

271.66

4.6

3.8

247.70

243.16

u/l

0.87

3172

14788

Pulmonary embolism

2596

12875

2.27

270.32

4.8

4.0

257.66

245.01

u/l

3.33

2486

12048

Other CVD (FINNGEN)

1061

2621

3.77

269.10

3.7

4.5

243.13

238.94

u/l

0.34

977

2470

STROKE

4409

17524

1.87

268.36

4.6

4.7

247.22

242.40

u/l

1.05

4170

16582

Pulmonary heart disease

2596

12932

2.26

267.12

4.8

4.0

257.66

245.25

u/l

3.23

2486

12106

All influenza

2070

9415

2.45

264.93

5.5

3.9

245.46

240.97

u/l

0.64

1946

8850

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

1119

3840

3.51

262.85

4.3

2.7

234.25

240.57

u/l

0.84

1086

3550

Bacterial pneumonia, not elsewhere classified

3179

14906

2.05

262.62

4.6

3.7

248.17

243.00

u/l

1.00

3019

13988

GI-bleeding

2855

14800

2.15

261.53

4.3

4.0

245.65

248.14

u/l

0.33

2684

13864

General examination and investigation of persons without complaint and reported diagnosis

5003

15613

1.79

260.15

4.9

3.9

239.57

245.37

u/l

1.64

4691

14840

Care involving use of rehabilitation procedures

4621

26045

1.79

259.62

3.9

4.0

247.90

238.61

u/l

2.69

4413

24486

Other systemic involvement of connective tissue (FG)

2151

9983

2.38

257.74

3.2

4.2

236.62

246.18

u/l

2.30

2008

9406

AV-block

1608

6012

2.78

256.62

3.4

4.1

261.65

244.38

u/l

4.09

1520

5626

Endocarditis

510

1050

7.25

256.44

3.7

4.1

284.99

241.82

u/l

4.23

492

984

Gout, idiopatic and unspecified

2340

11514

2.35

254.56

4.1

242.91

247.29

u/l

0.72

2203

10850

Other bacterial intestinal infections

1658

7043

2.71

253.18

5.7

4.1

248.81

244.98

u/l

0.38

1553

6619

Streptococcal septicaemia

914

2869

4.00

252.63

5.4

3.8

251.91

241.87

u/l

1.02

874

2689

Chronic periodontitis, complicated

1048

3596

3.70

252.38

5.9

4.5

244.66

245.02

u/l

0.02

1010

3415

Infections of the skin and subcutaneous tissue

4327

25439

1.81

251.40

4.7

4.3

240.62

242.27

u/l

0.25

4114

24121

Insulin, fast-acting

2990

15907

2.06

249.86

3.5

4.3

240.93

244.69

u/l

0.85

2839

15012

Symptoms and signs concerning food and fluid intake

976

3168

3.67

249.63

3.2

3.6

227.88

242.80

u/l

2.51

912

2977

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

3494

13066

1.97

249.45

4.4

2.7

243.95

241.72

u/l

0.41

3305

12086

Abdominal and pelvic pain

7883

26220

1.58

248.94

4.3

4.2

240.17

244.57

u/l

1.30

7441

24805

Explicit bacterial Sepsis

1049

3602

3.52

246.60

5.5

4.1

250.06

242.95

u/l

0.69

1002

3390

Adjustment and management of implanted device

1735

7640

2.63

246.12

4.4

3.8

257.66

244.32

u/l

3.33

1666

7100

Reimbursement for rheumatic diseases

4387

26122

1.79

245.90

3.1

4.3

241.97

242.88

u/l

0.16

4161

24660

Malignant melanoma of skin

1214

4578

3.28

244.93

8.3

4.1

240.89

243.95

u/l

0.16

1182

4314

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1098

2715

3.47

244.34

4.6

5.0

264.24

259.17

u/l

0.30

1042

2597

Gout, unspecified

1957

9175

2.50

242.34

4.2

4.1

243.10

243.98

u/l

0.09

1846

8627

Asthma-related pneumonia or sepsis

2983

16013

2.04

242.28

3.9

4.1

243.16

247.53

u/l

0.93

2827

14999

Asthma, hospital admissions 3, pneumonia

2983

16013

2.04

242.28

3.9

4.1

243.16

247.53

u/l

0.93

2827

14999

Bacterial intestinal infections, IBD co-morbidities

1673

7283

2.64

242.21

5.7

4.0

248.12

244.49

u/l

0.36

1570

6848

Asthma-related pneumonia

2975

15978

2.03

241.29

3.9

4.1

243.15

247.51

u/l

0.93

2819

14964

Benign neoplasms

7471

27624

1.57

240.47

4.4

4.1

235.53

243.52

u/l

2.84

7069

26176

Hard cardiovascular diseases

6099

25067

1.66

240.28

4.4

4.5

251.07

242.63

u/l

2.81

5762

23703

Dermatitis

4613

28078

1.75

239.78

4.6

4.2

241.17

242.93

u/l

0.29

4393

26546

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

988

3338

3.59

239.01

4.3

2.8

233.94

240.63

u/l

0.80

964

3091

Factors influencing health status and contact with health services

2464

5816

2.25

238.47

4.3

3.7

244.28

236.12

u/l

1.14

2331

5498

Chronic myeloproliferative disease

310

450

20.41

238.16

18.5

3.9

459.81

247.41

u/l

28.45

303

422

Constipation

6677

31425

1.60

237.31

3.8

4.3

240.05

245.32

u/l

1.74

6205

29758

Cytomegalovirus infection, IBD co-morbidity

375

636

10.47

237.04

12.6

4.8

271.27

242.26

u/l

2.47

366

603

Cardiomyopathy

1534

6468

2.70

236.68

7.4

4.4

261.48

243.66

u/l

3.21

1457

6094

Other and unspecified dermatitis

3867

22560

1.84

236.17

4.7

4.1

242.51

243.45

u/l

0.12

3683

21308

Pacemaker

2953

15604

2.06

236.10

4.1

3.9

264.77

248.50

u/l

6.82

2781

14573

Symptoms and signs involving cognition, perception, emotional state and behaviour

7234

33863

1.57

235.79

3.6

4.3

241.18

242.80

u/l

0.34

6762

32087

Benign neoplasm: Colon, unspecified

1814

8175

2.47

235.31

3.6

2.7

243.27

242.54

u/l

0.03

1672

7570

Disorders of lens

5351

21043

1.71

234.79

4.2

4.5

241.15

245.97

u/l

1.28

5019

19988

In situ neoplasms

2385

11398

2.16

232.29

4.6

2.6

247.42

239.74

u/l

1.44

2265

10540

Other/unspecified cytomegaloviral diseases

340

537

12.20

232.10

12.8

4.9

274.04

239.46

u/l

2.96

333

509

Idiopathic thrombocytopenic purpura

453

934

7.53

229.49

7.4

3.8

261.92

257.03

u/l

0.10

440

886

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1422

5960

2.85

228.84

3.3

4.5

251.99

242.35

u/l

0.90

1347

5636

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

3376

12884

1.93

228.42

4.5

2.7

246.86

241.68

u/l

1.10

3188

11913

Asthma, hospital admission 2, infections

4399

26307

1.75

228.30

3.7

4.2

237.62

244.75

u/l

3.08

4167

24792

Asthma-related infections

4399

26307

1.75

228.30

3.7

4.2

237.62

244.75

u/l

3.08

4167

24792

Diseases of the respiratory system

4933

14899

1.74

228.08

4.5

3.9

242.80

241.82

u/l

0.13

4667

14056

Bacterial pneumonia (organism specified)

3654

19263

1.86

227.96

5.1

3.9

249.07

246.00

u/l

0.56

3477

18054

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

3338

12742

1.94

227.87

4.5

2.7

247.02

241.94

u/l

1.05

3152

11780

Disorders of mineral metabolism

846

2697

3.90

227.49

4.5

4.4

250.44

246.60

u/l

0.26

800

2565

Other diseases of pericardium

548

1312

5.73

226.73

4.1

4.0

263.97

242.40

u/l

1.54

529

1228

Ischaemic heart disease, wide definition

5958

24099

1.64

224.51

4.2

4.5

251.67

242.27

u/l

3.24

5642

22755

Drug-induced neutropenia

798

2500

4.15

224.41

8.9

4.3

258.31

246.29

u/l

1.08

781

2366

Disorders of choroid and retina

6230

29795

1.61

224.06

3.9

4.3

244.83

244.56

u/l

0.04

5861

28127

Cytomegaloviral disease

376

675

9.48

223.56

12.5

4.8

271.06

238.14

u/l

3.18

367

640

Ischemic heart diseases

6006

24377

1.63

223.33

4.2

4.5

251.16

242.37

u/l

2.93

5694

23011

Peripheral artery disease

3821

18122

1.85

223.22

3.3

4.1

247.77

247.35

u/l

0.05

3582

17019

Other autoimmune haemolytic anaemias

282

396

21.27

222.66

20.1

3.6

305.84

245.11

u/l

5.45

273

375

Diabetic nephropathy

1584

7005

2.70

222.31

3.1

3.7

238.69

238.16

u/l

0.07

1520

6560

Insulin, fast-acting or short human

3001

16590

1.97

221.96

3.5

4.3

240.79

244.38

u/l

0.81

2849

15636

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4387

26945

1.74

220.97

4.1

247.55

243.28

u/l

0.87

4135

25427

Gout, strict definition

1740

8106

2.53

220.12

4.2

242.43

244.72

u/l

0.28

1637

7628

Genitourinary diseases

4666

14045

1.74

219.10

4.5

240.68

244.70

u/l

0.60

4433

13397

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

691

1983

4.40

218.95

5.1

2.9

259.08

235.16

u/l

1.13

675

1841

Persons encountering health services in other circumstances

2824

15345

1.98

217.36

3.8

4.2

241.07

242.50

u/l

0.16

2669

14431

Benign neoplasm: Colon

4233

25444

1.76

217.25

3.9

4.2

238.44

247.21

u/l

1.74

3981

23963

Malignant immunoproliferative diseases

231

259

29.71

217.11

10.1

2.8

226.47

241.33

u/l

0.98

224

245

Paroxysmal tachycardia

1571

5715

2.52

216.97

6.2

4.7

247.67

237.09

u/l

2.10

1494

5406

Persons encountering health services for examination and investigation

5063

15647

1.69

214.56

4.5

3.9

235.75

245.40

u/l

4.53

4770

14867

Ascites

798

2560

3.97

214.50

3.9

4.1

269.33

248.72

u/l

1.23

768

2430

Malignant neoplasm of skin

5018

24023

1.68

212.59

5.3

3.9

244.80

246.76

u/l

0.32

4771

22532

Coronary atherosclerosis

5374

22217

1.66

212.39

4.2

4.5

251.31

242.54

u/l

3.22

5066

20961

Gastro-oesophageal reflux disease

4978

28022

1.66

212.02

3.6

4.4

233.90

245.52

u/l

9.18

4625

26590

Enterocolitis due to Clostridium difficile

1076

4096

3.16

210.03

6.6

3.9

253.80

248.62

u/l

0.39

1016

3842

Unspecified haematuria

3483

17472

1.85

208.49

4.0

4.3

245.95

246.39

u/l

0.05

3280

16513

Other systemic involvement of connective tissue

2208

11301

2.16

208.27

3.3

4.1

236.10

244.80

u/l

2.37

2063

10611

Disorders of gallbladder, biliary tract and pancreas

7337

32393

1.53

208.14

4.2

242.20

243.07

u/l

0.14

6942

30599

Disorders of other endocrine glands

3202

18076

1.87

206.45

3.9

4.2

239.35

244.28

u/l

0.84

3000

17036

Hypertensive Heart Disease

1997

8003

2.27

205.45

3.4

4.4

248.61

250.21

u/l

0.17

1863

7513

Other abnormal findings of blood chemistry

547

1418

5.34

205.29

5.1

4.2

234.22

246.66

u/l

0.89

536

1338

Other acute lower respiratory infections

4031

23504

1.74

204.46

5.0

4.0

239.99

244.70

u/l

1.35

3828

22094

Diseases of oral cavity, salivary glands and jaws

7013

24253

1.55

204.15

4.6

3.8

242.47

246.24

u/l

1.00

6602

22916

Type 2 diabetes, definitions combined

6869

27747

1.54

203.09

3.8

4.5

236.67

245.79

u/l

5.47

6438

26249

Acute upper respiratory infections of multiple and unspecified sites

5315

25739

1.62

202.54

5.3

4.0

236.51

242.87

u/l

2.41

5041

24346

Viral infections characterized by skin and mucous membrane lesions

3082

17605

1.88

202.45

5.9

4.2

242.13

243.50

u/l

0.20

2933

16632

Left ventricular outflow tract obstruction (LVOTO), broad definition

959

3502

3.28

201.77

4.3

5.0

293.61

245.31

u/l

9.93

924

3353

Hyperkalaemia

631

1826

4.53

200.31

4.8

4.1

250.46

243.25

u/l

0.53

593

1723

Type 2 diabetes, strict (exclude DM1)

6890

27959

1.53

199.64

3.8

4.5

236.63

246.00

u/l

5.76

6459

26452

Pregnancy hypertension

2469

11835

2.00

197.51

3.7

4.0

235.84

234.59

u/l

0.11

2354

11205

Hyperlipidaemia, other/unspecified

3113

17066

1.88

196.74

3.6

4.3

243.43

246.94

u/l

0.72

2941

16121

Use of hypnotics and sedatives

7880

31884

1.49

195.17

4.1

4.2

237.64

244.06

u/l

3.30

7412

30211

Other (not insulin) diabetes medications

7019

29037

1.52

194.36

3.5

4.5

235.47

246.10

u/l

6.95

6560

27482

Other arthritis (FG)

2332

12400

2.04

193.84

3.6

4.4

239.20

244.34

u/l

0.57

2223

11743

Aortic valve malfunction, age under 60 years

896

3238

3.34

192.73

4.2

4.9

295.31

242.69

u/l

11.15

862

3097

Heart failure and coronary heart disease

2963

12647

1.94

191.68

4.3

4.0

265.06

246.31

u/l

7.63

2786

11817

Fibrosis and cirrhosis of liver

789

2696

3.71

191.27

3.3

4.3

240.45

244.20

u/l

0.31

760

2557

Acute bronchitis

3152

18055

1.83

190.65

4.8

4.0

238.36

244.99

u/l

2.05

2987

16906

Glomerulonephritis

981

3745

3.14

190.27

4.1

4.4

235.24

247.67

u/l

1.99

948

3541

Dorsalgia

7393

27748

1.50

189.05

3.8

4.3

234.49

243.07

u/l

4.49

6942

26350

Benign neoplasm of other and ill-defined parts of digestive system

1268

5413

2.63

188.73

4.4

2.7

232.18

239.75

u/l

1.60

1188

5007

Other nutritional deficiencies

4381

27202

1.66

188.70

3.5

4.3

236.95

240.22

u/l

0.64

4128

25838

Parodontitis or operation codes

6573

33291

1.52

187.98

4.4

4.2

241.67

243.67

u/l

0.45

6203

31508

Other retinal disorders

4883

25518

1.63

187.72

3.7

4.2

246.15

245.13

u/l

0.12

4589

24033

Low back pain

5312

26945

1.59

187.29

3.8

4.3

234.42

243.31

u/l

4.97

4972

25604

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

2412

7788

2.06

186.60

5.0

2.8

252.15

241.08

u/l

1.84

2312

7256

Chronic gastritis

2296

12369

2.04

186.50

3.8

4.2

246.43

248.89

u/l

0.23

2124

11648

Parodontitis

6558

33287

1.52

186.26

4.4

4.2

241.64

243.68

u/l

0.46

6188

31505

Chronic periodontitis, including avohilmo

6530

33283

1.52

185.21

4.4

4.2

241.64

243.69

u/l

0.46

6162

31503

Pre-eclampsia

1322

5766

2.51

184.16

4.3

4.0

244.53

235.16

u/l

0.73

1263

5446

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

186

196

37.19

183.99

9.3

2.9

204.24

243.18

u/l

6.51

180

184

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

7051

31994

1.50

183.17

4.3

4.2

244.93

242.30

u/l

0.73

6632

30264

Senile cataract

4848

19429

1.64

182.76

4.1

4.5

243.06

246.48

u/l

0.67

4532

18429

Spondylopathies

5979

24459

1.55

182.56

3.6

4.3

240.48

245.39

u/l

1.32

5606

23185

Atherosclerosis, excluding cerebral and coronary sclerosis

3503

17020

1.79

181.88

3.2

4.1

248.88

247.36

u/l

0.21

3280

15969

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2696

13241

1.88

180.48

3.6

4.0

234.79

236.46

u/l

0.18

2569

12529

Rheumatoid arthritis

2501

12594

1.95

179.99

3.0

4.4

249.72

246.39

u/l

0.51

2357

11899

Type 2 diabetes, definitions combined, including avohilmo

6784

27763

1.51

179.75

3.8

4.5

237.90

245.91

u/l

4.17

6359

26273

Other disorders of kidney and ureter

1189

5118

2.73

179.53

3.7

4.4

242.94

246.31

u/l

0.30

1147

4838

Fall on same level

8352

33421

1.44

179.20

3.8

4.3

238.91

243.07

u/l

1.81

7860

31735

Any operation in hilmo

282

133

11.49

178.26

4.0

2.1

233.91

223.67

u/l

0.28

269

126

Presence of other functional implants

4320

19520

1.66

176.45

3.7

4.0

246.17

244.40

u/l

0.19

4020

18376

Pre-eclampsia or eclampsia

1401

6381

2.39

176.04

4.2

4.1

246.38

235.72

u/l

0.88

1339

6022

Gastroduodenal ulcer

2184

11775

2.03

175.31

3.7

4.2

248.08

250.45

u/l

0.14

2046

11076

Other disorders of urethra and urinary system

4964

24484

1.59

175.17

3.9

4.1

242.62

243.77

u/l

0.17

4647

23149

Other functional intestinal disorders

3238

18529

1.77

175.02

3.9

4.1

237.22

249.57

u/l

4.44

3031

17477

Pain (limb, back, neck, head abdominally)

5645

18795

1.56

173.90

4.2

4.3

238.35

246.98

u/l

2.75

5317

17826

Other antidepressants

7859

29168

1.46

173.65

3.5

4.5

234.28

244.89

u/l

6.84

7332

27726

Non-small cell lung cancer

1478

7048

2.41

173.55

4.4

3.9

243.07

248.47

u/l

0.64

1442

6582

Malignant immunoproliferative diseases

231

348

21.44

173.48

10.1

4.3

226.47

244.86

u/l

1.24

224

328

Hypokalaemia

991

3951

2.90

173.44

2.9

4.3

244.70

244.48

u/l

0.02

918

3735

Hernia

6726

31864

1.49

173.41

4.0

4.3

240.94

244.47

u/l

1.14

6336

30127

Cirrhosis of liver, NAS

591

1823

4.39

172.88

3.4

4.2

242.44

249.92

u/l

0.53

572

1727

Cough

2897

16264

1.82

172.52

4.5

4.3

241.17

244.08

u/l

0.47

2738

15374

Other specified/unspecified arthritis

2030

10733

2.05

171.95

3.5

4.5

240.58

245.71

u/l

0.48

1940

10166

Disorders of calcium metabolism

636

2025

3.93

171.95

5.1

4.3

260.19

247.80

u/l

0.90

603

1924

Diaphragmatic hernia

2796

16360

1.85

171.79

3.8

4.2

238.30

248.12

u/l

3.55

2617

15394

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

486

1310

4.95

171.34

4.5

2.8

224.37

235.85

u/l

1.49

476

1221

Acute myeloid leukaemia and myelodysplastic syndromes

315

625

8.91

170.62

17.1

3.6

324.23

258.85

u/l

1.67

301

585

Other diseases of urinary system

7494

29972

1.46

168.95

3.8

4.2

238.59

242.75

u/l

1.25

7017

28428

Dizziness and giddiness

5423

29868

1.54

168.48

3.7

4.3

241.69

243.35

u/l

0.33

5078

28252

Pre-eclampsia or poor fetal growth

1760

8836

2.12

168.34

3.9

3.8

240.31

231.07

u/l

0.95

1678

8358

Polyneuropathies and other disorders of the peripheral nervous system

1834

9544

2.16

168.05

4.8

4.2

243.48

245.58

u/l

0.20

1741

8983

Fungal Sepsis

450

1180

5.24

166.09

8.7

4.0

262.23

247.60

u/l

0.81

433

1112

Osteoporosis

1999

10190

2.07

166.04

3.9

3.8

243.77

248.72

u/l

1.01

1857

9521

Pain in joint

4145

17445

1.64

165.65

3.5

4.4

236.51

245.38

u/l

2.24

3889

16586

Biguanides

6845

29724

1.48

165.56

3.4

4.5

233.79

246.46

u/l

9.76

6389

28153

Cardiomyopathies, Primary/intrinsic

1056

4437

2.72

164.83

8.9

4.5

261.06

240.41

u/l

3.01

1003

4176

Neurological diseases, wide definition

2132

5486

2.04

164.35

4.3

4.6

236.27

248.88

u/l

1.48

2012

5277

Type 1 diabetes

1888

9872

2.06

163.68

3.4

4.5

237.71

243.57

u/l

1.14

1808

9350

Abnormalities of heart beat

2471

13935

1.87

163.20

3.8

4.1

236.44

242.92

u/l

1.38

2320

13125

Asthma (diagnoses ohter than nonallergic)

6105

36499

1.49

162.33

3.5

4.2

236.24

242.93

u/l

3.76

5778

34483

Convulsions, not elsewhere classified

1562

7562

2.19

161.05

3.7

3.8

241.61

241.63

u/l

0.00

1465

7141

Cardiomyopathy (excluding other)

1077

4624

2.65

160.12

8.8

4.4

260.11

239.54

u/l

3.12

1024

4354

Dermatitis and eczema

7726

36706

1.43

159.99

4.4

4.1

239.45

242.97

u/l

1.05

7326

34710

Exposure to unspecified factor

6795

37593

1.46

159.32

3.7

4.3

238.89

242.92

u/l

1.39

6410

35593

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1265

5608

2.43

158.87

3.4

4.7

255.29

246.59

u/l

0.96

1224

5325

1009

4195

2.69

158.65

6.8

4.3

257.37

240.19

u/l

0.90

964

3958

Mantle cell lymphoma

214

332

22.19

157.65

10.2

4.0

243.58

240.55

u/l

0.13

209

311

Parodontitis and operation codes

6062

33050

1.49

157.54

4.4

4.2

241.16

243.47

u/l

0.52

5714

31309

Pneumocystosis

277

536

9.82

155.90

12.0

4.0

268.80

258.71

u/l

0.25

271

504

Cerebrovascular diseases

5552

27500

1.52

155.80

4.0

4.3

248.98

245.43

u/l

0.82

5209

25981

3031

18320

1.74

155.62

3.6

4.3

232.64

243.45

u/l

4.99

2880

17296

Other cataract

3297

15802

1.72

155.57

4.0

4.4

240.26

247.59

u/l

1.93

3125

14967

Type 1 diabetes, wide definition, subgroup 1

1538

7638

2.18

154.85

3.3

4.5

238.50

242.14

u/l

0.55

1471

7238

Other dorsopathies, not elsewhere classified

7351

27819

1.44

154.40

3.6

4.3

237.19

243.08

u/l

1.88

6884

26419

Soft tissue disorders

7532

28161

1.43

154.40

4.0

4.3

236.59

244.12

u/l

3.30

7091

26671

Later onset COPD, excluding more controls

1710

6856

2.16

153.84

3.0

3.7

238.09

247.88

u/l

1.94

1598

6391

Implicit fungal Sepsis

411

1068

5.30

153.71

8.5

4.1

263.69

247.84

u/l

0.84

398

1007

Other disorders involving the immune mechanism, not elsewhere classified

385

954

5.59

153.26

6.0

4.7

240.62

245.45

u/l

0.28

371

904

Gastric ulcer

1512

7577

2.23

152.75

3.9

4.2

250.18

251.50

u/l

0.05

1419

7122

ILD, hospital admission 2, with pulmonary infections

854

3390

2.97

152.42

4.8

3.7

273.02

245.67

u/l

4.05

811

3166

Other gastritis (incl. Duodenitis)

1804

9591

2.06

152.33

4.0

4.4

235.17

248.13

u/l

3.88

1677

9049

Zoster [herpes zoster]

1443

7145

2.27

151.29

6.6

4.0

247.49

246.51

u/l

0.08

1370

6702

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

182

231

17.36

151.26

8.6

3.0

284.37

240.98

u/l

1.33

175

215

Chronic lower respiratory diseases

8597

34389

1.40

150.97

3.7

4.3

237.70

243.64

u/l

3.07

8131

32550

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

593

1955

3.74

150.82

4.4

3.0

255.48

239.76

u/l

1.49

579

1806

Obesity

4034

26221

1.60

150.63

3.5

4.3

235.45

240.03

u/l

1.24

3801

24902

Other necrotizing vasculopathies

720

2664

3.33

150.41

3.9

4.2

248.04

249.55

u/l

0.08

685

2515

Obesity and other hyperalimentation

4052

26355

1.59

150.33

3.5

4.3

235.63

240.02

u/l

1.15

3817

25028

Other and unspecified polyneuropathies, also in other diseases

1609

8338

2.17

149.81

4.7

4.2

240.12

246.33

u/l

0.89

1526

7840

Lower back pain or/and sciatica

7234

36451

1.43

149.32

3.9

4.2

237.67

242.47

u/l

1.61

6804

34503

Gingivitis and periodontal diseases

6579

24031

1.46

149.21

4.4

3.8

240.35

245.43

u/l

1.79

6196

22718

Volume depletion

826

3269

2.95

147.44

3.4

4.0

236.02

244.38

u/l

1.32

765

3066

Diseases of spleen

266

511

8.51

146.89

7.4

3.8

294.58

239.90

u/l

2.92

259

484

Disorders of thyroid, IBD co-morbidities

1235

4075

2.36

145.83

5.2

4.7

232.17

246.46

u/l

2.14

1164

3909

Major coronary heart disease event

5383

24962

1.52

145.66

4.1

4.4

254.04

243.44

u/l

3.66

5081

23554

Missing teeth due to accident, extraction or parodontitis

979

4212

2.67

145.64

6.3

4.1

240.39

244.19

u/l

0.31

926

3988

Other necrotizing vasculopathies (FG)

603

2053

3.62

145.52

3.2

4.4

247.17

244.29

u/l

0.17

571

1947

Localized swelling, mass and lump of skin and subcutaneous tissue

2272

13122

1.86

144.93

5.3

4.2

234.30

245.14

u/l

2.95

2154

12366

Early onset COPD, excluding more controls

1467

7352

2.17

144.64

3.6

4.0

240.67

242.75

u/l

0.17

1377

6922

Melanocytic naevi

1677

8789

2.03

143.30

5.8

2.8

235.58

233.74

u/l

0.17

1609

8178

Pneumonia due to other infectious organisms, not elsewhere classified

367

917

5.34

143.07

10.8

3.6

268.47

244.69

u/l

1.39

356

871

Gestational [pregnancy-induced] hypertension

1432

7084

2.15

142.82

3.5

3.9

225.23

231.39

u/l

1.32

1365

6697

Other reaction to severe stress, and adjustment disorders

2274

13096

1.83

142.79

5.0

4.2

237.60

236.81

u/l

0.09

2162

12473

Noninfective enteritis and colitis

3218

20334

1.67

142.34

4.1

4.3

233.11

243.50

u/l

4.28

3041

19210

Other diseases of liver

1347

6632

2.26

142.08

3.8

4.5

238.15

240.94

u/l

0.31

1275

6291

Benzodiazepine use

7025

36469

1.42

141.82

3.7

4.2

234.51

243.41

u/l

5.43

6533

34569

Obesity due to excess calories

3015

18815

1.69

141.10

3.4

4.4

235.31

239.88

u/l

1.01

2847

17872

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

591

1999

3.46

140.72

5.6

3.0

245.31

235.34

u/l

1.09

575

1865

Injuries to the head

7643

36786

1.40

139.82

3.7

4.3

238.70

243.27

u/l

1.96

7162

34856

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1169

5504

2.39

139.68

4.6

4.1

244.96

243.83

u/l

0.08

1084

5186

Oesophageal varices

470

1435

4.36

138.95

4.1

243.31

245.37

u/l

0.10

454

1352

Colorectal cancer, excluding all cancers (controls excluding all cancers)

1807

9515

1.98

138.90

3.2

2.7

246.68

242.23

u/l

0.49

1717

8791

Cutaneous abscess, furuncle and carbuncle

1805

9855

1.98

138.46

4.9

4.4

237.13

239.26

u/l

0.27

1723

9355

Vascular disorders of the intestines

668

2473

3.29

138.41

4.3

3.8

250.46

251.85

u/l

0.06

623

2329

Benign neoplasm: Ascending colon

934

4016

2.64

138.18

4.1

2.7

228.09

240.21

u/l

3.23

886

3705

Hypertensive Renal Disease

419

1184

4.61

137.48

2.9

4.1

244.75

246.36

u/l

0.06

405

1103

Myocardial infarction

3894

18492

1.61

137.20

4.2

4.5

252.26

242.71

u/l

2.66

3672

17425

Other benign neoplasms of skin

2178

12312

1.84

136.83

4.2

2.7

239.36

240.22

u/l

0.10

2030

11418

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

351

885

5.45

136.43

6.0

4.6

239.03

246.44

u/l

0.45

339

840

Leukaemia of unspecified cell type

165

209

16.14

136.26

17.5

2.8

397.38

236.79

u/l

2.35

160

196

Other and unspecified aplastic anaemias

198

310

11.80

135.60

11.7

3.7

253.61

241.23

u/l

0.58

188

290

Retention of urine

2693

13962

1.76

135.41

3.7

4.2

244.76

247.10

u/l

0.21

2506

13187

Amputation

930

4070

2.68

135.23

3.6

3.9

254.04

244.88

u/l

0.86

875

3819

Cellulitis

1601

8499

2.06

135.15

4.7

4.5

243.12

240.61

u/l

0.27

1515

8048

Nephrotic syndrome

378

1014

5.05

134.95

4.2

4.5

239.65

256.64

u/l

0.83

367

963

Suppurative and necrotic conditions of lower respiratory tract

575

2004

3.62

134.80

3.5

4.2

225.47

246.78

u/l

2.79

556

1891

Benign neoplasm: Rectum, anus and anal canal

1314

6514

2.21

134.73

4.0

2.7

239.62

240.12

u/l

0.05

1232

6029

SLE (Finngen)

358

910

4.99

134.38

3.7

4.5

245.10

258.47

u/l

0.51

345

861

Weight loss

859

3638

2.77

134.14

3.1

4.2

230.53

250.98

u/l

2.92

803

3424

Statin medication

4599

17450

1.53

133.17

4.3

4.6

242.56

241.80

u/l

0.09

4360

16505

Mycoses

1916

10834

1.92

132.23

5.6

4.2

250.94

240.20

u/l

1.66

1814

10210

Benign neoplasm: Sigmoid colon

1202

5815

2.28

131.86

4.1

2.7

235.19

241.07

u/l

0.65

1146

5376

Episodal and paroxysmal disorders

7952

30349

1.38

131.69

3.9

4.3

236.79

244.51

u/l

3.70

7478

28764

Acute sinusitis

3313

19932

1.62

131.41

5.1

4.1

232.45

240.63

u/l

2.90

3132

18898

Hydronephrosis

913

3983

2.61

131.06

4.3

4.1

250.59

241.78

u/l

0.74

883

3735

Diabetic retinopathy, excluding more controls

1987

6244

1.97

130.87

3.3

3.9

236.06

237.21

u/l

0.17

1888

5848

Intestinal stricture

2304

13783

1.81

130.75

4.0

4.1

234.52

247.74

u/l

4.47

2179

12943

Other specific joint derangements/joint disorders

4848

22478

1.50

130.48

3.6

4.4

236.41

242.41

u/l

1.48

4552

21380

Myocardial infarction, without ST-elevation

3161

18837

1.66

130.43

3.5

4.1

250.75

247.75

u/l

0.46

2961

17680

Type 1 diabetes, wide definition

1575

8367

2.02

130.18

3.3

4.4

237.97

242.80

u/l

0.87

1505

7919

Paralytic ileus and intestinal obstruction

1912

10862

1.90

129.34

3.7

4.1

231.61

251.74

u/l

8.26

1797

10220

Other coagulation defects

619

2264

3.21

128.87

4.4

3.9

235.60

243.60

u/l

0.60

598

2138

Immunodeficiencies

477

1519

3.90

128.73

7.6

4.2

234.19

251.91

u/l

1.44

468

1442

Intracranial trauma

3869

19227

1.56

128.65

3.7

4.5

236.86

243.88

u/l

2.31

3615

18348

Abnormal weight loss

796

3330

2.82

128.26

2.9

4.2

230.74

251.87

u/l

2.73

741

3132

Malignant neoplasm of respiratory system and intrathoracic organs

1809

9352

1.96

128.22

4.2

3.9

253.47

247.68

u/l

0.64

1751

8700

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

408

1181

4.35

127.87

6.1

2.8

279.20

236.47

u/l

1.27

398

1109

Acute upper respiratory infections

7311

34056

1.39

127.67

4.9

3.9

235.91

244.00

u/l

5.17

6913

32177

ILD, hospital admissions 3, with pneumonia sepsis

745

3027

2.92

127.61

4.9

3.8

274.01

246.05

u/l

3.51

709

2829

Vocal cord dysfunction

906

3622

2.51

127.58

3.8

5.2

239.73

245.46

u/l

0.43

854

3472

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

1289

6489

2.18

126.71

3.2

2.6

245.62

243.66

u/l

0.16

1220

5993

Benign neoplasm: Rectum

1170

5702

2.26

126.05

4.1

2.7

237.68

240.57

u/l

0.34

1095

5277

Cardiodefibrillation

2898

18566

1.69

125.73

4.7

4.2

262.71

245.59

u/l

5.43

2746

17523

Peripheral arterial reconstruction

1465

7847

2.10

124.28

3.3

3.9

250.95

248.82

u/l

0.18

1356

7356

Diseases of the eye and adnexa

5624

19976

1.45

123.70

4.4

4.3

240.63

240.89

u/l

0.03

5329

19025

Benign neoplasm: Stomach

699

2769

2.88

123.11

4.6

2.8

234.20

237.96

u/l

0.37

648

2570

Disorders of parathyroid gland

1564

8404

2.02

123.04

3.7

3.9

238.16

248.90

u/l

2.41

1463

7842

Hepatomegaly and splenomegaly, not elsewhere classified

173

259

12.20

123.03

8.4

4.1

255.85

255.57

u/l

0.00

168

250

Protozoal diseases

340

912

5.24

122.86

10.8

4.4

260.83

258.13

u/l

0.09

329

869

Seropositive rheumatoid arthritis

1824

10340

1.89

122.72

2.8

4.3

251.27

246.01

u/l

0.76

1727

9736

Other CVD

1536

8367

2.04

122.09

3.4

3.9

250.49

250.68

u/l

0.01

1416

7812

Substance abuse, excluding more controls

3904

23198

1.54

121.85

3.0

4.6

232.12

244.45

u/l

4.54

3638

22126

Sulfasalazine

1894

10879

1.85

121.24

3.0

4.1

239.16

240.64

u/l

0.21

1792

10250

Major coronary heart disease event excluding revascularizations

4865

23736

1.49

121.10

4.1

4.4

253.58

243.35

u/l

2.97

4578

22383

COPD

3469

19070

1.60

121.03

3.3

4.3

239.50

248.38

u/l

3.19

3250

17957

Other skin changes

1313

6808

2.15

120.86

5.8

4.0

239.80

244.81

u/l

0.73

1246

6402

Other noninfective gastroenteritis and colitis

1721

9690

1.91

119.13

4.7

4.3

236.49

244.19

u/l

1.55

1624

9126

Rheumatoid arthritis, including avohilmo

2685

17029

1.68

119.10

3.0

4.2

247.76

244.36

u/l

0.61

2538

16004

Diseases of the musculoskeletal system and connective tissue

3803

12623

1.56

118.74

4.3

4.4

236.72

247.51

u/l

2.66

3578

12062

Cardiomyopathy, other and unspecified

659

2593

2.94

118.66

7.6

4.4

265.49

236.68

u/l

3.45

626

2438

Other viral diseases

1843

10532

1.85

118.60

6.6

4.3

246.07

238.94

u/l

1.22

1783

9998

Peripheral artery operations in Hilmo

1103

5429

2.29

117.96

3.3

4.0

249.90

244.10

u/l

0.56

1036

5067

Pyothorax

461

1535

3.88

117.87

3.3

4.0

219.97

242.71

u/l

4.41

446

1451

Other symptoms and signs involving the digestive system and abdomen

1156

5733

2.20

117.81

4.6

4.1

234.44

246.98

u/l

2.49

1078

5394

Other and unspecified coagulation defects

430

1350

3.84

117.33

4.5

4.2

235.17

248.95

u/l

0.81

419

1277

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

182

314

12.41

116.56

8.6

4.5

284.37

259.21

u/l

0.41

175

293

Viral hepatitis, IBD co-morbidity

400

1189

3.78

115.17

3.3

5.1

237.28

242.87

u/l

0.26

375

1144

Hypothyroidism, strict autoimmune

4875

22873

1.46

114.77

4.1

243.43

241.58

u/l

0.33

4597

21548

Sequelae of external causes of morbidity and mortality

1822

10597

1.86

114.51

4.4

4.2

242.00

242.87

u/l

0.10

1736

9958

Diseases of pulp and periapical tissues, including avohilmo

7736

30468

1.36

114.29

4.1

235.71

244.17

u/l

5.33

7307

28781

Cystitis

5806

25915

1.42

113.50

3.7

4.1

234.99

242.97

u/l

3.28

5447

24528

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1496

5127

1.98

113.26

3.3

3.5

213.82

221.83

u/l

1.59

1437

4863

Other diseases of intestine

967

4593

2.37

113.06

4.1

4.3

235.28

249.62

u/l

2.43

915

4358

Amputation of toe

674

2783

2.92

113.01

3.3

4.1

255.06

245.66

u/l

0.83

645

2617

Dental pulpitis 4

7735

30512

1.35

112.96

4.1

235.64

244.16

u/l

5.41

7304

28826

Abnormal findings on diagnostic imaging of other body structures

958

4533

2.37

112.87

4.3

4.1

240.04

248.27

u/l

0.77

921

4281

Dental pulpitis 1

7733

30524

1.35

112.58

4.1

235.65

244.13

u/l

5.36

7304

28836

Other obstetric conditions, not elsewhere classified

1524

5273

1.96

112.38

3.3

3.5

214.38

222.20

u/l

1.56

1463

5004

Neurological diseases

6167

22755

1.40

112.36

4.0

4.5

237.21

243.95

u/l

1.88

5807

21697

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

743

3159

2.65

112.27

4.6

2.9

233.90

237.55

u/l

0.24

721

2927

Diagnoses used for exclusion with ILD

1907

11288

1.82

112.26

4.0

4.1

246.01

245.56

u/l

0.04

1796

10614

Other and unspecified acquired haemolytic anaemias

176

303

11.73

112.06

16.2

3.5

436.33

236.08

u/l

8.23

164

287

Obesity related asthma

2239

13798

1.73

111.60

3.4

4.4

238.34

243.80

u/l

1.20

2117

13060

Other respiratory diseases principally affecting the interstitium

1427

7830

2.02

111.28

4.6

4.0

269.42

248.16

u/l

4.50

1353

7344

Melanocytic naevi of trunk

744

3160

2.60

111.04

5.9

2.9

237.98

229.19

u/l

0.58

714

2945

Arthropathies

6255

23441

1.40

110.76

3.9

4.4

232.49

242.96

u/l

5.72

5893

22256

Malignant neoplasm of urinary organs

885

4143

2.49

110.12

4.4

4.2

236.08

244.78

u/l

0.94

860

3898

Systemic lupus erythematosus

358

1051

4.27

109.83

3.7

4.3

245.10

250.54

u/l

0.24

345

1002

Osteonecrosis

533

1980

3.26

109.75

6.6

4.3

240.40

246.16

u/l

0.29

512

1878

Leukaemia of unspecified cell type

165

272

12.12

109.18

17.5

4.2

397.38

239.03

u/l

2.29

160

257

Malignant neoplasm of kidney, except renal pelvis

821

3747

2.57

108.95

4.4

4.2

236.25

245.09

u/l

0.87

800

3522

Angina pectoris

4347

20702

1.49

108.90

3.9

4.5

251.86

242.78

u/l

2.14

4112

19519

Chronic nephritic syndrome

414

1350

3.86

108.37

3.6

4.2

237.17

248.10

u/l

0.75

404

1276

Other chronic obstructive pulmonary disease

3305

18559

1.57

108.33

3.2

4.3

238.57

248.62

u/l

4.04

3088

17471

Other neurological diseases

5065

29618

1.43

107.99

4.0

4.1

241.14

245.54

u/l

1.36

4760

27912

Hypotension

1314

7098

2.06

107.61

3.4

3.8

244.02

248.02

u/l

0.44

1200

6621

Other/unspecified dorsalgia

2528

16051

1.65

107.58

4.0

4.3

233.73

243.21

u/l

3.44

2369

15200

SLE, strict definition

347

1014

4.32

107.47

3.7

4.4

245.43

246.43

u/l

0.04

334

962

SLE, ICD10

347

1014

4.32

107.47

3.7

4.4

245.43

246.43

u/l

0.04

334

962

Visual disturbances and blindness

3391

23091

1.54

107.39

4.1

4.2

240.35

244.49

u/l

0.68

3173

21783

Benign neoplasm: Caecum

723

3109

2.65

107.39

3.9

2.8

229.85

239.43

u/l

1.46

685

2869

Undetermined asthma, excluding more controls

798

3530

2.45

107.35

3.9

3.8

233.45

238.06

u/l

0.39

750

3308

Alcohol use disorder, Swedish definition

3850

24893

1.50

106.92

3.0

4.5

235.08

243.67

u/l

2.20

3601

23617

Clear cell adenocarcinoma of kidney

486

1773

3.54

106.67

4.5

4.2

224.37

250.17

u/l

3.32

476

1680

Dental operations

4914

18027

1.45

105.65

4.3

3.9

241.75

249.87

u/l

2.95

4631

16976

Dorsopathies

7220

27955

1.35

105.30

3.9

4.3

234.12

243.12

u/l

4.65

6779

26552

Hepatic failure, not elsewhere classified

383

1218

4.04

105.21

3.9

4.3

292.71

245.95

u/l

1.79

362

1153

Dysphagia

1728

10127

1.83

104.91

3.6

4.1

237.73

248.71

u/l

1.96

1610

9507

Pericarditis

348

1036

4.14

103.91

3.7

3.9

242.89

241.53

u/l

0.05

336

976

Psychiatric diseases

7766

29935

1.33

102.07

3.7

4.5

235.78

245.61

u/l

6.05

7258

28499

Mental and behavioural disorders due to psychoactive substance use

4037

27005

1.47

101.42

3.0

4.5

232.47

243.07

u/l

3.73

3765

25631

Sleep disorders (combined)

6675

33265

1.36

101.35

3.6

4.4

235.72

244.57

u/l

5.90

6264

31561

4002

26012

1.47

101.34

3.0

4.5

236.21

243.36

u/l

1.63

3752

24669

Candidiasis

965

4758

2.24

101.33

5.6

4.1

243.79

243.33

u/l

0.03

905

4500

Benign neoplasm: Transverse colon

704

3070

2.60

101.17

3.8

2.9

235.60

238.54

u/l

0.26

671

2844

Other or unspecified ileus, impaction or obstruction

1358

7510

1.97

101.02

3.7

4.1

229.89

253.69

u/l

8.61

1274

7063

Need for other prophylactic measures

499

1867

3.20

100.85

4.8

4.3

247.68

248.73

u/l

0.04

488

1773

4170

26632

1.46

100.79

3.0

4.5

235.73

243.30

u/l

1.88

3905

25266

Follow-up examination after treatment for conditions other than malignant neoplasms

2839

12133

1.59

100.69

3.9

3.8

235.05

244.38

u/l

2.87

2681

11529

Thoracic aortic aneurysm

1135

5998

2.14

100.65

3.7

4.5

254.63

243.95

u/l

1.55

1081

5679

All influenza (not pneumonia)

1019

5108

2.16

100.53

5.3

3.9

245.24

237.19

u/l

0.85

970

4811

Disorders of eyelid, lacrimal system and orbit

5682

33318

1.38

100.20

4.3

4.1

239.94

243.91

u/l

1.11

5354

31454

Congenital malformations, deformations and chromosomal abnormalities

3553

23589

1.50

99.98

3.8

4.3

239.06

239.60

u/l

0.08

3403

22358

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

1050

5230

2.13

99.92

4.3

2.8

244.29

242.74

u/l

0.15

1004

4807

Fentanyl

789

3616

2.43

99.91

5.0

3.8

250.32

246.78

u/l

0.22

741

3387

Spinal stenosis

3679

20119

1.50

99.73

3.5

4.3

245.22

247.22

u/l

0.26

3430

19042

Persons with potential health hazards related to communicable diseases

2177

13503

1.67

99.55

4.0

4.2

230.43

235.53

u/l

1.11

2099

12851

Stroke, excluding SAH

4357

23294

1.46

99.08

4.0

4.2

248.26

246.69

u/l

0.27

4083

21945

Stroke, including SAH

4546

24370

1.44

99.02

4.0

4.2

249.60

246.27

u/l

0.66

4263

22975

Sarcoidosis

1000

5057

2.19

98.44

4.7

4.4

241.82

244.45

u/l

0.19

950

4797

Nerve, nerve root and plexus disorders

7206

34895

1.33

98.25

3.7

4.3

240.22

243.06

u/l

0.67

6766

33006

Alcoholic liver disease

827

3929

2.41

98.09

2.4

4.6

253.97

240.95

u/l

0.71

764

3722

ILD, hospital admissions

1185

6398

2.07

97.81

4.5

4.0

269.40

246.21

u/l

4.74

1123

6014

Other chronic obstructive pulmonary disease, including avohilmo

3907

23085

1.48

97.76

3.2

4.3

238.41

247.21

u/l

3.44

3638

21791

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

680

2964

2.60

97.74

5.2

4.1

246.90

248.87

u/l

0.10

652

2803

Myocardial infarction, strict

3488

17645

1.52

97.69

4.2

4.4

252.03

242.88

u/l

2.21

3293

16613

Cholelithiasis, broad definition with cholecystitis

5854

30148

1.37

97.46

4.1

240.31

243.37

u/l

0.74

5509

28431

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

2065

7571

1.74

97.33

4.7

2.7

252.76

241.62

u/l

1.74

1967

7051

Eosinophilic disease (BM)

187

370

7.04

97.02

4.1

3.9

257.46

260.26

u/l

0.03

181

348

Substance abuse

3904

26514

1.46

96.94

3.0

4.5

232.12

242.93

u/l

3.73

3638

25170

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

862

4151

2.31

96.61

4.7

2.5

245.60

247.21

u/l

0.12

814

3795

Falls/tendency to fall

7630

29553

1.33

96.31

3.8

4.4

237.49

243.99

u/l

3.29

7198

28070

Hyperparathyroidism

1329

7334

1.95

96.17

3.5

3.9

236.06

249.30

u/l

2.84

1252

6836

Left ventricular outflow tract obstruction, narrow definition

430

1523

3.38

95.85

3.7

4.8

287.35

256.27

u/l

2.12

414

1451

Other interstitial pulmonary diseases

1194

6506

2.05

95.66

4.5

4.0

269.41

246.22

u/l

4.81

1131

6112

Sequelae with surgical and medical care as external cause

1444

8295

1.90

95.53

4.4

4.2

242.30

244.02

u/l

0.18

1377

7793

Interstitial lung disease

1194

6511

2.04

95.43

4.5

4.0

269.41

246.15

u/l

4.84

1131

6119

Interstitial lung disease endpoints

1194

6511

2.04

95.43

4.5

4.0

269.41

246.15

u/l

4.84

1131

6119

Dental caries 1 and operation codes

6298

24436

1.36

94.87

4.1

239.73

247.24

u/l

3.53

5941

23060

Urticaria and erythema

2228

14237

1.64

94.23

4.9

4.2

243.35

240.23

u/l

0.36

2104

13471

Chronic ulcer of skin, not elsewhere classified

600

2541

2.77

94.11

4.1

3.9

250.38

247.62

u/l

0.14

564

2395

IgA nephropathy (IgA glomerulonephritis)

270

736

4.88

94.02

4.3

4.5

237.06

238.13

u/l

0.05

262

698

Other complications of surgical and medical care, not elsewhere classified

711

3204

2.48

94.00

5.2

4.0

242.59

242.93

u/l

0.02

684

3031

Haemorrhage, not elsewhere classified

352

1129

3.84

93.83

4.1

3.4

285.85

242.78

u/l

3.37

330

1068

Other diseases of hard tissues of teeth

4074

21705

1.45

93.62

5.0

4.0

240.82

244.76

u/l

0.89

3857

20613

Any mental disorder

7874

30762

1.31

93.43

3.6

4.4

235.40

245.65

u/l

6.58

7332

29289

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

388

1312

3.48

92.87

5.7

2.7

302.80

239.03

u/l

3.03

369

1208

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1588

9324

1.79

92.85

3.0

4.4

225.01

235.96

u/l

2.10

1468

8923

Other diseases of anus and rectum

2022

12707

1.69

92.61

4.2

4.1

239.35

249.31

u/l

2.11

1873

11976

Acute peritonitis

564

2340

2.83

92.33

4.1

247.41

244.78

u/l

0.15

550

2220

Osteomyelitis

559

2313

2.84

92.10

3.4

4.2

248.27

248.75

u/l

0.02

532

2194

Anxiety disorders, excluding more controls

5317

26284

1.38

91.89

4.0

4.5

232.20

243.72

u/l

7.07

4986

25075

Osteoporosis with pathological fracture (FG)

546

2231

2.85

91.81

4.0

3.9

256.53

249.12

u/l

0.54

505

2081

Dental caries 3 and operation codes

6509

25496

1.35

91.72

4.1

238.70

246.87

u/l

4.38

6141

24085

External causes of morbidity and mortality

4740

17234

1.42

91.62

4.2

4.3

238.94

244.85

u/l

1.45

4471

16400

Other external causes of accidental injury

5933

22354

1.37

91.44

3.9

4.4

237.28

245.94

u/l

3.53

5567

21272

Sub-endpoint used in defining T1D endpoints

2007

12408

1.68

91.15

3.3

4.2

236.49

242.21

u/l

1.44

1920

11657

Other joint disorders

5839

23383

1.36

91.10

3.6

4.4

235.24

242.70

u/l

2.61

5479

22198

Malignant neoplasm of mesothelium and soft tissue

440

1645

3.33

91.01

4.7

4.0

259.57

243.84

u/l

0.37

430

1555

Visual disturbances

3066

21160

1.52

90.69

4.2

236.87

244.21

u/l

1.96

2882

19976

Undetermined asthma

798

3788

2.28

90.45

3.9

233.45

239.51

u/l

0.58

750

3552

Other infectious diseases

657

2939

2.56

90.01

6.1

4.0

245.77

247.79

u/l

0.10

634

2769

Accidents

5920

22354

1.36

89.89

4.0

4.4

237.94

245.94

u/l

3.03

5550

21272

Dental pulpitis 2

5187

19677

1.39

89.67

4.1

4.0

241.10

249.50

u/l

3.36

4888

18533

Mood disorders, excluding more controls

6330

29499

1.34

89.67

3.6

4.5

231.52

244.26

u/l

10.03

5918

28104

Myelodysplastic syndrome

156

296

9.96

89.66

11.9

3.5

269.38

241.72

u/l

1.83

144

277

Congenital malformations of the urinary system

477

1842

3.01

89.54

3.1

4.6

228.81

254.17

u/l

2.34

472

1752

Myalgia

1443

8372

1.83

89.53

3.3

4.4

230.85

242.00

u/l

2.43

1337

7936

Benign neoplasm: Colon, unspecified

1814

11311

1.73

88.65

3.6

4.2

243.27

246.27

u/l

0.16

1672

10651

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

759

3621

2.37

88.54

10.3

4.2

251.55

245.05

u/l

0.54

713

3416

Coronary revascularization (ANGIO or CABG)

3433

16848

1.50

88.45

3.8

4.4

252.86

243.61

u/l

2.32

3234

15861

Injuries to the abdomen, lower back, lumbar spine and pelvis

2590

17268

1.57

88.10

3.8

4.1

238.51

244.38

u/l

1.53

2409

16225

Phlebitis and thrombophlebitis (not including DVT)

1535

9141

1.80

88.04

5.1

4.2

245.54

243.46

u/l

0.20

1449

8615

Ischaemic Stroke, excluding all haemorrhages

4061

22293

1.44

87.82

3.8

4.2

246.47

247.08

u/l

0.09

3803

20983

Aortic aneurysm

1781

10879

1.74

87.63

3.6

4.2

253.31

247.24

u/l

1.00

1687

10226

Dental caries, including avohilmo

5710

22021

1.37

87.58

4.1

240.42

248.27

u/l

3.41

5382

20768

Dental caries 1

5715

22040

1.37

87.56

4.1

240.46

248.25

u/l

3.37

5386

20788

Non-small cell lung cancer, adenocarcinoma

593

2599

2.73

87.48

4.4

3.9

255.48

247.25

u/l

0.51

579

2435

Non-small cell lung cancer, adenocarcinoma, helper endpoint

593

2599

2.73

87.48

4.4

3.9

255.48

247.25

u/l

0.51

579

2435

Congenital malformations of aortic and mitral valves

372

1287

3.50

86.94

3.6

4.6

283.84

247.55

u/l

3.88

358

1229

Persons encountering health services for specific procedures, not carried out

543

2249

2.71

86.62

3.5

4.2

227.19

230.34

u/l

0.29

511

2121

Polymyalgia rheumatica

1030

5526

2.08

86.56

2.9

3.9

241.15

248.44

u/l

0.84

940

5150

Mixed connective tissue disease

509

2069

2.83

85.94

3.3

4.3

242.23

248.83

u/l

0.43

481

1956

Cholelithiasis

5568

29686

1.36

85.86

4.1

241.24

243.16

u/l

0.37

5238

27986

Concussion

3127

18794

1.49

85.73

3.6

4.6

236.43

243.94

u/l

2.26

2913

17930

Systemic lupus erythematosus, unspecified

291

879

4.14

85.64

3.7

4.3

249.51

245.31

u/l

0.15

279

838

COPD, hospital admission 2, with asthma infections

2380

13483

1.60

85.39

3.3

4.1

238.78

249.08

u/l

2.92

2213

12651

COPD, hospital admissions

3318

19908

1.49

84.61

3.2

4.2

239.09

248.02

u/l

3.01

3096

18755

Benign neoplasm of other and ill-defined parts of digestive system

1268

7279

1.90

84.29

4.4

4.2

232.18

244.98

u/l

3.37

1188

6843

Acute posthaemorrhagic anaemia

324

1052

3.74

84.29

4.2

3.8

260.72

247.90

u/l

0.49

295

985

Coxarthrosis [arthrosis of hip](FG)

3687

19113

1.45

84.11

3.6

4.4

242.19

246.35

u/l

0.98

3447

18055

Congenital malformations of heart and great arteries

874

4291

2.15

83.95

3.6

4.7

273.34

247.49

u/l

3.40

841

4078

Gonarthrosis [arthrosis of knee](FG)

5017

22080

1.38

83.88

3.8

4.4

241.31

245.08

u/l

0.83

4701

20887

Asthma, including avohilmo

7900

36433

1.29

83.86

3.5

4.3

235.80

243.82

u/l

5.43

7458

34464

Carcinoma in situ of skin of other and unspecified parts of face

584

2564

2.61

83.57

4.6

2.3

269.51

243.38

u/l

2.01

555

2339

Sleep apnoea

6062

31747

1.33

83.14

3.7

4.4

237.03

245.09

u/l

4.52

5682

30113

Other embolism and thrombosis

952

5018

2.09

83.01

5.3

4.2

249.97

244.92

u/l

0.44

908

4725

Benign neoplasm of other and unspecified endocrine glands

741

3547

2.27

82.98

3.8

2.9

230.31

234.17

u/l

0.40

691

3297

Other and unspecified drugs and medicaments

630

2859

2.49

82.77

4.9

4.2

246.69

250.01

u/l

0.17

604

2697

COPD, early/later onset

3331

20027

1.48

82.75

3.2

4.2

239.39

247.93

u/l

2.78

3111

18870

Idiopathic gout

755

3711

2.34

82.73

3.5

4.1

240.72

242.37

u/l

0.12

706

3509

Misadventures to patients during surgical and medical care

978

5202

2.06

82.65

4.4

4.1

256.86

242.87

u/l

1.27

936

4912

ILD, hospital admissions 1, main diag only

1043

5713

2.04

82.51

4.6

4.1

270.01

245.55

u/l

4.45

989

5375

Amyloidosis, other/unspecified

210

532

5.61

82.18

6.3

4.5

247.15

244.99

u/l

0.11

205

505

2910

19125

1.52

82.08

4.7

3.8

247.49

248.62

u/l

0.13

2736

17908

Malignant neoplasm of bronchus and lung

1453

8159

1.81

81.43

4.1

3.8

258.06

247.20

u/l

1.26

1403

7580

Budesonide

844

4272

2.13

81.01

4.2

225.66

236.62

u/l

2.02

807

4022

Diseases of the myoneural junction and muscle

898

4694

2.12

80.90

3.1

4.2

263.36

246.99

u/l

2.00

824

4416

Skin changes due to chronic exposure to nonionizing radiation

2764

18165

1.53

80.70

4.7

3.8

248.21

249.16

u/l

0.10

2604

17003

Secondary polycythaemia

250

718

4.55

80.55

2.8

4.0

236.01

249.88

u/l

0.48

231

679

Dental caries 3

5940

23305

1.34

80.54

4.1

238.45

247.77

u/l

5.15

5593

22011

Noninfectious colitis NAS

931

4908

2.06

80.36

4.9

4.3

237.70

245.00

u/l

0.71

884

4640

Other (seronegative) rheumatoid arthritis, wide

1319

7744

1.84

80.16

3.1

4.2

248.63

244.68

u/l

0.55

1236

7275

Seropositive rheumatoid arthritis, wide

1821

11591

1.67

80.05

2.8

4.2

251.32

244.97

u/l

1.10

1725

10872

Charcot foot

199

490

5.53

79.78

3.4

4.6

234.72

233.90

u/l

0.04

189

465

Other intervertebral disc disorders

5522

25840

1.34

79.55

3.8

4.3

238.07

244.42

u/l

1.98

5183

24524

Congenital malformations of the circulatory system

942

4833

2.05

79.54

3.8

4.7

271.39

246.29

u/l

3.60

899

4591

Neurotic, stress-related and somatoform disorders

5470

29770

1.34

79.53

4.0

4.3

231.40

242.04

u/l

6.56

5130

28286

Substance use, excluding alcohol

1200

6834

1.87

79.51

2.9

4.7

226.47

236.82

u/l

1.86

1097

6517

Other specified/unspecified systemic involvement of connective tissue

455

1819

2.88

79.41

3.2

4.3

242.49

249.82

u/l

0.44

434

1721

In situ neoplasms

2385

16118

1.56

79.35

4.6

3.8

247.42

245.01

u/l

0.29

2265

15099

Functional dyspepsia

1653

10272

1.70

79.24

3.8

4.4

229.88

244.88

u/l

5.28

1553

9708

Amyloidosis

235

658

4.80

79.23

5.9

4.5

243.82

244.41

u/l

0.03

228

627

Dental pulpitis 2, only avohilmo

5258

20356

1.36

79.21

4.1

241.11

249.31

u/l

3.32

4954

19184

Other malignant neoplasms of skin (=non-melanoma skin cancer)

3821

22096

1.43

78.82

4.3

3.9

246.10

248.02

u/l

0.32

3605

20697

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1765

11208

1.68

78.42

2.8

4.2

251.72

244.74

u/l

1.22

1672

10519

Actinic keratosis

2697

17811

1.53

78.35

4.7

3.8

248.70

249.31

u/l

0.06

2538

16663

Anxiety disorders

5531

30127

1.33

78.14

4.0

4.3

231.37

242.12

u/l

6.79

5189

28619

Asthma, hospital admissions , main diagnosis only

5283

36324

1.34

78.05

3.5

4.2

237.62

243.04

u/l

2.11

4991

34351

Symptoms and signs involving the nervous and musculoskeletal systems

3723

27258

1.42

78.03

3.5

4.2

238.93

244.44

u/l

1.15

3518

25754

Obesity, other/unspecified

1937

12514

1.62

77.98

3.6

4.3

231.12

238.25

u/l

1.53

1832

11878

Other inflammatory liver diseases

514

2197

2.68

77.85

3.9

4.3

254.02

243.69

u/l

0.67

484

2080

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

464

1893

2.80

77.48

3.7

2.6

257.56

236.69

u/l

0.99

448

1745

Diabetic retinopathy

2447

10477

1.58

77.01

3.2

3.7

239.48

238.06

u/l

0.22

2309

9841

Other/unspecified seropositive rheumatoid arthritis

1787

11431

1.66

76.88

2.8

4.2

251.62

245.16

u/l

1.11

1692

10722

Disorders of the thyroid gland

6340

32469

1.31

76.71

4.4

4.1

241.33

241.42

u/l

0.02

5975

30665

Myocarditis

326

1099

3.32

76.70

5.6

4.8

272.01

235.35

u/l

3.44

314

1035

Depression

6064

32549

1.31

76.61

3.6

4.4

231.11

242.66

u/l

8.20

5684

30921

Benign neoplasm of mouth and pharynx

659

3121

2.31

76.08

4.4

2.9

234.01

234.66

u/l

0.04

612

2912

Non-allergic asthma (mode), excluding more controls

1112

6193

1.88

75.96

3.6

3.8

243.01

243.24

u/l

0.01

1048

5801

Problems related to lifestyle

683

3281

2.27

75.88

3.0

4.6

232.82

236.91

u/l

0.29

639

3106

Methotrexate

939

5043

2.00

75.80

2.7

4.1

244.94

241.53

u/l

0.40

885

4732

COPD related to multimorbidity

2857

16950

1.50

75.69

3.1

4.2

241.15

249.56

u/l

2.27

2659

15943

Coxarthrosis

3424

16711

1.44

75.52

3.7

4.5

242.85

247.40

u/l

1.00

3202

15801

Stomatitis and related lesions

575

2592

2.45

75.45

6.8

4.0

261.58

246.10

u/l

0.64

545

2454

Bicuspidal aortic valve syndrome

323

1121

3.49

75.24

3.5

4.6

282.84

245.92

u/l

3.52

310

1068

Other diseases of the respiratory system

1471

9056

1.75

75.17

3.8

4.0

262.32

248.41

u/l

2.38

1379

8460

Other respiratory disorders and diseases

1471

9056

1.75

75.17

3.8

4.0

262.32

248.41

u/l

2.38

1379

8460

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

818

4219

2.12

75.00

3.7

2.5

232.91

243.66

u/l

1.33

769

3881

Other disorders of lacrimal gland

2126

14182

1.58

74.94

4.6

4.2

241.66

245.17

u/l

0.40

1981

13358

Other diseases of lip and oral mucosa

1060

5948

1.92

74.88

5.4

4.0

245.28

245.70

u/l

0.02

1012

5616

Fitting and adjustment of other devices

2302

14510

1.55

74.53

4.0

3.9

239.92

242.92

u/l

0.47

2132

13514

Disorders of lacrimal system

2600

18095

1.50

73.65

4.4

4.1

241.62

245.48

u/l

0.54

2432

17024

Dentofacial anomalies [including malocclusion]

1513

9224

1.70

73.56

3.9

233.46

240.83

u/l

1.26

1433

8769

Covid-19 suspected case

1194

6946

1.82

73.02

4.7

4.2

240.51

237.75

u/l

0.23

1154

6558

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

254

781

4.04

72.70

3.2

2.7

238.61

241.01

u/l

0.11

248

721

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

1156

6708

1.84

72.38

3.0

2.7

250.09

244.56

u/l

0.50

1099

6191

Disorder of lipoprotein metabolism, unspecified

982

5467

1.96

72.38

3.4

4.3

247.20

246.83

u/l

0.02

918

5144

Basal cell carcinoma

3900

23156

1.40

72.28

4.4

4.0

246.94

247.44

u/l

0.07

3677

21723

Sciatica+with lumbago

3143

21490

1.44

71.96

3.7

4.4

240.75

243.50

u/l

0.32

2981

20402

Inflammatory bowel disease

1945

12820

1.59

71.86

3.6

4.5

226.98

239.90

u/l

4.92

1845

12120

Leiomyoma of uterus

2117

7794

1.58

71.81

4.0

2.7

238.34

234.76

u/l

0.58

1980

7254

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

265

842

3.87

71.80

5.9

3.0

229.16

240.55

u/l

1.05

251

787

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

2036

8691

1.58

71.51

3.9

2.7

262.49

238.07

u/l

5.13

1911

8052

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

2036

8691

1.58

71.50

3.9

2.7

262.42

238.07

u/l

5.11

1911

8052

Diseases of peritoneum

754

3872

2.16

71.43

4.0

4.1

246.53

246.26

u/l

0.02

728

3655

Basal cell carcinoma, including avohilmo

3980

23463

1.39

71.37

4.4

4.0

247.54

247.06

u/l

0.06

3754

22012

Injuries to the thorax

2948

21108

1.46

71.36

4.0

4.2

238.28

244.83

u/l

2.13

2747

19914

Other disorders of ear

6081

31914

1.30

71.05

4.1

4.3

242.31

244.06

u/l

0.41

5718

30193

Amiodarone users

812

4320

2.12

71.00

7.1

4.2

268.80

243.36

u/l

3.83

777

4079

Mood [affective] disorders

6589

34439

1.29

70.80

3.6

4.3

230.61

243.24

u/l

10.83

6169

32691

Secondary right heart disease

377

1473

3.08

70.72

5.7

3.8

286.53

248.86

u/l

2.32

365

1381

DVT of lower extremities

1316

7990

1.77

70.59

4.4

4.1

242.51

245.22

u/l

0.30

1235

7504

Mood disorders

6606

34502

1.29

70.57

3.6

4.3

230.64

243.32

u/l

10.92

6182

32750

Fracture of lumbar spine and pelvis

1464

9118

1.72

70.57

4.0

3.9

243.30

246.11

u/l

0.37

1357

8519

Drug-induced osteoporosis with pathological fracture

188

494

5.46

70.50

4.4

4.0

255.56

253.37

u/l

0.04

174

464

Drug-induced cataract

243

749

4.18

70.31

6.5

4.5

241.52

248.99

u/l

0.26

233

710

Arthropathies in other diseases classified elsewhere

318

1138

3.33

69.79

3.3

4.6

232.05

247.79

u/l

1.27

301

1081

Parodontitis or/and operation codes

4127

18372

1.38

69.33

4.3

4.4

240.31

237.79

u/l

0.54

3883

17432

Insulin, fast-acting (human)

923

5069

1.95

69.20

3.3

4.3

239.45

239.35

u/l

0.01

881

4789

Colectomy operation

1203

7195

1.81

69.19

3.7

4.1

229.39

246.20

u/l

4.40

1140

6763

COPD, hospital admissions 3, with asthma pneumonia sepsis

1990

11323

1.59

69.12

3.3

4.0

239.78

248.22

u/l

1.74

1848

10604

Sleep apnoea, including avohilmo

6285

32356

1.29

68.90

3.7

4.4

236.20

244.71

u/l

5.39

5900

30691

Other metabolic disorders

769

3989

2.07

68.78

8.0

4.2

235.24

239.82

u/l

0.39

733

3787

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

402

1612

2.79

68.63

4.9

3.0

253.81

236.97

u/l

1.58

388

1495

L02BX Other hormone antagonists and related agents

518

2407

2.64

68.45

7.0

4.0

281.12

239.42

u/l

4.22

500

2274

Nonalcoholic fatty liver disease

624

3032

2.28

68.36

3.3

4.5

227.98

243.32

u/l

2.68

593

2878

Acute pancreatitis

1340

8242

1.74

68.20

4.1

4.3

249.79

245.00

u/l

0.30

1252

7750

Polyarthrosis

1303

7608

1.75

68.09

3.5

4.4

239.37

249.11

u/l

2.28

1191

7155

Other pulmonary heart/vessel disease

408

1685

2.87

68.08

5.6

3.9

282.22

248.68

u/l

2.19

394

1579

Eosinophilia

188

502

5.10

67.97

4.8

4.1

258.12

242.98

u/l

0.37

182

477

Emergency coronary revascularization (for ACS)

3978

21530

1.38

67.89

3.7

4.2

252.96

246.78

u/l

1.43

3743

20239

Vitreous haemorrhage

742

3866

2.13

67.77

3.9

4.2

252.69

243.40

u/l

0.73

708

3646

Exclusions for E4_PCOS_BROAD

1057

6096

1.85

67.55

4.1

4.4

244.89

244.19

u/l

0.03

999

5787

Hypothyroidism, other/unspecified

5799

30146

1.30

67.52

4.2

4.0

241.91

241.36

u/l

0.09

5465

28474

Depression or dysthymia

4873

20917

1.34

67.50

3.7

4.7

234.69

248.10

u/l

6.84

4557

19985

Cholangitis (primary sclerosing, PSC), with reimbursement 202

183

475

4.93

67.37

3.3

4.8

225.18

234.99

u/l

0.66

178

458

Irritable bowel syndrome

1603

10263

1.64

67.27

3.4

4.2

228.35

243.33

u/l

4.06

1487

9723

Chronic pancreatitis

894

4954

1.98

67.26

3.2

4.5

233.27

242.34

u/l

0.86

854

4682

Cholangitis (primary sclerosing, PSC)

487

2172

2.56

67.23

3.3

4.1

244.79

243.87

u/l

0.04

467

2057

Abnormal results of function studies

592

2841

2.31

67.07

4.1

4.3

240.95

245.30

u/l

0.28

543

2688

Fracture of rib(s), sternum and thoracic spine

1973

13296

1.57

66.90

4.0

4.2

237.69

244.86

u/l

1.80

1821

12517

Arthrosis

4711

19790

1.34

66.75

3.7

4.5

237.49

245.11

u/l

3.11

4411

18730

Carcinoma in situ of skin

535

2481

2.43

66.74

4.6

2.7

255.46

240.50

u/l

1.13

505

2288

Sicca syndrome [Sjögren]

594

2866

2.30

66.47

3.2

4.2

236.31

247.49

u/l

1.17

568

2700

Injury, poisoning and certain other consequences of external causes

3759

13874

1.39

66.43

4.2

4.3

238.63

245.95

u/l

1.75

3554

13189

Gonarthrosis

4304

18689

1.36

66.04

3.7

4.5

241.13

246.17

u/l

1.20

4026

17694

Open wound of head

3387

24749

1.40

65.28

3.7

4.3

241.23

246.91

u/l

1.44

3162

23424

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

731

3819

2.09

64.99

2.9

2.7

244.41

243.31

u/l

0.07

693

3498

Unspecified acute lower respiratory infection

971

5537

1.88

64.92

5.9

4.3

247.62

241.50

u/l

0.60

933

5222

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2915

21141

1.43

64.76

2.9

4.5

233.26

242.63

u/l

2.22

2726

20071

Mental and behavioural disorders due to alcohol

3314

23874

1.40

64.65

3.0

4.5

234.34

243.14

u/l

2.19

3106

22667

Spondylosis

3462

22090

1.39

64.41

3.6

4.4

238.15

245.87

u/l

2.76

3255

20958

Crohn disease

819

4441

1.98

64.36

3.5

4.5

224.38

239.17

u/l

2.63

781

4212

Other and unspecified myopathies

641

3237

2.22

64.28

2.9

4.0

267.60

245.94

u/l

2.46

585

3044

Seronegative rheumatoid arthritis

779

4168

2.02

64.26

3.4

4.4

249.87

242.98

u/l

0.84

733

3936

Collagenous colitis

623

3107

2.23

64.07

4.6

4.3

231.40

249.58

u/l

2.39

586

2945

Anxiety (asthma-related co-morbidities)

3292

19067

1.40

64.07

3.5

4.5

225.10

240.20

u/l

9.24

3083

18192

Elevated blood glucose level

594

2912

2.27

64.01

3.8

4.2

244.04

245.57

u/l

0.08

556

2758

Viral pneumonia (known virus, not influenza)

238

770

3.94

63.74

7.6

4.3

255.66

260.58

u/l

0.12

225

732

Degeneration of macula and posterior pole

3217

19600

1.41

63.68

3.6

4.1

250.00

247.82

u/l

0.18

2993

18389

Procreative management

1673

9161

1.60

63.68

4.9

4.4

235.82

241.15

u/l

0.75

1593

8716

Hypothyreosis and Thyroxine purchase for inclusion criteria

5958

31293

1.29

63.60

4.2

4.0

241.82

241.38

u/l

0.08

5614

29554

Chronic hepatitis, not elsewhere classified

285

1012

3.35

63.37

3.7

4.6

257.72

246.32

u/l

0.29

278

967

Temporomandibular joint disorders

889

4941

1.90

63.24

3.2

4.4

229.35

242.76

u/l

2.28

829

4700

Adrenocortical insufficiency

295

1069

3.28

63.22

4.6

4.5

264.65

254.62

u/l

0.18

280

1016

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1588

10287

1.61

62.89

3.0

4.3

225.01

233.85

u/l

1.54

1468

9795

Personality disorders, excluding more controls

1364

8522

1.67

62.81

3.0

4.5

224.59

235.28

u/l

2.42

1275

8164

Isolated proteinuria

266

920

3.53

62.68

4.9

4.1

224.72

249.15

u/l

1.70

256

869

Open wound of lower leg

954

5476

1.87

62.62

3.5

4.4

243.62

244.76

u/l

0.10

898

5171

Spondylopathies in diseases classified elsewhere

154

382

5.85

62.39

9.7

4.3

244.66

250.14

u/l

0.20

149

366

Alcohol use disorder, ICD-based

2678

19302

1.44

62.24

2.8

4.5

232.63

241.91

u/l

1.99

2503

18317

Postprocedural endocrine and metabolic disorders, not elsewhere classified

696

3616

2.07

62.00

8.4

4.2

233.40

239.95

u/l

0.58

662

3434

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

277

969

3.26

61.90

3.4

4.6

242.00

240.13

u/l

0.08

266

924

Exclusions for E4_PCOS_CONSORTIUM

4033

19153

1.35

61.81

3.9

4.0

238.12

239.99

u/l

0.33

3773

18104

Coronary artery bypass grafting

2111

11118

1.53

61.28

3.4

4.3

256.38

244.05

u/l

3.04

1993

10424

Poisoning by drugs, medicaments and biological substances

1324

8290

1.67

60.97

2.7

4.4

232.19

236.26

u/l

0.35

1231

7883

Urticaria

1670

11037

1.58

60.71

4.9

4.2

241.33

239.39

u/l

0.17

1581

10447

Other disorders of adrenal gland

341

1354

2.90

60.59

4.6

4.4

259.25

255.00

u/l

0.08

325

1286

Acute pancreatitis (for exclusion)

1340

8488

1.68

60.59

4.1

4.2

249.79

242.97

u/l

0.48

1252

8008

Special screening examination for other diseases and disorders

547

2628

2.25

60.48

3.8

4.0

241.11

250.09

u/l

0.60

532

2493

Non-allergic asthma (mode)

1112

6623

1.75

60.01

3.6

3.9

243.01

245.45

u/l

0.17

1048

6214

COPD-related respiratory insufficiency

892

5126

1.92

59.98

3.1

4.1

243.99

247.56

u/l

0.38

833

4812

Abnormal findings on examination of urine, without diagnosis

363

1501

2.82

59.85

4.8

4.2

225.59

248.10

u/l

2.69

348

1421

Herpesviral [herpes simplex] infections

739

3984

2.01

59.62

6.4

4.1

244.67

245.43

u/l

0.04

698

3761

Chronic tubulo-interstitial nephritis

299

1118

3.08

59.55

3.4

4.1

229.43

249.67

u/l

1.22

289

1045

Transient ischemic attack

3541

22202

1.37

59.46

4.0

4.1

243.41

247.05

u/l

0.85

3333

20881

Osteonecrosis due to drugs

160

428

5.54

59.25

11.6

4.1

251.72

243.72

u/l

0.16

152

404

Migraine

2574

15681

1.44

59.12

3.9

4.3

228.20

238.79

u/l

3.73

2435

14917

Disorders of skin appendages

2733

19884

1.42

59.03

4.7

4.2

234.95

239.46

u/l

0.95

2582

18853

Decubitus ulcer and pressure area

459

2114

2.48

59.03

4.2

3.7

240.35

249.67

u/l

0.62

424

1981

Disturbances of skin sensation

1525

9950

1.60

58.99

3.8

4.1

227.77

238.06

u/l

2.33

1431

9414

Invasive ventilation

542

2658

2.29

58.89

3.9

4.2

254.43

251.05

u/l

0.18

518

2517

All anxiety disorders

3339

20063

1.37

58.80

3.5

4.3

224.70

239.19

u/l

8.77

3126

19133

Gout due to impairment of renal function

144

361

6.18

58.60

3.7

4.3

244.99

241.44

u/l

0.14

137

343

Unspecified fall

3041

22405

1.39

58.35

3.5

4.2

240.31

245.96

u/l

1.44

2832

21127

Subjective visual disturbances

1485

9692

1.62

58.22

3.9

4.2

235.00

241.29

u/l

0.82

1398

9136

Benign neoplasm: Ascending colon

934

5487

1.87

58.16

4.1

4.2

228.09

244.08

u/l

4.53

886

5170

Abnormalities of gait and mobility

862

4947

1.91

58.12

2.8

4.1

238.80

246.46

u/l

0.72

805

4645

Allergic asthma (mode), excluding more controls

1139

6791

1.70

57.87

3.2

3.7

226.97

232.55

u/l

0.91

1087

6416

Malignant neoplasm of digestive organs

2605

18688

1.44

57.63

3.5

4.0

249.73

249.19

u/l

0.05

2477

17500

Vitamin B12 deficiency anaemia

752

4136

1.98

57.45

3.8

3.9

262.81

251.00

u/l

0.51

706

3876

Other diseases of arteries and capillaries

639

3341

2.11

57.38

3.7

4.1

244.96

244.93

u/l

0.00

608

3145

Poisoning by medicine

1190

7371

1.69

57.36

2.7

4.4

232.69

236.78

u/l

0.32

1109

7020

Other disorders of glucose regulation and pancreatic internal secretion

582

2946

2.17

57.07

3.2

4.1

245.73

246.82

u/l

0.05

548

2787

Asthma/COPD (KELA code 203)

6025

34276

1.27

57.02

3.3

4.3

237.41

243.36

u/l

2.48

5686

32440

malignant neoplasm of male genital organs

3080

14549

1.41

56.67

4.7

4.2

250.90

244.13

u/l

1.06

2917

13754

Other anxiety disorders

2379

15039

1.44

56.54

3.4

4.2

225.66

236.93

u/l

3.99

2231

14326

Diseases of salivary glands

1144

7059

1.71

56.53

4.1

3.9

238.06

245.40

u/l

0.79

1074

6653

Benign neoplasm: Stomach

699

3796

2.04

56.51

4.6

4.2

234.20

249.80

u/l

2.29

648

3575

Other local infections of skin and subcutaneous tissue

681

3657

2.03

56.15

4.4

4.2

245.64

243.42

u/l

0.11

659

3455

Complications of internal orthopaedic prosthetic devices, implants and grafts

1478

9746

1.61

56.06

3.4

3.9

243.73

246.87

u/l

0.40

1363

9137

Other and unspecified local infections of skin and subcutaneous tissue

645

3409

2.07

55.91

4.4

4.2

246.83

244.05

u/l

0.14

627

3224

Dental operations, only avohilmo

4985

20123

1.30

55.56

3.9

4.3

240.57

249.54

u/l

3.84

4687

18995

Anosmia

121

250

5.31

55.49

4.0

2.7

235.29

228.51

u/l

0.32

116

236

Artificial opening status

410

1852

2.54

55.29

3.7

4.0

241.95

250.67

u/l

0.37

394

1750

Respiratory insufficiency

535

2649

2.21

55.14

3.2

3.6

264.83

246.29

u/l

1.59

495

2476

Benign neoplasm: Adrenal gland

436

2001

2.41

55.13

3.6

3.1

236.55

234.80

u/l

0.10

407

1874

Diabetes mellitus in pregnancy

1349

5511

1.64

55.13

3.3

3.8

223.17

227.69

u/l

0.58

1284

5245

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1935

13454

1.50

55.09

4.6

4.2

237.50

243.26

u/l

0.95

1826

12706

Diabetic retinopathy, strict definition

1242

6966

1.70

54.78

3.4

3.8

239.80

236.62

u/l

0.50

1174

6547

Dental pulpitis 4, only avohilmo

7432

32002

1.24

54.59

3.8

4.2

235.35

244.32

u/l

5.85

7016

30259

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

407

1825

2.48

54.59

3.9

2.6

231.64

237.68

u/l

0.46

384

1685

Unspecified privation

721

3980

1.97

54.42

4.0

4.3

236.83

246.08

u/l

1.04

682

3768

Hypothyroidism, strict autoimmune, 3 medication purchases required

5275

28768

1.28

54.35

4.1

4.0

244.05

241.59

u/l

0.53

4973

27149

Other/unspecified rheumatoid arthritis

850

4933

1.87

54.32

3.0

4.0

249.34

247.56

u/l

0.16

792

4621

Benign lipomatous neoplasm

1449

9509

1.59

54.28

4.3

2.7

239.93

238.44

u/l

0.13

1355

8842

Melanocytic naevi, other sites/unspecified

434

1991

2.37

54.21

6.3

3.1

231.23

229.67

u/l

0.07

424

1862

Diseases of the ear and mastoid process

7661

32061

1.23

54.14

4.1

4.2

239.92

242.23

u/l

0.55

7195

30422

Conductive and sensorineural hearing loss

5214

28904

1.28

53.99

4.0

4.3

243.47

244.79

u/l

0.26

4868

27308

Other viral hepatitis

392

1731

2.49

53.97

3.3

4.5

239.30

235.66

u/l

0.18

370

1650

Shoulder lesions

4994

24292

1.29

53.67

3.8

4.4

238.09

245.35

u/l

2.56

4714

22987

Erosion of teeth

153

410

4.66

53.63

6.5

4.5

241.69

236.38

u/l

0.21

147

396

Disorders of sclera, cornea, iris and ciliary body

3262

24780

1.36

53.53

4.1

4.2

241.69

242.25

u/l

0.06

3106

23430

Folate deficiency anaemia

113

248

6.81

53.38

4.5

4.8

285.93

243.85

u/l

0.82

107

234

Injuries to the hip and thigh

2991

20543

1.38

53.29

3.7

4.1

244.25

245.75

u/l

0.22

2757

19299

Intestinal adhesions without obstruction

578

2997

2.12

53.22

3.8

4.0

230.05

250.68

u/l

2.82

549

2835

Biological medication for rheuma

867

5053

1.82

53.14

2.7

4.6

225.94

239.53

u/l

3.17

826

4807

Other and unspecified effects of external causes

1519

10133

1.56

52.95

3.6

4.4

228.09

238.92

u/l

2.83

1430

9605

Dental caries 1, only avohilmo

5638

23180

1.27

52.92

3.9

4.3

239.39

248.59

u/l

4.61

5311

21884

Viral hepatitis

455

2156

2.31

52.75

3.5

4.5

238.12

240.88

u/l

0.13

429

2052

Viral and other specified intestinal infections

1117

6780

1.67

52.41

4.7

4.0

229.83

238.55

u/l

1.41

1063

6431

Hernia of abdominal wall

2880

21602

1.38

52.37

3.9

4.3

242.03

243.98

u/l

0.25

2723

20419

Other viral diseases, not elsewhere classified

1055

6484

1.71

52.29

5.6

4.5

243.43

242.64

u/l

0.06

1014

6144

Exposure to other specified factors

4405

32655

1.30

52.29

4.0

4.3

235.46

242.66

u/l

2.55

4128

31006

Other symptoms and signs involving cognitive functions and awareness

2851

20041

1.38

51.65

3.2

4.1

242.25

247.26

u/l

0.77

2614

18902

Paracetamol of NSAID medication

1193

3691

1.68

51.27

4.0

4.6

241.95

251.94

u/l

0.94

1125

3553

Melanocytic naevi of trunk

744

4220

1.90

51.08

5.9

4.2

237.98

242.08

u/l

0.21

714

3990

Cardiac arrest

427

1701

2.36

51.05

4.7

4.5

273.06

240.52

u/l

3.96

400

1601

Melanocytic naevi

1677

11518

1.52

50.91

5.8

4.1

235.58

239.30

u/l

0.40

1609

10880

Pruritus

673

3705

1.96

50.81

4.3

4.1

246.30

245.12

u/l

0.08

630

3505

Early onset COPD

1467

9874

1.57

50.39

3.6

4.6

240.67

245.08

u/l

0.45

1377

9357

Superficial injury of head

1352

8918

1.59

50.16

3.1

4.4

236.95

244.79

u/l

1.32

1257

8385

Donors of organs and tissues

126

307

5.14

50.12

15.6

4.4

214.84

233.04

u/l

1.33

121

292

Mesothelioma, excluding all cancers (controls excluding all cancers)

144

395

4.89

50.11

3.1

2.7

208.67

243.42

u/l

7.38

144

367

Sensorineural hearing loss

4964

27911

1.28

50.08

3.8

4.3

243.89

245.28

u/l

0.26

4628

26357

Pneumothorax

502

2535

2.19

50.03

4.1

4.0

244.43

243.02

u/l

0.08

479

2379

Ventral hernia

1513

10249

1.55

50.03

4.1

4.2

241.25

246.38

u/l

0.50

1428

9636

Other abnormalities of plasma proteins

160

473

4.48

49.96

7.0

4.2

237.55

243.78

u/l

0.29

153

447

Malignant neoplasm of other connective and soft tissue

223

799

3.46

49.95

5.8

4.2

298.21

248.12

u/l

0.71

218

751

Spondyloarthritis

1095

6895

1.67

49.81

3.2

4.3

227.93

240.47

u/l

3.09

1028

6508

Fibromyalgia

485

2397

2.17

49.79

2.4

4.3

211.80

243.08

u/l

8.10

450

2281

Intracranial injury

3549

26614

1.32

49.34

3.6

4.2

237.91

244.94

u/l

2.43

3299

25154

Papulosquamous disorders

2368

17387

1.41

49.31

3.6

4.3

238.44

244.01

u/l

1.07

2229

16430

Polyuria

1451

9789

1.57

49.29

3.6

4.2

231.32

245.62

u/l

3.69

1339

9252

Benign neoplasm: Skin of eyelid, including canthus

793

4608

1.83

49.28

4.1

2.8

238.28

239.54

u/l

0.12

743

4262

Ulcerative colitis

1442

9673

1.56

49.23

3.6

4.4

227.11

238.94

u/l

3.45

1362

9169

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

367

1629

2.41

49.02

3.4

4.2

216.08

234.95

u/l

2.22

349

1552

Benign neoplasm of major salivary glands

541

2804

2.08

48.93

4.0

2.9

238.04

235.05

u/l

0.22

514

2607

Dental caries 3, only avohilmo

5848

24350

1.26

48.84

3.9

4.3

237.66

247.97

u/l

6.32

5504

23014

Dermatitis due to substances taken internally

385

1770

2.42

48.83

6.0

4.0

254.42

248.06

u/l

0.32

360

1674

Viral warts

603

3247

2.00

48.75

5.0

4.3

231.20

243.80

u/l

1.72

579

3070

Malignant neoplasm of eye, brain and central nervous system

328

1420

2.64

48.66

5.4

4.2

249.87

246.29

u/l

0.14

318

1343

Injuries to the knee and lower leg

7591

36387

1.22

48.25

3.7

4.3

236.98

243.13

u/l

3.46

7170

34439

Opening and dilatation of root channel of tooth

410

1937

2.33

48.23

4.7

4.4

234.16

244.19

u/l

0.53

380

1843

Dental pulpitis 1, only avohilmo

7385

32176

1.22

48.11

3.7

4.3

235.53

244.19

u/l

5.42

6971

30426

Epilepsy

1893

13392

1.46

48.06

4.2

4.3

245.38

247.39

u/l

0.14

1781

12659

Pneumonia derived septicemia

277

1120

2.88

47.92

4.4

4.2

248.14

256.11

u/l

0.26

264

1052

Operations for atrial fibrillation

175

570

4.19

47.79

3.1

4.4

273.01

247.65

u/l

0.94

167

539

5-aminosalicylic acid

1136

7268

1.63

47.74

3.6

4.3

225.95

235.27

u/l

2.21

1076

6879

Other headache syndromes

2361

17371

1.40

47.68

3.4

4.3

228.35

242.26

u/l

6.13

2206

16467

Other general symptoms and signs

299

1220

2.66

47.67

3.1

3.8

266.44

253.39

u/l

0.26

291

1155

Allergic asthma (mode)

1139

7129

1.62

47.61

3.2

3.8

226.97

234.59

u/l

1.47

1087

6738

Polycystic ovarian syndrome, consortium definition

3721

17424

1.32

47.52

3.5

3.9

235.61

239.65

u/l

0.97

3481

16438

Other diseases of stomach and duodenum

450

2232

2.24

47.20

3.3

4.3

224.74

251.94

u/l

4.72

427

2116

Personal history of other diseases and conditions

569

3009

1.99

47.02

5.6

3.7

265.01

238.61

u/l

0.92

530

2850

Myositis

225

830

3.23

46.96

3.7

4.6

266.42

240.20

u/l

2.53

219

791

Soft tissue disorders related to use, overuse and pressure

1611

11175

1.51

46.71

3.7

4.5

244.87

246.12

u/l

0.07

1502

10567

Other disorders of veins

2247

16483

1.41

46.67

3.5

4.1

243.76

243.05

u/l

0.09

2094

15540

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

172

547

3.82

46.55

5.6

2.7

237.09

238.21

u/l

0.04

166

515

Malignant neoplasm of head and neck

602

3322

2.00

46.50

4.7

4.2

232.68

245.98

u/l

0.99

582

3133

Wegener granulomatosis

158

482

4.18

46.46

3.5

4.4

257.59

245.35

u/l

0.35

150

458

Other diseases of biliary tract

593

3253

2.00

46.26

4.0

4.1

270.26

251.31

u/l

0.63

563

3059

Benign neoplasm: Caecum

723

4225

1.88

46.20

3.9

4.2

229.85

245.87

u/l

2.92

685

3974

Pyogenic arthritis

466

2356

2.17

46.01

3.5

4.5

239.74

245.54

u/l

0.34

440

2238

Chronic viral hepatitis

326

1427

2.51

45.90

3.2

4.4

233.39

230.67

u/l

0.12

305

1355

Acute generalized exanthematous pustulosis

325

1435

2.57

45.88

6.4

4.1

245.77

248.01

u/l

0.10

304

1355

Acidosis

186

631

3.67

45.86

2.9

4.6

260.60

238.90

u/l

0.49

174

603

Benign neoplasm: Descending colon

405

1953

2.30

45.55

3.9

3.0

233.53

237.41

u/l

0.27

384

1813

Selective serotonin reuptake inhibitors

6691

29269

1.23

45.51

3.5

4.5

236.29

245.05

u/l

4.00

6251

27822

Benign neoplasm of eye and adnexa

532

2811

2.04

45.45

4.5

3.0

231.62

236.81

u/l

0.50

506

2602

Benign neoplasm: Sigmoid colon

1202

7955

1.61

45.38

4.1

4.2

235.19

245.11

u/l

1.33

1146

7481

Benign neoplasm: Rectum, anus and anal canal

1314

8855

1.58

45.37

4.0

4.2

239.62

247.00

u/l

1.10

1232

8326

Adverse effects, not elsewhere classified

1083

6953

1.63

45.36

3.8

4.4

225.99

242.30

u/l

4.50

1025

6573

Disorders of magnesium metabolism

213

7.00

45.24

3.4

4.6

248.50

249.37

u/l

0.02

201

Carcinoma in situ of skin of trunk

228

865

3.13

45.13

5.0

2.6

240.65

241.77

u/l

0.06

219

793

Migraine with aura

1187

7769

1.58

44.81

3.6

4.2

231.19

238.36

u/l

0.97

1130

7381

Other symptoms and signs involving the circulatory and respiratory systems

421

2068

2.22

44.66

3.3

4.2

249.39

245.54

u/l

0.14

388

1957

Hypoglycaemia, other or unspecified

452

2292

2.16

44.24

3.4

4.2

244.47

248.87

u/l

0.20

425

2175

Malignant neoplasm of small intestine

204

747

3.41

44.24

6.1

4.1

229.84

258.78

u/l

1.50

192

702

Nonischemic cardiomyopathy

408

2005

2.28

44.15

10.0

4.6

261.40

237.55

u/l

1.55

389

1900

Recurrent or chronic depression

2237

11839

1.40

43.95

3.4

5.0

224.88

244.55

u/l

9.66

2101

11374

Disorders of muscles

633

3578

1.90

43.86

3.9

4.6

243.58

242.20

u/l

0.10

606

3394

Giant cell arteritis

331

1519

2.54

43.69

2.9

3.9

236.63

251.13

u/l

0.79

307

1423

Disorders of tooth development and eruption

290

1191

2.57

43.65

6.4

4.1

252.95

254.98

u/l

0.05

273

1133

Benign neoplasm: Rectum

1170

7769

1.61

43.59

4.1

4.2

237.68

246.83

u/l

1.43

1095

7325

Other arthrosis

3215

17822

1.33

43.56

3.5

4.5

240.81

245.86

u/l

1.02

3015

16901

Vascular diseases of the intestine

299

1311

2.63

43.40

4.0

3.9

265.05

249.56

u/l

0.54

282

1229

Other and unspecified disorders of skin and subcutaneous tissue

445

2270

2.17

43.17

4.9

4.1

237.86

250.02

u/l

0.78

406

2139

L02BB Anti-androgens

711

4226

1.86

43.14

6.3

3.8

274.87

243.21

u/l

3.06

679

3953

Seropositive rheumatoid arthritis, strict definition

923

5802

1.69

43.11

2.8

4.3

252.14

243.88

u/l

0.87

873

5476

Other diseases of jaws

435

2193

2.16

42.93

5.8

4.0

233.38

246.45

u/l

0.96

407

2082

Vasculitis limited to skin, not elsewhere classified

212

796

3.17

42.86

4.3

4.0

241.07

252.87

u/l

0.42

203

750

Excessive, frequent and irregular menstruation

2144

8654

1.42

42.78

3.5

3.9

234.10

241.33

u/l

0.84

2001

8152

Mental and behavioural disorders due to opioids

233

903

2.86

42.64

2.5

4.6

232.26

232.42

u/l

0.00

218

860

Ulcerative colitis, NAS

817

4986

1.73

42.51

3.9

4.5

224.18

240.60

u/l

3.73

771

4728

Other diseases of pancreas

519

2809

2.04

42.48

3.8

4.3

236.24

246.83

u/l

0.84

486

2657

Intestinal malabsorption

317

1430

2.49

42.41

3.3

4.2

216.45

249.09

u/l

3.84

303

1352

Duodenal ulcer

752

4518

1.79

42.38

3.2

4.3

241.04

249.59

u/l

0.58

705

4265

Delirium, not induced by alcohol and other psychoactive substances

773

4684

1.78

42.34

3.0

3.8

250.09

247.81

u/l

0.17

699

4398

Disorders of oesophagus in diseases classified elsewhere

186

660

3.46

42.30

4.8

4.2

253.51

256.97

u/l

0.09

176

621

6-mercaptopurine

195

693

3.15

42.22

7.4

4.0

240.17

236.53

u/l

0.12

190

663

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1392

9581

1.52

42.22

3.0

4.8

231.16

246.17

u/l

3.11

1293

9138

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1742

12477

1.45

42.07

3.7

4.3

239.86

242.71

u/l

0.35

1626

11780

Supervision of high-risk pregnancy

853

3092

1.72

42.03

3.4

3.8

228.86

226.89

u/l

0.09

808

2938

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

319

1442

2.45

42.02

4.3

2.5

222.74

242.27

u/l

2.90

309

1322

Complications of cardiac and vascular prosthetic devices, implants and grafts

189

681

3.41

41.89

4.4

3.9

257.28

242.90

u/l

0.90

183

638

Coronary angioplasty

2570

14994

1.37

41.88

4.0

4.4

252.60

244.08

u/l

1.37

2411

14096

Carcinoma in situ of skin of other and unspecified parts of face

584

3311

1.97

41.88

4.6

3.6

269.51

247.97

u/l

1.41

555

3078

1958

12707

1.43

41.83

3.3

3.8

246.56

250.09

u/l

0.45

1803

11854

Other disorders of gingiva or/and edentulous alveolar ridge

337

1566

2.39

41.72

5.7

3.8

248.54

246.70

u/l

0.07

323

1482

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

1050

6534

1.61

41.60

4.2

2.8

250.67

241.17

u/l

1.29

977

6026

Other problems related to primary support group, including family circumstances

582

3154

1.90

41.56

5.9

4.3

268.02

241.58

u/l

1.02

561

3003

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

430

2177

2.12

41.44

5.4

3.0

236.19

233.33

u/l

0.19

408

2036

Non-selective monoamine reuptake inhibitors

2347

17126

1.37

41.33

3.1

4.5

236.21

247.65

u/l

3.03

2167

16224

Drug-induced adrenocortical insufficiency

156

506

3.82

41.32

5.6

4.3

293.30

242.54

u/l

0.70

149

482

Other and unspecified urticaria

1071

7005

1.60

41.31

4.7

4.2

246.55

242.25

u/l

0.28

1014

6623

Other and unspecified vasculitis limited to skin

198

734

3.23

41.16

4.4

4.0

243.03

256.16

u/l

0.44

191

689

Benign neoplasm: Transverse colon

704

4217

1.83

41.11

3.8

4.2

235.60

244.76

u/l

1.08

671

3980

Psoriasis

1652

11790

1.46

40.96

3.5

4.4

239.97

242.89

u/l

0.31

1559

11137

Carcinoma in situ of skin of scalp and neck

189

689

3.34

40.86

5.5

2.6

238.84

243.34

u/l

0.25

182

636

Seborrhoeic keratosis

1378

9563

1.52

40.64

4.8

4.0

239.54

248.31

u/l

1.09

1311

8988

Generalized skin eruption due to drugs and medicaments

284

1248

2.58

40.63

6.6

4.2

247.86

250.97

u/l

0.12

265

1175

Carcinoma in situ of skin of ear and external auricular canal

130

382

4.38

40.61

4.1

2.5

241.07

240.19

u/l

0.03

122

354

Disorders of continuity of bone

544

3005

1.94

40.61

4.5

4.4

237.65

244.50

u/l

0.63

506

2856

Cholecystectomy

4276

30669

1.26

40.58

4.2

4.1

239.89

243.94

u/l

0.87

4044

28888

Carcinoma in situ of skin of upper limb, including shoulder

177

623

3.44

40.57

4.8

2.7

260.60

241.83

u/l

0.82

169

578

Portal vein thrombosis

147

467

3.97

40.55

5.4

4.5

283.28

258.56

u/l

0.42

142

440

Pneumococcal septicemia

260

1106

2.72

40.44

4.3

4.1

244.74

256.59

u/l

0.43

247

1039

Other or ill-defined heart diseases

322

1481

2.37

40.21

5.5

4.0

251.75

236.70

u/l

0.81

301

1393

Sequelae of cerebrovascular disease

2303

15248

1.38

40.15

3.9

4.0

245.24

249.18

u/l

0.69

2131

14318

Amputation of foot

229

935

2.99

40.04

2.9

4.1

244.55

247.73

u/l

0.16

215

879

Personal history of malignant neoplasm

255

1073

2.69

40.03

5.1

3.9

241.02

247.85

u/l

0.27

239

1013

Squamous cell neoplasms and carcinomas of the skin

862

5465

1.70

39.87

4.7

3.7

245.60

247.49

u/l

0.15

814

5078

Unknown and unspecified causes of morbidity

421

2147

2.10

39.74

4.9

3.6

241.81

238.52

u/l

0.24

407

2027

Follow-up examination after treatment for malignant neoplasms

640

3738

1.83

39.58

4.2

3.8

242.20

251.93

u/l

0.69

609

3513

Somatoform disorder

904

5754

1.65

39.44

3.5

4.3

229.34

242.65

u/l

2.15

821

5460

Mental and behavioural disorders due to tobacco

524

2900

1.96

39.38

2.7

4.6

225.09

245.24

u/l

3.01

474

2760

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

849

5317

1.67

39.30

2.9

4.5

230.32

234.12

u/l

0.26

788

5040

Heart failure and hypertrophic cardiomyopathy

171

609

3.56

39.26

11.7

4.0

266.21

246.64

u/l

0.92

163

571

Injuries to the ankle and foot

3800

27791

1.27

39.26

4.0

4.3

235.00

240.30

u/l

1.63

3600

26388

Other Crohn's disease

409

2080

2.12

39.23

3.4

4.5

223.00

241.07

u/l

1.62

393

1978

Personality disorders

1364

9451

1.49

39.11

3.0

4.4

224.59

233.57

u/l

1.86

1275

9002

Melanoma in situ

267

1163

2.61

39.09

5.4

2.8

242.25

236.95

u/l

0.22

253

1079

Rheumatism, unspecified

799

4956

1.70

39.02

3.2

4.4

237.44

246.28

u/l

0.96

754

4695

Smoking dependency

524

2911

1.95

38.91

2.7

4.5

225.09

245.54

u/l

3.08

474

2770

Cerebral palsy and other paralytic syndromes

686

4105

1.78

38.85

4.1

4.2

263.48

246.06

u/l

0.55

644

3866

Primary biliary cholangitis (PBC)

170

595

3.37

38.84

2.9

3.9

235.38

252.65

u/l

0.55

161

559

Lumbar disc prolapse

3796

24222

1.27

38.81

3.9

4.4

238.71

244.00

u/l

1.12

3600

23034

Other diseases of upper respiratory tract

7371

32696

1.19

38.63

4.0

4.2

239.36

244.63

u/l

1.84

6933

30934

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

284

1270

2.49

38.54

4.0

2.8

236.88

232.60

u/l

0.12

276

1191

Diseases of male genital organs

3531

14123

1.30

38.47

4.2

4.8

238.09

248.01

u/l

2.84

3366

13464

Crohn's disease of small intestine

416

2149

2.10

38.32

3.6

4.4

218.36

241.97

u/l

2.61

402

2051

Maternal care for other known or suspected fetal problems

955

3883

1.63

38.22

3.4

3.7

219.75

223.11

u/l

0.35

910

3707

Recurring oral aphthae, including avohilmo

796

4970

1.70

38.19

5.7

4.2

252.19

246.44

u/l

0.27

759

4691

Injuries to the shoulder and upper arm

5132

35741

1.23

38.10

3.9

4.3

237.79

244.71

u/l

3.44

4809

33825

Unspecified jaundice

363

1804

2.23

38.01

3.6

4.1

256.74

246.36

u/l

0.59

345

1706

Benign neoplasm: Small intestine

261

1138

2.59

37.98

4.3

3.2

231.37

238.38

u/l

0.65

245

1062

Other specified/unspecified bacterial intestinal infections

430

2267

2.08

37.91

4.1

4.4

239.70

251.66

u/l

0.62

395

2150

Recurring oral aphthae

318

1506

2.36

37.85

8.5

4.0

265.00

245.34

u/l

0.47

307

1422

Suicide or other Intentional self-harm

1285

8871

1.50

37.78

3.0

4.5

231.01

236.70

u/l

0.62

1180

8437

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

498

2754

1.97

37.75

4.0

4.1

253.07

248.47

u/l

0.16

473

2600

Spondylopathies (FG)

754

4638

1.71

37.74

2.8

4.7

225.31

235.23

u/l

1.64

701

4417

Filling of root of tooth

225

922

2.80

37.70

5.5

4.3

228.00

250.11

u/l

1.43

211

881

Hypoparathyroidism

266

1180

2.58

37.60

4.8

4.2

249.31

253.27

u/l

0.16

239

1103

Thyroiditis, ILD-related definition

624

3662

1.80

37.58

4.0

4.2

229.75

243.42

u/l

1.79

595

3457

Abnormal serum enzyme levels

2019

14954

1.39

37.56

4.4

4.2

259.19

244.34

u/l

2.19

1940

14150

Other disorders of bone

1082

7241

1.56

37.48

4.5

233.30

240.10

u/l

1.12

1028

6868

Crohn's disease NAS

397

2038

2.11

37.27

3.7

4.5

226.56

243.95

u/l

1.56

376

1942

Tumor necrosis factor alpha inhibitors

733

4493

1.72

37.27

2.6

4.6

224.47

239.07

u/l

3.20

698

4273

Postpartum care and examination

572

2027

1.87

37.20

3.9

3.4

228.28

218.68

u/l

0.88

545

1912

ILD-related respiratory insufficiency

268

1210

2.61

37.18

4.7

3.8

287.16

248.16

u/l

2.96

262

1148

Benign neoplasm: Skin of other and unspecified parts of face

560

3201

1.86

37.05

4.7

2.8

243.54

237.02

u/l

0.38

517

2959

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1330

9153

1.48

37.02

4.6

4.0

247.12

233.92

u/l

1.13

1263

8696

Meniscus derangement

3431

18704

1.29

36.87

3.8

4.5

240.68

245.96

u/l

1.23

3248

17748

Chronic sinusitis

2440

18740

1.34

36.87

4.2

4.4

237.21

242.46

u/l

0.96

2302

17773

Diseases of external ear

1960

14633

1.39

36.85

4.0

4.3

240.78

243.86

u/l

0.31

1795

13795

Respiratory conditions due to other external agents

180

680

3.22

36.54

5.1

3.8

247.63

254.16

u/l

0.18

173

638

Gingival hyperplasia

233

983

2.69

36.53

5.8

3.5

248.75

248.81

u/l

0.00

225

929

Poor fetal growth

523

2925

1.87

36.49

3.4

3.7

227.44

226.35

u/l

0.06

499

2779

Psoriatic and enteropathic arthropathies

655

3928

1.76

36.48

3.0

4.8

240.42

239.43

u/l

0.05

619

3731

Sequelae of other external causes

356

1782

2.20

36.41

4.3

4.1

244.38

247.42

u/l

0.15

341

1686

Migraine with aura and triptan purchases

705

4293

1.71

36.36

3.5

4.1

219.17

235.28

u/l

2.46

661

4068

Chronic Coagulation defects

172

625

3.16

36.33

3.4

4.5

225.75

248.86

u/l

0.74

162

595

Rash and other nonspecific skin eruption

592

3473

1.83

36.26

4.5

4.1

234.70

247.89

u/l

1.68

567

3276

Acquired absence of limb

104

286

4.87

36.21

3.1

4.2

243.37

237.38

u/l

0.15

266

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3066

23796

1.29

36.19

4.0

4.4

236.00

244.29

u/l

2.66

2897

22618

Fracture of femur

1659

11048

1.43

36.08

3.6

3.8

246.53

248.37

u/l

0.19

1517

10285

Hyperhidrosis

177

650

3.01

35.92

2.8

3.2

216.50

243.51

u/l

1.65

161

618

Benign neoplasm of middle ear and respiratory system

422

2240

2.02

35.66

3.6

3.1

249.56

234.73

u/l

1.13

403

2084

Left bundle-branch block

427

2284

2.02

35.60

4.0

247.04

239.62

u/l

0.58

401

2136

Disorders of adult personality and behaviour

1410

10005

1.45

35.47

3.1

4.5

223.28

234.04

u/l

2.72

1310

9538

Neuromuscular dysfunction of bladder

581

3422

1.83

35.38

3.1

4.5

223.55

244.96

u/l

3.96

537

3254

Benign neoplasm: Parotid gland

416

2206

2.03

35.35

4.0

2.9

232.87

234.25

u/l

0.10

400

2055

Malignant neoplasm of bone and articular cartilage

104

293

4.86

35.28

8.2

4.6

231.68

239.25

u/l

0.32

104

280

Mesothelioma

144

498

3.78

35.27

3.1

4.0

208.67

249.15

u/l

6.41

144

469

IBD patients in KELA-register

1237

8598

1.49

35.21

3.6

4.5

223.16

237.38

u/l

4.29

1179

8179

Coeliac disease

699

4309

1.72

35.18

3.7

4.2

230.57

244.01

u/l

1.72

667

4082

Single delivery by caesarean section

816

2930

1.67

35.17

3.8

241.13

231.26

u/l

0.42

787

2798

Other symptoms and signs involving the nervous and musculoskeletal systems

2367

18269

1.33

34.80

3.8

4.3

240.14

243.64

u/l

0.40

2247

17231

Speech therapy

1593

11633

1.43

34.79

4.4

4.2

246.31

244.03

u/l

0.17

1534

10929

Thyrotoxicosis, other and/or unspecified

1064

7217

1.54

34.62

5.5

4.1

236.84

243.60

u/l

0.78

1006

6784

Vitamin deficiency, wide

322

1584

2.25

34.57

3.1

4.2

256.39

250.63

u/l

0.11

308

1504

Vitamin deficiency

322

1584

2.25

34.57

3.1

4.2

256.39

250.63

u/l

0.11

308

1504

Disorders of synovium and tendon

3023

21623

1.29

34.57

3.9

4.4

238.64

243.96

u/l

1.26

2847

20504

Coxibs

1945

7660

1.39

34.57

3.6

4.6

231.07

249.71

u/l

7.95

1805

7320

Chronic rhinitis, nasopharyngitis and pharyngitis

1739

12853

1.40

34.54

3.7

4.5

236.86

242.82

u/l

0.63

1639

12202

Diabetic neuropathy

785

5029

1.69

34.46

2.9

3.8

231.39

237.98

u/l

1.46

748

4719

Injuries to unspecified part of trunk, limb or body region

596

3555

1.80

34.46

4.4

4.1

248.40

246.32

u/l

0.09

562

3361

Conjunctivitis (acute, non atopic)

1485

10671

1.44

34.42

5.0

4.4

234.43

241.00

u/l

0.95

1416

10111

Cardiac murmurs and other cardiac sounds

504

2815

1.87

34.41

4.1

4.6

243.20

247.87

u/l

0.27

473

2678

Acute pharyngitis

724

4475

1.67

34.21

5.3

4.5

230.84

239.89

u/l

0.95

702

4284

Fracture of shoulder and upper arm

2072

15749

1.36

34.16

3.8

4.3

236.64

245.71

u/l

2.49

1931

14832

Iridocyclitis

1295

9153

1.47

34.09

4.3

236.43

241.27

u/l

0.76

1249

8631

Superficial injury of lower leg

1323

9376

1.46

33.95

3.4

4.4

240.33

240.82

u/l

0.04

1245

8842

Asthma and allergy, excluding more controls

549

3133

1.79

33.89

3.0

3.7

222.51

232.00

u/l

0.96

528

2967

Inflammatory diseases of the central nervous system

500

2853

1.88

33.83

4.1

4.2

246.61

246.32

u/l

0.01

469

2701

Benign neoplasm: Duodenum

178

690

3.00

33.61

4.3

2.9

229.60

241.08

u/l

0.96

167

649

Inflammatory diseases of female pelvic organs

3005

17971

1.29

33.54

3.5

3.9

232.09

239.76

u/l

1.61

2796

16984

Presence of other devices

1370

9817

1.45

33.37

4.1

3.8

237.01

246.32

u/l

2.02

1304

9190

Small fibre neuropathy

221

961

2.71

33.32

6.2

4.0

241.47

241.67

u/l

0.01

208

909

Migraine without aura

886

5810

1.58

33.17

3.8

4.2

223.37

235.66

u/l

2.04

833

5532

Symptoms and signs involving speech and voice

1881

14189

1.37

33.06

4.3

4.1

233.08

245.13

u/l

4.65

1769

13353

Other nutritional anaemias

104

302

4.39

32.97

5.3

4.2

344.01

236.75

u/l

1.01

283

Visual impairment including blindness (binocular or monocular)

432

2385

1.97

32.92

2.9

3.8

263.89

251.46

u/l

0.34

390

2241

Other overlap syndromes

150

540

3.29

32.83

3.5

3.9

233.98

257.93

u/l

0.78

142

512

Amputation of ankle bones

186

753

2.94

32.72

3.3

3.7

251.93

249.33

u/l

0.09

174

711

Other symptoms and signs involving the urinary system

657

4080

1.72

32.72

3.6

4.4

222.74

240.29

u/l

3.93

632

3874

Malignant neoplasm of colon

947

6392

1.57

32.65

3.1

4.1

243.84

247.64

u/l

0.33

901

5983

Tobacco use

324

1630

2.18

32.62

3.0

4.2

228.61

243.02

u/l

0.74

310

1546

Cholecystitis

873

5779

1.60

32.62

4.1

246.78

246.46

u/l

0.02

814

5412

Type of accident

1565

11494

1.41

32.61

3.7

4.2

241.96

241.54

u/l

0.04

1460

10851

Unspecified misadventure during surgical and medical care

355

1860

2.11

32.19

4.6

4.3

258.90

249.28

u/l

0.37

341

1761

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

122

393

3.67

32.16

5.0

2.7

254.17

241.25

u/l

0.61

116

361

Complications following infusion, transfusion and therapeutic injection

128

428

3.61

32.06

7.1

4.2

242.75

257.85

u/l

0.32

119

405

Abnormality of red blood cells

155

6.60

31.82

3.2

4.8

235.25

242.09

u/l

0.17

149

Other congenital malformations

463

2619

1.88

31.78

4.8

4.7

238.22

248.29

u/l

0.59

451

2500

COPD, hospital admissions 1, only main diagnosis

2285

15149

1.33

31.75

3.2

4.1

239.69

248.66

u/l

2.03

2122

14217

Heartburn

576

3472

1.76

31.60

4.1

4.3

232.55

244.26

u/l

1.04

541

3280

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1328

7680

1.44

31.55

3.4

2.7

266.35

240.24

u/l

3.30

1248

7110

Polyarthritis, unspecified

255

1191

2.39

31.46

3.5

4.5

237.02

244.71

u/l

0.43

247

1127

Other interventions on the root canals of the tooth

140

495

3.31

31.45

6.6

4.2

232.68

258.61

u/l

0.79

131

471

Gonarthrosis,primary

5665

30290

1.20

31.44

3.7

4.3

243.41

245.70

u/l

0.46

5309

28634

Inflammatory bowel disease, strict (require KELA)

1237

8783

1.46

31.41

3.6

4.5

223.16

236.92

u/l

4.12

1179

8349

Dermatophytosis

794

5202

1.62

31.37

4.7

4.3

255.23

242.98

u/l

0.73

754

4930

Other follicular disorders

397

2158

1.97

31.32

4.4

4.3

220.45

242.52

u/l

2.78

369

2050

Temporal arteritis

278

1360

2.34

31.27

2.9

3.8

239.84

250.68

u/l

0.45

258

1277

Disorders of vitreous body and globe

2969

23316

1.28

31.22

4.1

4.2

245.65

246.03

u/l

0.04

2826

21987

Shock, not elsewhere classified

245

4.62

31.16

8.8

3.4

266.96

251.69

u/l

0.28

229

Familial hypercholesterolemia

980

6714

1.54

31.06

3.6

4.2

244.58

248.02

u/l

0.27

925

6312

Other obstructive and reflux uropathy

262

1235

2.31

31.03

3.9

4.1

232.50

244.16

u/l

0.57

249

1154

Use of pramipexole

1291

9300

1.45

30.94

3.6

4.2

237.23

245.34

u/l

1.84

1178

8724

Deforming dorsopathies

1540

11381

1.40

30.74

3.8

4.5

240.18

245.00

u/l

0.70

1448

10799

Malignant neoplasm, without specification of site

240

1112

2.45

30.66

5.8

3.4

317.13

242.53

u/l

1.93

226

1039

Infections with a predominantly sexual mode of transmission

1409

10235

1.41

30.65

4.1

227.97

232.09

u/l

0.63

1312

9735

Tubulo-interstitial nephritis, not specified as acute or chronic

411

2277

1.94

30.58

3.3

4.1

235.63

243.46

u/l

0.51

379

2126

Lichen simplex chronicus and prurigo

401

2216

1.97

30.55

3.3

4.3

240.32

248.63

u/l

0.49

386

2095

Lung diseases due to external agents

878

5913

1.57

30.38

3.3

4.0

251.90

246.82

u/l

0.36

819

5540

Respiratory disorders in diseases classified elsewhere

124

423

3.62

30.37

4.8

4.3

271.79

259.37

u/l

0.25

119

403

Unspecified nephritic syndrome

176

716

2.86

30.30

3.7

4.4

238.54

252.93

u/l

0.47

167

675

Postmenopausal osteoporosis with pathological fracture

383

2104

2.01

30.20

3.7

3.8

256.82

251.95

u/l

0.22

355

1949

Adalimumab

462

2653

1.85

30.19

2.8

4.7

223.07

240.32

u/l

2.53

440

2520

Giant cell arteritis with polymyalgia rheumatica

278

1379

2.31

30.17

2.9

3.8

239.84

250.10

u/l

0.42

258

1290

Abscess of lung

134

479

3.40

30.12

3.9

4.5

235.52

248.38

u/l

0.39

128

451

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

348

1828

2.02

30.10

3.1

4.6

239.39

234.13

u/l

0.22

323

1751

Hyperplasia of prostate

2551

11473

1.31

29.96

4.2

4.6

237.40

247.41

u/l

2.94

2413

10914

Other epidermal thickening

288

1440

2.21

29.77

4.8

4.1

230.45

245.99

u/l

1.37

274

1356

Bronchiectasis

526

3175

1.80

29.72

4.6

4.3

234.01

250.79

u/l

2.05

498

2971

Late syphilis

122

418

3.61

29.71

3.2

4.3

232.58

243.03

u/l

0.62

114

395

Haemangioma and lymphangioma, any site

410

2282

1.90

29.60

3.6

3.0

233.81

234.05

u/l

0.01

389

2130

Discitis, unspecified

144

541

3.22

29.57

5.6

4.2

226.91

242.99

u/l

1.07

138

512

Hypertrophic cardiomyopathy

292

1480

2.22

29.56

8.4

4.2

260.90

247.10

u/l

0.79

280

1399

Bipolar affective disorders

917

6223

1.53

29.45

3.0

4.5

219.75

236.25

u/l

3.69

839

5936

Benign neoplasm of meninges

472

2747

1.82

29.43

4.0

2.9

241.16

238.57

u/l

0.10

440

2542

Disorders of vitreous body

2868

22673

1.27

29.41

4.2

245.63

246.05

u/l

0.04

2734

21380

Iron deficiency

133

470

3.19

29.36

3.3

4.0

210.34

258.90

u/l

1.85

121

446

Acute gastritis

470

2748

1.83

29.32

3.8

4.4

233.06

250.73

u/l

2.18

440

2595

Right hemicolectomy

409

2315

1.94

29.30

4.0

3.9

238.82

250.03

u/l

0.75

391

2174

Asthma and allergy

549

3263

1.72

29.30

3.0

3.9

222.51

234.46

u/l

1.39

528

3094

Ovarian cyst

1901

8325

1.35

29.25

3.5

3.9

232.72

241.96

u/l

2.05

1802

7852

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

159

6.43

29.23

8.0

4.6

226.90

251.22

u/l

1.01

152

Thyrotoxicosis

1327

9666

1.42

29.20

5.0

4.0

236.48

242.86

u/l

0.95

1254

9090

Carcinoma in situ of skin

535

3271

1.78

29.12

4.6

4.0

255.46

245.99

u/l

0.56

505

3060

Benign neoplasm of ovary

738

4800

1.60

29.08

3.7

2.8

237.33

241.39

u/l

0.44

706

4427

Menorrhagia

1848

7708

1.36

29.08

3.4

4.0

236.63

245.01

u/l

0.85

1724

7245

Barrett oesophagus

336

1796

2.08

29.02

2.9

4.6

223.86

250.62

u/l

3.63

314

1706

Other benign neoplasms of skin

2178

17064

1.32

28.96

4.2

4.1

239.36

245.23

u/l

1.08

2030

16053

Haemorrhoids and perianal venous thrombosis

1705

12921

1.36

28.85

4.1

234.42

251.53

u/l

5.30

1583

12167

Maternal care for other conditions predominantly related to pregnancy

802

5237

1.55

28.65

3.1

4.0

219.47

232.16

u/l

2.14

767

4975

Other diseases of oesophagus

594

3716

1.70

28.60

3.4

4.2

241.98

249.97

u/l

0.65

557

3508

Benign neoplasm of other and unspecified endocrine glands

741

4879

1.61

28.54

3.8

4.4

230.31

244.73

u/l

2.33

691

4624

Specific personality disorders

1134

8056

1.45

28.52

3.1

4.3

222.40

233.85

u/l

2.55

1054

7669

Benign neoplasm of mouth and pharynx

659

4235

1.65

28.38

4.4

4.2

234.01

244.64

u/l

0.95

612

3996

Acute and subacute iridocyclitis

1069

7555

1.47

28.28

4.3

238.31

240.17

u/l

0.19

1030

7150

Mucosal proctocolitis

675

4343

1.63

28.27

3.8

4.6

223.42

238.75

u/l

2.85

646

4131

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

122

425

3.38

28.23

5.4

2.8

283.09

242.18

u/l

1.02

117

397

Crohn disease (strict definition, require KELA, min 2 HDR)

349

1885

1.98

28.14

3.5

4.5

218.44

242.61

u/l

2.21

335

1796

Pain in thoracic spine

796

5317

1.56

27.99

3.7

4.4

232.53

242.17

u/l

1.47

745

5044

Reactive arthropathies

504

3034

1.76

27.93

3.2

4.7

235.89

242.67

u/l

0.44

476

2889

Erosion of teeth, including avohilmo

988

6639

1.49

27.90

4.4

3.9

233.77

237.22

u/l

0.39

921

6348

Other noninfective disorders of lymphatic vessels and lymph nodes

230

1083

2.36

27.84

5.0

3.9

255.01

244.94

u/l

0.38

217

1022

Pregnancy examination and test

601

2294

1.68

27.80

3.5

221.20

219.97

u/l

0.08

579

2166

Retinal detachments and breaks

2125

16706

1.31

27.75

4.3

4.2

246.04

246.75

u/l

0.09

1993

15737

Artificial joint operation, meniscal resection

5679

32474

1.18

27.75

3.7

4.3

240.14

245.45

u/l

1.92

5336

30700

Syphilis

188

819

2.62

27.74

3.2

4.3

236.02

249.76

u/l

0.58

177

781

Irregular menses

2107

13307

1.31

27.71

3.8

3.9

227.58

236.74

u/l

2.72

1986

12602

Polyarteritis nodosa and related conditions

118

410

3.44

27.66

4.1

4.5

241.09

260.01

u/l

0.40

112

393

Alcohol dependence

1601

12115

1.37

27.65

2.7

4.7

234.19

243.24

u/l

1.48

1489

11530

Diplopia

751

4991

1.59

27.63

4.0

4.1

240.42

243.00

u/l

0.18

708

4702

Focal epilepsy

1186

8565

1.44

27.63

4.4

4.3

250.79

242.30

u/l

0.52

1115

8093

Arterial embolism and thrombosis

386

2176

1.93

27.61

3.8

263.98

246.54

u/l

0.82

360

2044

Behavioural syndromes associated with physiological disturbances and physical factors

1557

11701

1.36

27.44

3.7

4.2

227.37

235.14

u/l

2.02

1458

11117

Postprocedural disorders of digestive system, not elsewhere classified

223

1047

2.40

27.44

3.3

4.2

230.64

260.10

u/l

1.80

212

992

Melanocytic naevi of lower limb, including hip

218

1003

2.36

27.34

7.8

3.2

225.36

230.87

u/l

0.38

210

942

Crohn's disease of large intestine

298

1544

2.08

27.34

3.2

4.5

222.60

243.77

u/l

1.76

283

1470

Panic disorder

678

4384

1.60

27.32

3.4

4.3

219.75

234.31

u/l

2.32

620

4171

Reactive arthropathies, FINNGEN

395

2237

1.88

27.27

3.4

4.6

234.07

240.93

u/l

0.34

374

2118

Anterior Iridocyclitis

1128

8102

1.45

27.22

4.3

237.97

241.25

u/l

0.39

1087

7665

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

352

1922

1.94

27.18

5.5

3.0

232.43

232.74

u/l

0.02

333

1800

Drug-induced osteoporosis

106

353

3.72

27.12

4.0

4.7

283.14

270.27

u/l

0.17

332

Pneumonia due to Streptococcus pneumoniae

256

1263

2.21

27.11

5.6

3.9

239.90

241.09

u/l

0.05

241

1195

Other abnormal uterine and vaginal bleeding

1249

6450

1.43

27.08

3.4

4.0

242.60

248.05

u/l

0.64

1148

6044

Special screening examination for infectious and parasitic diseases

1087

5721

1.45

27.01

3.6

4.0

222.73

239.73

u/l

4.09

1013

5485

Encephalitis

195

870

2.52

27.00

4.6

4.4

281.26

251.16

u/l

0.43

180

820

Crohn disease (strict definition, require KELA)

352

1932

1.95

26.99

3.4

4.5

218.12

242.11

u/l

2.24

338

1843

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

634

4071

1.64

26.97

3.2

2.7

256.68

239.61

u/l

1.08

606

3759

Haemangioma, any site

383

2150

1.88

26.97

3.6

3.0

235.03

234.27

u/l

0.03

364

2007

Infective dermatitis

667

4343

1.62

26.91

3.9

4.2

239.83

243.51

u/l

0.29

634

4113

Other encephalitis

185

811

2.57

26.73

4.7

4.5

285.20

254.11

u/l

0.42

172

766

Unstable angina pectoris

2506

16694

1.28

26.68

3.5

4.2

255.45

245.29

u/l

1.27

2348

15670

Nonorganic sleeping disorders, excluding more controls

876

6013

1.51

26.66

3.5

4.6

223.87

240.16

u/l

4.28

818

5748

Dipeptidyl peptidase 4 (DPP-4) inhibitors

741

4966

1.59

26.65

2.7

4.5

238.21

250.28

u/l

1.12

689

4700

Carcinoma in situ of skin of lower limb, including hip

139

538

3.03

26.61

4.2

2.8

243.88

237.99

u/l

0.24

134

500

Superficial injury of hip and thigh

840

5746

1.53

26.59

3.7

3.9

239.09

244.75

u/l

0.68

787

5367

Rotator cuff syndrome

3695

22863

1.22

26.49

3.8

4.4

241.95

246.13

u/l

0.72

3490

21655

Injuries to the elbow and forearm

3900

29558

1.21

26.45

3.9

4.2

235.11

242.59

u/l

3.36

3652

27956

Colitis, primary sclerosing, strict definition

264

4.02

26.19

3.1

4.3

203.60

237.33

u/l

2.60

251

Type 1 diabetes, definitions combined

472

2819

1.74

26.13

4.3

4.7

229.98

241.09

u/l

1.35

461

2691

Hypopituitarism

384

2188

1.88

26.10

3.8

4.9

239.83

250.25

u/l

0.50

365

2088

Cerebral cysts

320

1726

2.00

26.09

3.6

4.1

250.68

247.34

u/l

0.08

297

1634

Retinal vascular occlusion

752

5081

1.57

25.98

3.8

4.1

247.50

244.98

u/l

0.19

704

4746

L04AC Interleukin inhibitors

272

1391

2.11

25.97

2.7

4.6

227.90

246.17

u/l

1.24

260

1327

Acute lymphadenitis

328

1782

1.97

25.96

5.2

4.3

228.52

244.85

u/l

1.37

312

1684

Persistent mood disorders

1033

7359

1.45

25.92

3.4

4.4

230.47

241.98

u/l

1.93

950

6931

Alcohol-induced chronic pancreatitis

409

2394

1.85

25.82

2.7

4.5

235.91

245.09

u/l

0.35

387

2280

Right bundle-branch block

232

1128

2.27

25.82

4.2

3.9

246.21

241.24

u/l

0.17

215

1058

Retinal vascular disorders

761

5163

1.56

25.70

3.8

4.1

247.47

245.09

u/l

0.18

711

4825

Ulcer of oesophagus

463

2808

1.78

25.69

3.4

4.3

240.08

248.53

u/l

0.65

435

2669

N06DA Anticholinesterases

1227

13372

0.72

25.67

2.6

3.6

249.86

250.99

u/l

0.08

1083

12445

Use of anticholinesterases

1227

13372

0.72

25.67

2.6

3.6

249.86

250.99

u/l

0.08

1083

12445

Cervicalgia

1130

8193

1.43

25.67

3.4

4.4

236.05

243.20

u/l

0.99

1052

7753

Open wound of ankle and foot

572

3635

1.66

25.65

3.9

4.3

243.33

242.23

u/l

0.07

543

3441

1337

9455

1.40

25.64

3.2

3.7

246.30

251.11

u/l

0.50

1217

8801

Injury of unspecified body region

447

2683

1.79

25.49

4.5

4.1

251.04

249.78

u/l

0.04

425

2535

Keratitis

1890

14766

1.31

25.49

4.2

4.3

245.80

242.48

u/l

0.29

1790

13927

Benign neoplasm: Rectosigmoid junction

234

1147

2.25

25.47

3.0

2.9

220.49

236.22

u/l

2.49

219

1069

malignant neoplasm of female genital organs

807

5534

1.53

25.46

4.5

3.9

246.75

251.07

u/l

0.42

772

5162

Other blood glucose lowering drugs, excl. Insulins

1019

7303

1.46

25.36

2.8

4.4

235.46

250.49

u/l

2.64

955

6875

Fracture of foot, except ankle

1218

8948

1.40

25.33

4.3

4.4

234.13

238.86

u/l

0.74

1148

8483

Psoriasis vulgaris

1039

7460

1.45

25.24

3.6

4.4

237.35

240.15

u/l

0.28

979

7084

Type 1 diabetes, strict (exclude DM2)

467

2808

1.73

25.23

4.3

4.7

230.55

241.40

u/l

1.29

456

2683

Psoriatic arthropathies

552

3487

1.67

25.22

3.1

4.8

243.27

245.10

u/l

0.08

521

3313

Focal epilepsy, strict definition

1090

7891

1.44

25.15

4.5

4.3

251.97

243.16

u/l

0.50

1023

7459

Moderate visual impairment, binocular

208

986

2.36

24.95

2.5

3.4

233.85

263.07

u/l

1.54

183

933

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

367

2091

1.87

24.88

3.4

4.5

217.96

240.98

u/l

2.28

352

1995

Other and unspecified tonsillitis

1580

10204

1.34

24.78

4.3

227.07

236.85

u/l

1.70

1507

9776

Oter anti-inflammatory and antirheumatic agents, non-steroids

1551

6497

1.37

24.77

3.5

4.6

237.52

254.01

u/l

3.87

1435

6190

Acute suppurative otitis media

1185

8092

1.40

24.67

4.4

4.2

235.18

233.09

u/l

0.12

1118

7703

Toxic liver disease

119

443

3.16

24.58

5.8

4.4

256.24

253.96

u/l

0.04

112

421

Malignant neoplasm of liver and intrahepatic bile ducts

244

1243

2.22

24.57

3.6

3.9

249.76

244.75

u/l

0.25

237

1174

Trochanteric bursitis

719

4846

1.55

24.49

3.4

4.2

243.84

247.32

u/l

0.11

661

4576

Umbilical hernia

1525

11666

1.35

24.47

3.8

4.5

246.05

243.27

u/l

0.23

1452

11089

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

576

3690

1.63

24.47

4.3

2.9

247.70

234.11

u/l

1.09

536

3438

Other disorders of nervous system

402

2377

1.82

24.44

4.0

4.2

240.56

248.43

u/l

0.46

376

2250

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

255

1300

2.10

24.41

4.8

3.1

256.12

234.57

u/l

1.94

245

1223

Drug-induced polyneuropathy

288

4.03

24.39

11.7

4.0

253.48

243.02

u/l

0.29

276

Mental and behavioural disorders due to sedatives or hypnotics

359

2046

1.87

24.30

3.1

4.6

229.48

241.61

u/l

0.77

319

1943

Melanocytic naevi, other sites/unspecified

434

2613

1.77

24.30

6.3

4.3

231.23

243.32

u/l

0.72

424

2481

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

205

973

2.32

24.24

4.1

2.6

255.81

241.98

u/l

0.46

197

900

Other peripheral vascular diseases

444

2692

1.75

24.17

3.9

4.1

247.20

244.75

u/l

0.12

417

2538

Disorders of conjunctiva

4534

32462

1.19

24.14

4.3

4.2

240.00

241.78

u/l

0.25

4286

30731

Colorectal cancer

1425

10847

1.37

24.13

3.1

4.1

249.93

248.47

u/l

0.10

1358

10166

Acetic acid derivatives and related substances

1883

7608

1.32

24.12

3.7

4.6

236.59

249.83

u/l

1.89

1772

7270

Fracture of lower leg, including ankle

3090

25523

1.23

24.12

3.5

4.4

238.44

243.68

u/l

1.32

2917

24161

Alcohol abuse, main dg, excluding more controls

784

5390

1.51

23.99

2.7

4.9

237.02

240.48

u/l

0.23

744

5168

Fissure and fistula of anal and rectal regions

1308

9803

1.38

23.97

4.4

4.3

237.84

246.26

u/l

1.21

1225

9286

Malnutrition

148

621

2.75

23.97

3.9

4.4

277.95

246.47

u/l

1.39

134

585

Emphysema

457

2812

1.75

23.94

3.5

4.3

257.07

250.83

u/l

0.24

435

2631

Inguinal hernia

3707

21000

1.21

23.94

4.1

4.4

242.85

245.98

u/l

0.60

3512

19883

Atopic dermatitis, strict definition with reimbursement

1359

9898

1.36

23.88

4.1

4.2

242.37

234.83

u/l

0.54

1294

9432

Later onset COPD

1891

11715

1.32

23.88

2.9

3.9

238.51

251.02

u/l

4.19

1758

10939

Carcinoma in situ of skin of trunk

228

1151

2.27

23.87

5.0

3.7

240.65

251.66

u/l

0.57

219

1087

Parodontitis, operation under 40 years and operation codes

375

2159

1.81

23.87

4.0

223.39

220.47

u/l

0.18

359

2052

Mixed and other personality disorders

395

2320

1.79

23.85

2.8

4.7

223.00

239.91

u/l

1.46

370

2211

Assault

614

4014

1.59

23.78

2.7

4.6

227.09

235.13

u/l

0.68

568

3833

Benign neoplasm: Cerebral meninges

413

2461

1.77

23.73

4.2

3.0

242.14

238.43

u/l

0.12

385

2281

Abscess of anal and rectal regions

458

2807

1.72

23.71

4.1

4.5

251.11

247.26

u/l

0.10

438

2684

Parodontitis, under 40 years, or operation codes

393

2297

1.78

23.70

4.1

4.0

226.50

221.35

u/l

0.33

376

2186

Drug-induced systemic lupus erythematosus

186

4.71

23.69

3.9

4.6

257.78

245.22

u/l

0.39

179

Bacterial, viral and other infectious agents

457

2802

1.72

23.64

5.2

4.6

237.33

242.62

u/l

0.36

440

2669

Carcinoma in situ of skin of ear and external auricular canal

130

526

3.07

23.64

4.1

3.4

241.07

247.08

u/l

0.20

122

491

Orchitis and epididymitis

576

3747

1.63

23.61

4.5

4.6

230.96

245.71

u/l

1.27

545

3546

Sulfonylureas

2369

15298

1.27

23.60

2.8

4.3

235.87

253.06

u/l

7.04

2207

14375

Childhood asthma (age<16), excluding more controls

512

2513

1.66

23.60

3.4

3.6

218.08

227.72

u/l

0.90

486

2409

Other disorders of bladder

739

5070

1.54

23.57

3.4

4.4

236.76

242.87

u/l

0.46

674

4807

Focal epilepsy, mode (most common among epilepsy diagnosis)

1027

7450

1.43

23.45

4.3

250.33

242.65

u/l

0.51

965

7035

Cervical disc disorders

2090

16707

1.28

23.43

3.9

4.5

234.93

244.92

u/l

3.69

1947

15892

Pain associated with micturition

632

4200

1.58

23.20

4.2

4.3

226.89

243.68

u/l

2.82

575

3980

Parodontitis, under 40 years and operation codes

372

2156

1.79

23.15

4.0

223.64

220.32

u/l

0.21

356

2049

Parodontitis, under 40 years

390

2290

1.77

23.14

4.1

4.0

226.77

221.07

u/l

0.37

373

2179

Prurigo nodularis

174

795

2.49

23.12

2.9

4.2

243.36

250.94

u/l

0.19

169

754

Benign neoplasm: Other and unspecified parts of mouth

187

871

2.35

23.07

4.3

3.6

233.10

236.82

u/l

0.14

165

813

Other ulcerative colitis

321

1803

1.90

22.99

3.2

4.4

227.95

245.23

u/l

1.25

306

1720

Other juvenile arthritis

202

964

2.24

22.96

3.3

4.9

249.70

241.77

u/l

0.15

196

926

Benign neoplasm: Skin of trunk

212

1036

2.21

22.92

5.1

3.2

236.01

233.50

u/l

0.08

193

980

Attention to artificial openings

241

1243

2.13

22.90

4.0

4.2

231.27

246.49

u/l

0.84

224

1172

Contact with and exposure to communicable diseases

1375

10386

1.35

22.72

3.6

4.2

227.18

233.06

u/l

1.09

1321

9884

Combinations of oral blood glucose lowering drugs

1680

13167

1.32

22.71

3.5

4.6

231.81

249.45

u/l

4.75

1584

12524

Traumatic subdural haemorrhage

803

5532

1.50

22.69

4.1

4.3

242.29

250.84

u/l

0.92

745

5213

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

444

2731

1.71

22.67

3.7

2.8

250.25

244.48

u/l

0.40

415

2525

Failed induction of labour

232

1168

2.09

22.63

3.4

3.6

216.77

224.37

u/l

0.67

227

1105

Carcinoma in situ of colon

101

361

3.34

22.63

3.5

2.9

239.52

249.49

u/l

0.36

101

338

Ankylosing spondylitis

494

3123

1.66

22.58

2.9

4.7

228.00

240.82

u/l

1.62

457

2975

Other shoulder lesions

486

3060

1.67

22.53

3.7

4.5

227.77

242.14

u/l

2.61

456

2899

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

311

1758

1.94

22.52

3.9

251.77

248.93

u/l

0.11

299

1647

Other congenital malformations of skin

228

1156

2.14

22.43

6.1

4.2

212.03

256.74

u/l

3.82

221

1100

Abnormal findings on diagnostic imaging of central nervous system

252

1324

2.06

22.41

4.8

4.2

225.33

248.96

u/l

1.76

233

1255

Carpal tunnel syndrome

3404

25870

1.21

22.34

3.6

4.3

240.37

243.12

u/l

0.49

3212

24461

Carcinoma in situ of skin of scalp and neck

189

920

2.42

22.19

5.5

3.7

238.84

246.76

u/l

0.48

182

865

Childhood asthma (age<16)

512

2554

1.63

22.17

3.4

3.8

218.08

228.78

u/l

1.06

486

2451

Other benign neoplasms of connective and other soft tissue

428

2621

1.71

21.99

4.3

2.8

231.10

231.91

u/l

0.05

400

2442

Other disorders of eye and adnexa

701

4808

1.52

21.86

3.9

4.2

235.37

244.17

u/l

0.85

663

4545

Carcinoma in situ of skin of upper limb, including shoulder

177

845

2.45

21.72

4.8

3.8

260.60

247.82

u/l

0.47

169

788

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

224

3.92

21.67

8.5

3.1

262.51

234.53

u/l

0.70

212

Extreme obesity with alveolar hypoventilation

256

1376

2.04

21.67

2.4

4.7

236.85

246.70

u/l

0.61

228

1303

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

349

2041

1.81

21.62

2.8

4.1

221.77

242.42

u/l

2.07

329

1941

Otitis externa

1149

8594

1.38

21.54

4.1

4.3

237.94

239.45

u/l

0.09

1070

8145

Other aneurysm

344

2022

1.84

21.53

4.4

4.0

249.97

246.17

u/l

0.19

328

1898

Juvenile arthritis (FINNGEN)

220

1110

2.10

21.50

3.1

4.8

249.35

243.76

u/l

0.11

213

1060

Asthma and opportunity respiratory infection

303

1725

1.93

21.45

3.9

4.0

233.71

252.07

u/l

1.36

287

1618

Other specified disorders of kidney and ureter

216

1101

2.17

21.41

4.9

4.3

265.28

254.08

u/l

0.31

205

1047

Pain and other conditions associated with female genital organs and menstrual cycle

856

5830

1.44

21.39

2.9

4.0

213.63

236.59

u/l

10.50

797

5526

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

306

3.45

21.27

4.8

2.7

237.73

241.82

u/l

0.18

284

Malignant neoplasm of prostate

2743

14348

1.24

21.27

4.4

4.2

252.62

244.14

u/l

1.40

2582

13562

Abnormal involuntary movements

724

5036

1.50

21.23

3.5

4.2

235.04

243.53

u/l

0.94

676

4755

Generalized anxiety disorder

661

4489

1.52

21.23

3.4

4.3

216.99

235.04

u/l

3.48

596

4268

Hidradenitis suppurativa

188

905

2.24

21.16

2.2

4.3

208.11

241.18

u/l

3.30

171

865

Abnormal findings on antenatal screening of mother

303

1699

1.85

21.11

2.7

3.7

207.52

223.07

u/l

1.82

285

1608

Internal derangement of knee

2055

16535

1.27

21.04

3.7

4.6

231.10

244.54

u/l

5.44

1924

15707

Oesophagitis

334

1957

1.84

21.03

3.4

4.6

231.84

251.03

u/l

2.28

315

1859

Other specified congenital malformation syndromes affecting multiple systems

109

417

2.96

20.99

3.6

5.8

254.97

274.65

u/l

0.47

109

405

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

209

1053

2.15

20.93

3.9

2.9

249.66

235.03

u/l

0.77

195

986

Voice disturbances

1398

10797

1.33

20.93

4.0

4.2

232.62

244.44

u/l

3.80

1326

10185

Wet age-related macular degeneration

1065

7804

1.40

20.88

3.3

3.7

245.87

250.82

u/l

0.52

990

7236

Phobic anxiety disorders

561

3697

1.57

20.78

3.4

4.3

219.88

235.48

u/l

2.71

532

3523

Laparoscopic right hemicolectomy

361

2183

1.81

20.75

3.0

3.9

222.52

250.14

u/l

4.34

341

2056

Benign neoplasm of urinary organs

238

1260

2.04

20.67

4.1

2.9

234.83

238.37

u/l

0.20

222

1175

Qualitative platelet defects

105

6.15

20.65

5.3

3.9

245.46

237.26

u/l

0.12

Chronic laryngitis and laryngotracheitis

779

5519

1.47

20.63

3.5

4.4

239.87

243.16

u/l

0.29

715

5213

Allergic purpura

176

838

2.29

20.59

3.7

3.9

233.40

250.40

u/l

0.78

167

794

Congenital malformations of cardiac septa

353

2030

1.78

20.58

3.9

4.8

277.19

255.72

u/l

0.89

337

1931

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

155

704

2.44

20.56

3.6

2.8

217.73

239.76

u/l

2.62

150

661

Benign neoplasm: Adrenal gland

436

2758

1.69

20.53

3.6

4.3

236.55

247.70

u/l

0.82

407

2608

Paralytic ileus

242

1298

2.04

20.52

3.4

4.1

236.25

257.54

u/l

0.99

225

1233

Speech disturbances, not elsewhere classified

514

3370

1.62

20.51

5.0

4.1

233.40

247.99

u/l

1.62

470

3163

Other disorders of eyelid

2599

20849

1.23

20.45

3.8

4.1

240.69

248.16

u/l

1.80

2459

19585

Other and unspecified visual disturbances

510

3333

1.61

20.43

4.9

4.1

232.52

247.03

u/l

2.12

481

3154

Appendectomy

3452

28248

1.20

20.34

4.1

4.3

235.02

240.64

u/l

1.61

3266

26789

Other renal tubulo-interstitial diseases

140

610

2.53

20.32

4.2

4.0

269.79

244.59

u/l

0.41

135

568

Colon adenocarcinoma

731

5158

1.50

20.29

2.9

4.0

244.41

246.47

u/l

0.14

693

4828

Any prescribed medicine buy

8.03

20.28

4.9

2.3

241.05

244.00

u/l

0.05

Spontaneous rupture of synovium and tendon

464

2975

1.65

20.28

4.2

4.5

244.85

245.83

u/l

0.06

426

2816

Suppurative and unspecified otitis media

1718

12060

1.29

20.18

4.5

4.2

236.15

234.09

u/l

0.15

1621

11467

Seborrhoeic dermatitis

539

3576

1.59

20.16

4.5

4.0

235.09

242.21

u/l

0.54

504

3392

Special screening examination for neoplasms

271

1511

1.93

20.11

3.6

4.0

264.21

244.81

u/l

0.59

252

1420

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

283

1590

1.88

20.04

5.5

3.1

229.36

232.19

u/l

0.17

269

1492

Other inflammation of eyelid

697

4867

1.50

20.03

5.1

4.2

229.41

245.12

u/l

3.85

651

4585

Other erythematous conditions

210

1083

2.12

20.00

4.0

4.1

235.50

250.33

u/l

0.83

199

1027

Other bursopathies

734

5176

1.48

19.98

3.8

4.6

241.79

243.58

u/l

0.13

686

4906

Corns and callosities

390

2410

1.72

19.97

4.2

244.17

248.92

u/l

0.15

366

2273

Artrosis, including avohilmo

5212

24965

1.16

19.93

3.7

4.5

236.33

245.39

u/l

4.89

4886

23698

Migraine without aura and triptan purchases

650

4455

1.50

19.91

3.4

4.2

219.00

234.46

u/l

2.44

612

4224

Conjunctivitis

3929

29421

1.18

19.83

4.2

238.10

241.22

u/l

0.45

3703

27854

Bullous disorders

352

2131

1.78

19.80

3.7

4.0

241.74

245.77

u/l

0.21

333

2003

Diseases of middle ear and mastoid

2978

20477

1.21

19.77

4.5

4.1

237.39

238.76

u/l

0.15

2822

19399

Benign neoplasm: Choroid

288

1641

1.88

19.76

5.1

3.0

228.04

237.71

u/l

0.76

272

1529

Striking against or struck by other objects

1653

13105

1.29

19.74

4.0

4.5

242.01

239.26

u/l

0.24

1564

12463

Arthropathic psoriasis

595

4042

1.54

19.71

3.0

4.5

244.82

244.26

u/l

0.02

563

3840

Fall on and from stairs and steps

1348

10446

1.33

19.70

3.6

4.2

238.53

241.68

u/l

0.34

1270

9825

Amenorrhoea

301

1725

1.82

19.67

4.4

4.0

236.87

233.17

u/l

0.16

285

1630

Systemic sclerosis (FG)

147

666

2.45

19.66

3.1

4.6

255.62

257.17

u/l

0.03

142

630

Xerosis cutis

118

493

2.82

19.60

6.0

3.9

234.83

244.66

u/l

0.59

110

466

Urolithiasis

1923

15573

1.27

19.58

3.9

4.2

239.25

245.03

u/l

0.65

1808

14721

Calculus of kidney and ureter

1771

14218

1.28

19.53

3.9

4.3

240.11

244.69

u/l

0.43

1662

13444

Other and unspecified erythematous conditions

192

969

2.18

19.51

4.0

4.2

234.09

251.15

u/l

0.89

181

918

Glaucoma secondary to other eye disorders

258

1436

1.95

19.49

3.7

4.0

250.28

250.25

u/l

0.00

249

1361

Personal history of medical treatment

263

3.59

19.48

4.2

243.62

232.14

u/l

0.54

250

Superficial injury of wrist and hand

949

6997

1.40

19.39

3.1

4.6

233.96

239.46

u/l

0.37

886

6640

Other and unspecified parapsoriasis

178

4.81

19.39

4.8

4.2

217.92

243.92

u/l

1.65

167

Post-traumatic stress disorder

332

1964

1.76

19.34

3.3

4.0

208.47

237.91

u/l

3.97

303

1878

Unspecific neurodegenerative disorder

1746

14964

0.78

19.33

2.7

3.8

249.58

250.33

u/l

0.06

1542

14007

Coxarthrosis, primary

3622

26977

1.19

19.27

3.6

4.2

241.03

247.49

u/l

2.25

3392

25396

Benign leiomyoma with endometriosis

639

4403

1.50

19.25

3.4

2.9

243.71

243.14

u/l

0.03

585

4077

Follow-up care involving plastic surgery

208

1080

2.08

19.16

3.8

4.0

231.01

230.41

u/l

0.02

176

1019

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

206

1070

2.10

19.15

2.8

2.7

228.48

237.03

u/l

0.48

196

996

Other extrapyramidal and movement disorders in other diseases

1230

9472

1.34

19.08

3.3

4.1

237.78

244.84

u/l

0.90

1128

8908

Gestational diabetes (for exclusion)

1335

7259

1.32

19.08

3.2

3.7

223.64

227.76

u/l

0.52

1265

6921

Oxicams

1560

6952

1.31

19.06

3.6

4.6

241.98

252.74

u/l

1.77

1461

6634

Neuralgia and neuritis, unspecified

279

1593

1.87

19.03

3.6

4.6

240.38

243.54

u/l

0.09

257

1515

Melanoma in situ

267

1523

1.94

19.03

5.4

4.0

242.25

251.52

u/l

0.37

253

1435

Benign lipomatous neoplasm of other sites/unspecified

410

2584

1.66

18.99

4.3

2.8

233.47

237.66

u/l

0.37

384

2398

Speech and linguistic disorders, excluding more controls

350

1984

1.73

18.99

5.0

4.5

244.54

252.91

u/l

0.41

336

1892

therapeutic use

197

1019

2.15

18.94

2.6

4.1

245.77

250.83

u/l

0.15

176

965

Benign neoplasm of male genital organs

131

576

2.55

18.92

4.7

2.7

231.23

236.82

u/l

0.30

125

540

Neovascular glaucoma

255

1431

1.94

18.78

3.8

4.0

250.56

248.93

u/l

0.06

246

1346

!Aliquae complicationes praecoces traumatis

244

1348

1.96

18.76

4.8

4.2

244.43

247.70

u/l

0.11

229

1275

Early complications of trauma

244

1348

1.96

18.76

4.8

4.2

244.43

247.70

u/l

0.11

229

1275

Nummular dermatitis

471

3090

1.61

18.74

4.1

4.3

228.35

244.88

u/l

2.84

445

2921

Vitamin D deficiency

112

460

2.73

18.70

2.7

4.8

227.57

240.31

u/l

0.80

107

436

Disorders of vestibular function (Vertigo)

2604

21660

1.22

18.70

3.7

4.1

237.11

245.42

u/l

2.92

2410

20399

Leisure time condition

924

6842

1.40

18.66

3.5

4.3

242.45

242.61

u/l

0.01

845

6466

Scoliosis

421

2682

1.64

18.58

3.6

4.1

243.55

242.33

u/l

0.06

395

2542

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

335

3.11

18.55

3.5

3.0

227.25

243.64

u/l

0.88

314

Postzoster neuralgia

113

474

2.78

18.55

7.4

4.0

272.58

246.00

u/l

0.83

108

445

Inflammatory disease of uterus

601

4125

1.50

18.46

3.4

4.0

236.36

236.05

u/l

0.01

566

3899

Dissociative [conversion] disorders

185

931

2.12

18.39

2.3

3.8

217.37

239.64

u/l

0.82

171

881

Total colectomy operation

241

1336

1.95

18.35

4.3

216.83

251.48

u/l

3.28

230

1273

Total colectomy

241

1336

1.95

18.35

4.3

216.83

251.48

u/l

3.28

230

1273

Benign neoplasm: Small intestine

261

1493

1.92

18.34

4.3

4.0

231.37

250.77

u/l

1.72

245

1415

Rosacea

567

3869

1.53

18.34

4.8

4.2

245.12

244.75

u/l

0.02

537

3659

Other and unspecified rosacea

438

2838

1.63

18.24

4.6

4.2

248.77

247.69

u/l

0.05

416

2678

Erythema nodosum

178

894

2.18

18.24

5.1

4.0

258.10

251.34

u/l

0.15

167

848

Alzheimer disease, including avohilmo

1414

12900

0.77

18.21

2.6

3.6

247.68

251.80

u/l

0.43

1238

12018

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

180

901

2.13

18.20

5.2

4.6

238.28

254.93

u/l

0.80

175

856

Maternal care for known or suspected fetal abnormality and damage

551

3297

1.53

18.16

3.5

3.6

215.22

226.04

u/l

1.16

530

3138

Other other unspecified disorders of the circulatory system

232

1282

1.98

18.10

3.3

4.3

285.60

248.58

u/l

2.29

225

1209

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

472

3111

1.59

18.08

3.1

2.8

265.77

238.88

u/l

1.48

451

2876

Varicose veins

3643

23688

1.18

18.07

4.1

4.0

249.62

245.33

u/l

0.79

3397

22314

Pleural plaque

634

4466

1.50

18.01

3.4

4.0

238.81

248.46

u/l

0.97

594

4182

Benign neoplasm: Liver/bile ducts

119

509

2.55

17.92

4.0

3.2

224.43

235.06

u/l

0.57

113

481

Benign neoplasm of bone and articular cartilage

339

2064

1.71

17.88

4.2

3.1

241.60

230.63

u/l

0.51

322

1926

Benign neoplasm: Duodenum

178

912

2.20

17.82

4.3

4.2

229.60

244.79

u/l

1.41

167

867

Other disorders of the musculoskeletal system and connective tissue

781

5685

1.43

17.79

3.6

4.3

239.97

244.58

u/l

0.49

732

5364

Crohn disease (strict definition, all UC cases excluded)

263

1505

1.86

17.76

3.8

4.6

224.85

246.76

u/l

1.30

252

1430

Other female pelvic inflammatory diseases

756

5459

1.43

17.72

3.1

4.1

229.56

243.67

u/l

2.21

686

5132

Other disorders of optic [2nd] nerve and visual pathways

343

2117

1.72

17.68

4.2

243.18

252.40

u/l

0.44

326

2009

Sickle-cell disorders

7.27

17.61

9.4

3.6

267.74

240.70

u/l

0.31

Dementia in Alzheimer disease

587

7145

0.68

17.59

2.6

3.4

247.53

251.39

u/l

0.24

471

6616

Alzheimer disease

1169

11341

0.76

17.58

2.6

3.5

251.37

251.95

u/l

0.04

1003

10542

Emotionally unstable personality disorder

518

3485

1.53

17.58

2.8

4.4

214.94

232.90

u/l

2.80

474

3322

Ankylosing spondylitis, ICD10

469

3109

1.58

17.55

2.9

4.4

227.21

242.12

u/l

1.81

433

2949

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

481

3208

1.57

17.44

3.0

2.7

266.72

239.48

u/l

1.54

459

2967

Benign neoplasm: Skin of ear and external auricular canal

204

1089

2.01

17.37

4.0

2.8

242.16

237.84

u/l

0.26

187

1012

Sleep disorders

1023

7775

1.35

17.13

3.5

4.4

226.77

238.98

u/l

2.79

954

7376

Alcohol-induced acute pancreatitis

222

1231

1.97

17.11

2.8

4.4

213.19

240.01

u/l

4.89

204

1174

Radiculopathy

929

6988

1.38

17.02

3.4

4.3

240.27

245.61

u/l

0.66

871

6576

Carrier of infectious disease

142

674

2.32

16.97

4.1

4.0

217.84

252.76

u/l

1.82

134

635

Non-small cell lung cancer, squamous, helper endpoint

319

1962

1.75

16.95

4.3

3.7

222.74

248.07

u/l

3.38

309

1819

Non-small cell lung cancer, squamous

319

1962

1.75

16.95

4.3

3.7

222.74

248.07

u/l

3.38

309

1819

Nail disorders

423

2765

1.61

16.92

5.7

4.4

235.22

244.33

u/l

0.89

401

2617

Alzheimer’s disease, wide definition

872

9697

0.73

16.91

2.5

3.5

249.52

250.59

u/l

0.07

747

8986

Other/unspecified synovitis and tenosynovitis

602

4220

1.48

16.87

3.7

4.6

240.32

242.88

u/l

0.17

572

3994

Dissection of aorta

212

1167

1.99

16.84

3.4

4.0

270.30

243.41

u/l

1.55

202

1102

Event of undetermined intent

315

1922

1.73

16.82

3.9

4.3

247.43

242.29

u/l

0.17

291

1823

Superficial injury of abdomen, lower back and pelvis

753

5486

1.42

16.81

3.4

4.3

234.54

241.41

u/l

0.76

703

5172

Benign neoplasm: Liver

105

437

2.62

16.81

4.3

3.2

226.18

235.41

u/l

0.41

100

413

Malignant neoplasm of stomach

319

1967

1.74

16.78

3.7

3.9

233.96

248.61

u/l

1.01

300

1840

Volvulus

164

827

2.18

16.75

4.3

4.1

241.80

245.88

u/l

0.15

157

783

Atrial septal defect

206

1109

1.98

16.74

4.5

5.0

267.46

270.60

u/l

0.06

198

1058

Ocular pain

390

2508

1.63

16.72

4.4

4.2

227.80

244.01

u/l

1.77

367

2368

Atopic dermatitis

2613

18799

1.20

16.56

3.8

4.2

236.07

237.95

u/l

0.19

2464

17859

Injuries to the wrist and hand

5706

36851

1.13

16.55

3.9

4.3

238.28

242.12

u/l

0.94

5375

34955

Unspecified urinary incontinence

462

3097

1.57

16.52

3.1

4.1

235.87

246.76

u/l

1.31

406

2913

Benign neoplasm: Tongue

145

700

2.26

16.48

5.0

3.1

245.77

237.60

u/l

0.16

140

659

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1684

13629

1.26

16.46

4.0

4.3

230.73

235.55

u/l

0.79

1600

12966

Benign neoplasm: Descending colon

405

2659

1.63

16.45

3.9

4.3

233.53

247.60

u/l

1.32

384

2504

Disorders of porphyrin and bilirubin metabolism

322

3.01

16.43

5.1

4.7

213.37

245.54

u/l

2.21

310

Other and unspecified psoriasis

370

2371

1.66

16.42

3.4

4.4

235.11

249.56

u/l

1.31

344

2252

Synovial cyst of popliteal space [Baker]

406

2655

1.61

16.36

4.1

4.3

244.93

247.68

u/l

0.13

381

2509

Olecranon bursitis

366

2345

1.66

16.32

3.4

4.9

245.43

239.81

u/l

0.24

346

2224

Other/unspecified reactive arthropathies

351

2222

1.67

16.27

3.5

4.3

235.98

244.63

u/l

0.39

332

2107

Etanercept

302

1838

1.73

16.27

2.5

4.5

232.37

247.82

u/l

1.20

281

1747

Mental and behavioural disorders due to use of other stimulants, including caffeine

136

640

2.28

16.24

2.1

4.6

227.45

231.85

u/l

0.14

128

614

Lesion of lateral popliteal nerve

281

1688

1.78

16.22

4.6

4.3

258.39

243.75

u/l

0.41

266

1604

Other specified/unspecified soft tissue disorders

278

1662

1.78

16.20

3.1

3.9

235.44

248.55

u/l

1.13

262

1570

Leiomyoma of uterus

2958

14305

1.19

16.19

4.0

3.9

242.35

243.19

u/l

0.11

2764

13455

Systemic sclerosis

147

722

2.24

16.16

3.1

4.4

255.62

256.45

u/l

0.02

142

682

Testicular hypofunction

185

984

2.04

16.15

5.4

4.9

241.21

240.12

u/l

0.02

175

936

Visual field defects

473

3208

1.55

16.11

3.9

4.0

234.94

247.62

u/l

1.20

443

3024

Other arterial embolism and thrombosis

182

967

2.06

16.06

3.4

3.8

243.14

252.83

u/l

0.42

173

909

Psoriatic arthropathies, ICD10

538

3736

1.50

16.03

3.1

4.4

243.70

244.42

u/l

0.03

509

3542

Hallux valgus (acquired)

1745

10278

1.25

15.98

3.7

4.4

247.35

247.01

u/l

0.03

1635

9702

Other hammer toe(s) (acquired)

931

6624

1.36

15.94

3.3

4.4

251.08

248.60

u/l

0.13

863

6235

Other hearing loss

1614

12897

1.26

15.91

4.1

3.9

238.04

248.57

u/l

2.98

1526

12063

Colorectal adenocarcinoma

1156

9063

1.32

15.91

3.0

4.1

250.09

248.41

u/l

0.11

1099

8484

Malignant neoplasm of ovary

253

1487

1.83

15.90

5.6

4.2

257.50

251.05

u/l

0.24

242

1391

Benign neoplasm: Pancreas

141

687

2.26

15.82

4.3

2.9

231.21

241.15

u/l

0.38

134

642

Nonsuppurative otitis media

1083

7220

1.32

15.82

4.8

4.1

238.27

236.33

u/l

0.10

1038

6857

Otitis externa, unspecified

533

3702

1.50

15.77

4.1

4.3

227.55

244.03

u/l

2.36

501

3501

Hypermobility syndrome

220

1232

1.87

15.75

3.3

4.2

214.69

241.24

u/l

2.10

211

1175

Impetigo

211

1172

1.91

15.70

5.1

4.6

261.61

251.64

u/l

0.13

201

1115

Benign neoplasm: Kidney

169

878

2.08

15.69

4.3

3.1

236.20

238.62

u/l

0.11

157

820

Pneumonitis due to solids and liquids

459

3111

1.55

15.68

2.8

3.8

254.82

248.60

u/l

0.24

424

2907

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

786

5830

1.39

15.65

3.9

4.5

224.11

238.45

u/l

3.29

745

5528

Open wound of forearm

479

3268

1.53

15.64

3.8

4.1

232.81

243.48

u/l

1.15

434

3088

Benign neoplasm: Pituitary gland, craniopharyngeal duct

224

1268

1.87

15.63

3.7

3.1

224.49

232.15

u/l

0.59

212

1188

Lesion of ulnar nerve

731

5374

1.41

15.62

3.8

4.6

245.78

241.29

u/l

0.15

689

5115

Other condition

678

4920

1.43

15.62

4.1

4.3

241.68

241.93

u/l

0.02

648

4654

Drug-induced hypoglycaemia without coma

114

516

2.50

15.61

2.5

3.8

244.65

250.66

u/l

0.18

105

486

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

120

551

2.40

15.61

2.7

2.9

211.43

244.28

u/l

6.03

115

515

Noninflammatory disorders of female genital tract

2117

8794

1.23

15.60

3.9

233.30

240.81

u/l

0.88

2013

8288

Testicular dysfunction

204

1132

1.95

15.58

5.2

4.8

237.92

237.31

u/l

0.01

194

1079

Fracture of skull and facial bones

1068

8279

1.32

15.58

3.9

4.5

239.41

241.33

u/l

0.17

998

7850

Ulcerative colitis (strict definition, require KELA)

814

6076

1.38

15.55

3.8

4.5

224.42

238.17

u/l

3.19

771

5768

Transport accidents

2417

18070

1.20

15.54

3.8

4.5

234.83

244.53

u/l

3.05

2287

17227

Injuries to the neck

1100

8561

1.32

15.52

3.8

4.3

221.30

236.66

u/l

5.98

1039

8108

Other specified/unspecified inflammatory spondylopathies

231

1322

1.84

15.51

2.3

4.6

227.23

241.86

u/l

1.03

217

1264

Benign neoplasm of brain and other parts of central nervous system

283

1715

1.73

15.45

4.1

3.1

240.22

234.92

u/l

0.26

265

1607

Disorders of ocular muscles, binocular movement, accommodation and refraction

2323

19401

1.21

15.44

4.3

4.2

243.27

240.90

u/l

0.22

2208

18356

Disorders of optic nerve and visual pathways

467

3178

1.53

15.40

3.9

4.3

237.91

245.79

u/l

0.52

445

3018

Other and unspecified follicular disorders

212

1193

1.91

15.39

6.2

4.1

233.87

247.04

u/l

0.67

201

1127

Carbimazole or st.post thyroidectomy, condition for graves disease

976

7490

1.34

15.38

5.9

4.1

233.31

242.29

u/l

1.54

921

7055

Cyst of kidney

403

2681

1.60

15.36

3.6

4.3

232.45

247.03

u/l

1.33

386

2526

TMD related pain

168

875

2.05

15.35

2.4

4.5

216.16

247.28

u/l

1.51

153

839

Other specified and unspecified personality disorders

424

2828

1.56

15.28

3.0

4.4

234.31

239.21

u/l

0.27

399

2692

Familial hypercholesterolemia, with ischemic heart disease

581

4149

1.48

15.25

3.4

4.2

245.32

241.64

u/l

0.22

543

3877

Diseases of inner ear

3038

25665

1.18

15.23

3.8

4.1

238.08

245.52

u/l

2.72

2823

24210

Complications of other internal prosthetic devices, implants and grafts

218

1243

1.89

15.23

3.6

3.8

249.29

246.60

u/l

0.09

206

1175

Encephalopathy

308

3.04

15.23

3.3

4.1

230.77

259.19

u/l

1.13

291

Lupus erythematosus

149

753

2.18

15.22

3.3

4.0

241.78

246.57

u/l

0.13

140

717

Benign neoplasm of breast

465

3158

1.52

15.20

3.7

2.8

240.67

237.94

u/l

0.17

441

2920

Arterial embolism and thrombosis of lower extremity artery

217

1239

1.90

15.17

4.1

4.0

278.85

252.31

u/l

0.68

199

1166

Nonspecific lymphadenitis

293

1802

1.71

15.13

4.0

4.7

223.58

245.26

u/l

2.14

283

1712

Universal erythroderma, KELA reimbursement

103

453

2.58

15.13

4.0

4.2

235.03

236.74

u/l

0.07

429

Assault by bodily force

333

2109

1.64

15.10

2.7

4.7

218.54

239.38

u/l

2.71

307

2013

Nonorganic sleeping disorders

876

6638

1.36

15.06

3.5

4.4

223.87

239.31

u/l

3.93

818

6296

Benign neoplasm: Skin, unspecified

185

1001

1.97

15.06

4.3

3.0

246.36

238.25

u/l

0.26

171

937

Benign paroxysmal vertigo

1528

12429

1.26

15.04

3.6

4.2

232.67

245.92

u/l

4.31

1412

11692

Restless leg syndrome

626

4523

1.44

15.03

3.5

4.2

234.85

246.19

u/l

1.34

575

4259

Beta thalassaemia

21.65

15.00

12.2

4.6

217.94

231.53

u/l

0.24

Allergic urticaria

392

2585

1.58

15.00

5.7

4.2

232.17

247.17

u/l

1.38

377

2445

Benign neoplasm of major salivary glands

541

3823

1.48

14.88

4.0

4.2

238.04

245.00

u/l

0.57

514

3614

Maltreatment syndromes

229

1323

1.82

14.83

2.6

4.5

230.70

235.46

u/l

0.23

216

1263

Other histiocytosis syndromes

12.62

14.82

4.8

4.6

199.32

235.12

u/l

1.33

Systemic sclerosis, icd10

146

740

2.17

14.80

3.1

4.3

256.19

254.49

u/l

0.03

141

697

Enthesopathies of lower limb, excluding foot

1081

8448

1.31

14.78

3.9

4.6

234.90

242.39

u/l

1.21

1010

8019

Benign neoplasm: Anus and anal canal

145

732

2.15

14.65

3.1

2.9

247.59

242.74

u/l

0.15

138

685

Temporomandibular joint disorders, including avohilmo

1865

15446

1.23

14.62

3.4

4.1

228.01

235.85

u/l

2.08

1745

14644

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

332

2120

1.63

14.62

4.4

3.1

248.71

232.38

u/l

0.67

307

1990

Excessive attrition of teeth

1962

8809

1.23

14.58

4.1

3.9

235.05

238.64

u/l

0.56

1842

8383

Acute nephritic syndrome

138

690

2.21

14.58

3.5

4.6

226.86

256.09

u/l

1.43

132

657

Alcohol abuse, main dg

784

5886

1.37

14.55

2.7

4.6

237.02

238.16

u/l

0.07

744

5597

Alcohol withdrawal state with delirium

397

2658

1.58

14.54

2.7

4.5

256.26

244.32

u/l

0.32

361

2528

Faecal incontinence

446

3046

1.53

14.53

3.2

4.0

264.13

252.21

u/l

0.43

420

2859

Redundant prepuce, phimosis and paraphimosis

1051

8168

1.31

14.53

3.8

4.8

234.42

245.67

u/l

1.21

1001

7786

Benign neoplasm: salivary glands, exclude unknown (D119)

482

3353

1.51

14.49

4.1

4.2

233.31

245.88

u/l

1.33

464

3176

Chorioretinal inflammation

168

899

2.03

14.48

4.1

4.4

236.96

247.03

u/l

0.39

157

848

Benign neoplasm: other/unspecified salivary gland

144

729

2.14

14.46

3.8

3.0

250.41

235.30

u/l

0.53

133

686

Carcinoma in situ of skin of lower limb, including hip

139

707

2.24

14.42

4.2

3.8

243.88

246.38

u/l

0.09

134

661

Schizophrenia or delusion, excluding more controls

1419

11376

1.26

14.41

2.7

4.6

233.38

241.14

u/l

1.30

1304

10861

Deficiency of other B group vitamins

136

680

2.21

14.37

3.6

3.9

236.01

241.69

u/l

0.18

127

642

Type 1 diabetes, strict definition, subgroup 1

305

1910

1.65

14.21

4.0

4.7

234.49

234.32

u/l

0.01

297

1823

Degenerative diseases of the nervous system

1394

12905

0.79

14.19

2.5

3.7

248.27

251.14

u/l

0.26

1211

12044

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

868

6631

1.34

14.15

3.8

4.5

224.53

237.55

u/l

3.17

825

6297

Malignant neoplasm of bladder

447

3086

1.53

14.15

3.6

3.8

231.87

245.30

u/l

1.15

424

2888

Insomnia

727

5414

1.38

14.14

3.7

4.4

228.93

239.75

u/l

1.55

679

5128

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

388

2585

1.56

14.12

3.2

4.3

235.26

237.62

u/l

0.10

365

2448

Superficial injury of thorax

767

5771

1.37

14.10

4.5

4.2

236.56

242.59

u/l

0.74

726

5447

Other psoriatic arthropathies

516

3645

1.47

14.08

3.1

4.5

245.13

244.27

u/l

0.03

487

3456

Fracture of forearm

2864

23154

1.18

14.05

3.8

4.2

237.23

243.99

u/l

2.08

2694

21852

Correction of physiology of bite - demanding therapy visit

317

2026

1.64

13.99

3.7

4.4

235.72

243.31

u/l

0.39

294

1922

Marfan's syndrome

133

4.12

13.93

2.3

4.0

286.11

236.23

u/l

1.65

128

Excessive vomiting in pregnancy

317

2021

1.62

13.91

3.8

4.4

212.62

238.52

u/l

3.91

300

1909

Use of rivastigmine

430

6157

0.67

13.86

2.5

3.4

247.37

249.98

u/l

0.12

372

5684

KRA_PSY_EATING, excluding more controls

306

1926

1.63

13.84

3.5

3.9

210.78

233.05

u/l

2.71

282

1846

Ptosis of eyelid

600

4378

1.43

13.79

3.7

4.2

244.18

247.26

u/l

0.17

569

4118

Overexertion and strenuous or repetitive movements

490

3440

1.48

13.78

3.5

4.4

227.93

242.01

u/l

1.51

468

3263

Mixed hyperlipidaemia

236

1417

1.79

13.78

3.7

4.4

246.50

245.63

u/l

0.03

219

1350

Post-traumatic wound infection, not elsewhere classified

149

780

2.08

13.74

3.9

4.2

230.50

241.20

u/l

0.42

139

740

Primary gonarthrosis, bilateral

2984

22671

1.17

13.73

3.5

4.3

239.65

247.97

u/l

2.91

2762

21389

Fall on same level involving ice and snow

3041

26441

1.17

13.71

3.6

4.3

237.93

243.03

u/l

1.36

2870

24982

Pediculosis, acariasis and other infestations

288

1813

1.67

13.68

4.6

4.4

246.15

242.42

u/l

0.14

271

1726

Paraplegia, diplegia of upper limbs

134

678

2.17

13.68

4.4

4.2

293.69

245.06

u/l

0.37

124

641

Use of donepezil

692

8839

0.73

13.67

2.7

3.5

252.23

249.96

u/l

0.12

616

8168

Other enthesopathies

1486

12151

1.25

13.67

3.4

4.6

238.40

244.10

u/l

0.42

1386

11538

Pure hyperglyceridaemia

136

693

2.15

13.61

3.8

4.8

226.18

240.60

u/l

1.01

126

663

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

247

3.08

13.57

6.6

2.9

229.88

236.43

u/l

0.28

232

Atopic dermatitis, strict definition

1246

9787

1.27

13.57

4.0

4.3

242.83

235.02

u/l

0.52

1192

9318

Postmenopausal bleeding

1393

6168

1.27

13.56

4.3

4.2

244.74

251.50

u/l

0.67

1302

5794

Maternal care for known or suspected abnormality of pelvic organs

895

4718

1.33

13.52

3.7

4.0

228.52

231.21

u/l

0.17

859

4484

Other and unspecified hereditary haemolytic anaemias

11.01

13.49

21.1

3.1

243.53

236.71

u/l

0.09

Follicular cysts of skin and subcutaneous tissue

927

7206

1.32

13.45

4.5

4.4

238.38

240.09

u/l

0.15

876

6835

Viral infections of the central nervous system

355

2351

1.58

13.45

4.9

4.2

233.23

246.12

u/l

0.99

342

2221

Orthopaedic devices associated with adverse incidents

122

607

2.29

13.44

2.4

4.3

223.14

252.23

u/l

1.27

104

570

Other disorders of iris and ciliary body

158

851

2.02

13.43

3.0

3.8

234.21

255.02

u/l

0.95

149

803

False labour

1043

5103

1.30

13.38

3.0

4.0

214.20

230.24

u/l

1.93

979

4861

Chondrocostal junction syndrome [Tietze]

193

1104

1.87

13.31

3.5

4.1

224.42

255.39

u/l

2.12

183

1050

Other and unspecified injuries of head

318

2066

1.62

13.28

3.3

4.1

248.91

249.27

u/l

0.01

293

1952

Postprocedural disorders of nervous system

306

1960

1.62

13.28

3.1

4.2

218.53

238.02

u/l

2.21

291

1877

Type 1 diabetes, strict definition

320

2061

1.60

13.24

4.0

4.7

233.39

235.09

u/l

0.11

312

1971

Pulmonary oedema

122

607

2.24

13.19

6.2

3.6

262.76

246.58

u/l

0.74

116

572

Malignant neoplasm of oral cavity

206

1213

1.85

13.15

4.4

4.1

234.13

251.18

u/l

0.42

200

1142

Monoarthritis, not elsewhere classified

224

1338

1.77

13.14

3.5

4.6

226.62

247.08

u/l

1.93

213

1272

Algoneurodystrophy

156

837

1.99

13.10

2.5

4.3

221.53

249.95

u/l

1.29

146

797

Benign neoplasm of eye and adnexa

532

3840

1.45

13.02

4.5

4.1

231.62

246.37

u/l

1.91

506

3615

Other maternal disorders predominantly related to pregnancy

2409

12919

1.19

12.90

3.5

4.1

229.41

237.65

u/l

2.22

2280

12253

Sequelae of injuries, of poisoning and of other consequences of external causes

1155

9260

1.28

12.89

3.7

4.5

235.94

239.60

u/l

0.39

1082

8808

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

667

4967

1.38

12.88

3.3

4.0

220.08

235.28

u/l

2.84

612

4690

Ulcerative enterocolitis

167

923

1.93

12.87

3.5

4.3

231.30

239.21

u/l

0.43

159

875

Melanocytic naevi of lower limb, including hip

218

1302

1.78

12.86

7.8

4.0

225.36

244.20

u/l

1.39

210

1239

Preterm labour and delivery

1018

8026

1.29

12.86

4.2

4.1

242.01

237.43

u/l

0.29

964

7591

Diseases of tongue

326

2145

1.60

12.85

3.9

3.8

232.23

249.66

u/l

1.46

307

2025

Amputation of thigh

179

1019

1.91

12.80

4.5

3.5

271.94

246.39

u/l

0.60

160

954

Bronchitis, not specified as acute or chronic

455

3198

1.48

12.76

4.3

4.4

233.31

248.02

u/l

1.80

423

3005

Ulcerative ileocolitis

206

1213

1.80

12.74

3.3

4.3

230.44

246.62

u/l

0.67

200

1160

Pemphigoid

168

943

1.96

12.73

4.0

3.7

240.92

254.45

u/l

0.52

156

879

Papilloedema, unspecified

126

639

2.15

12.71

4.5

4.1

250.96

240.00

u/l

0.27

120

610

Corneal ulcer

873

6783

1.32

12.65

4.0

4.4

237.76

238.77

u/l

0.10

826

6428

Gonarthrosis, primary, with knee surgery

3346

24058

1.16

12.59

3.5

4.3

242.03

247.99

u/l

1.61

3108

22703

Septal defects

305

1940

1.61

12.59

3.5

4.9

272.79

257.95

u/l

0.47

291

1849

Colonic or urogenital fistula

1405

11542

1.24

12.57

4.3

237.11

243.01

u/l

0.80

1313

10893

Endometriosis

1646

8093

1.23

12.56

3.2

4.0

236.78

242.88

u/l

0.72

1538

7625

Alzheimer’s disease (Late onset)

816

8995

0.76

12.55

2.5

3.4

248.18

251.23

u/l

0.24

700

8328

Melanocytic naevi of other and unspecified parts of face

236

1442

1.71

12.50

4.5

3.3

230.03

231.35

u/l

0.06

220

1349

Viral agents as the cause of diseases classified to other chapters

125

637

2.14

12.50

4.9

4.2

256.52

252.00

u/l

0.10

117

610

Spondylolisthesis/Spondylolysis

910

7129

1.31

12.42

3.8

4.5

239.92

244.08

u/l

0.41

853

6768

Benign neoplasm: Conjunctiva

149

803

1.98

12.41

4.1

2.9

235.45

237.08

u/l

0.05

142

754

Carcinoma in situ of other and unspecified sites

184

1064

1.86

12.40

3.3

2.6

221.89

239.91

u/l

2.74

174

990

Other disorders starting during childhood or adolecense, excluding more controls

184

1011

1.82

12.36

4.6

4.8

242.99

265.62

u/l

0.65

175

963

Hydrocele

705

5359

1.36

12.31

5.0

4.5

246.62

248.17

u/l

0.08

670

5063

Fall involving bed

183

1063

1.87

12.30

2.8

3.6

257.58

258.38

u/l

0.02

159

996

Convalescence

254

1593

1.67

12.27

3.7

3.9

253.87

233.15

u/l

1.07

239

1502

Degenerative macular diseases

682

5171

1.37

12.23

3.2

4.0

265.20

246.16

u/l

0.50

637

4820

193

3188

0.58

12.20

2.2

4.1

289.72

244.90

u/l

0.73

174

3000

Certolizumab pegol

394

2.43

12.14

1.7

4.0

212.34

243.49

u/l

2.43

378

Other retinal artery occlusion

154

856

1.98

12.11

2.8

3.9

242.70

255.72

u/l

0.36

137

799

conjunctival haemorrhage

409

2862

1.50

12.09

4.6

4.1

256.59

247.72

u/l

0.57

394

2699

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

223

3.11

12.08

4.6

3.0

237.54

243.73

u/l

0.21

209

Other and unspecified nerve root and plexus disorders, also in other diseases

905

7112

1.31

12.05

3.6

4.5

234.20

239.82

u/l

0.68

852

6758

Speech and linguistic disorders

360

2337

1.53

12.04

4.9

4.7

245.82

251.17

u/l

0.25

346

2216

Intentional self-harm by unspecified means

260

2.80

12.04

1.7

4.4

208.90

243.58

u/l

1.99

252

Unspecified human immunodeficiency virus [HIV] disease

300

2.75

12.02

3.5

4.1

221.08

248.53

u/l

0.78

286

Twin gestation

311

2041

1.57

12.00

3.6

4.1

241.84

230.05

u/l

0.26

300

1938

156

873

1.97

12.00

3.3

4.0

239.76

245.24

u/l

0.17

143

824

Other predominantly sexually transmitted diseases, not elsewhere classified

692

5237

1.35

11.99

4.0

4.2

226.36

233.63

u/l

0.71

639

4970

Personal history of certain other diseases

395

2.39

11.95

3.0

3.2

222.95

231.70

u/l

0.36

375

Carcinoma in situ of colon

101

492

2.37

11.93

3.5

4.0

239.52

244.64

u/l

0.17

101

466

Idiopathic pulmonary fibrosis

447

3192

1.48

11.92

3.8

3.9

287.04

246.76

u/l

3.58

413

2992

Retinal detachment with retinal break

705

5387

1.36

11.92

4.7

4.4

247.49

244.85

u/l

0.21

658

5085

Cysts of oral region, not elsewhere classified

228

1406

1.71

11.91

3.8

4.0

252.40

244.02

u/l

0.24

219

1334

Acute alcohol intoxication, ICD10

981

7800

1.29

11.86

2.8

4.6

235.45

238.01

u/l

0.20

920

7435

Superficial injury of ankle and foot

511

3705

1.42

11.83

4.3

4.5

221.75

242.46

u/l

4.23

491

3523

Psoriasis (vulgaris), strict definition

166

942

1.89

11.83

2.4

4.7

222.48

238.29

u/l

1.27

156

892

Oesophageal obstruction

211

1286

1.76

11.80

3.5

4.3

240.77

257.81

u/l

0.69

196

1219

Fenamates

892

4697

1.31

11.80

3.7

4.7

239.69

249.93

u/l

1.19

842

4488

Other noninflammatory disorders of uterus, except cervix

1104

6039

1.28

11.78

3.5

4.1

238.40

251.08

u/l

2.85

1034

5669

severe traumatic brain injury, does not include concussion

1219

9952

1.26

11.76

3.9

4.0

242.20

247.23

u/l

0.60

1129

9318

Acute laryngitis and tracheitis

468

3286

1.43

11.72

3.9

4.3

232.91

240.53

u/l

0.55

445

3130

Disorders of myoneural junction and muscle in diseases classified elsewhere

221

3.07

11.69

2.9

4.6

260.04

240.50

u/l

0.75

209

Macular pucker

831

6520

1.32

11.67

3.6

4.3

244.10

245.42

u/l

0.10

778

6123

Carcinoma in situ, bladder

172

995

1.87

11.64

3.2

2.6

222.73

240.82

u/l

2.55

162

926

Impacted cerumen

530

3900

1.42

11.63

3.3

4.1

241.54

248.91

u/l

0.52

449

3667

Granulomatous disorders of skin and subcutaneous tissue

136

729

2.01

11.63

6.5

3.9

240.92

251.58

u/l

0.27

128

695

Dronedarone medication

167

959

1.89

11.62

3.0

4.1

247.67

245.51

u/l

0.08

154

896

426

2.30

11.55

3.2

3.8

241.24

223.19

u/l

0.62

408

D07AA Corticosteroids, weak (group I)

697

5312

1.34

11.53

3.9

4.4

244.36

243.02

u/l

0.05

666

5031

Otalgia

369

2545

1.51

11.52

4.1

4.3

245.92

251.04

u/l

0.21

346

2408

Multiple gestation

317

2109

1.55

11.49

3.6

4.0

240.84

230.62

u/l

0.22

306

2001

Corneal scars and opacities

151

844

1.94

11.48

4.7

4.2

242.58

257.11

u/l

0.54

142

799

Spirochaetal infections, other/unspecified

428

3046

1.47

11.44

3.9

4.3

236.27

248.53

u/l

1.16

391

2883

Other symptoms and signs involving general sensations and perceptions

200

1207

1.76

11.43

2.8

4.2

269.84

253.50

u/l

0.21

184

1143

Enteropathic arthropathies

121

628

2.07

11.38

2.6

5.0

218.92

247.93

u/l

1.38

116

602

Disorders of orbit

223

1385

1.70

11.36

4.6

4.4

232.43

251.32

u/l

0.90

213

1304

Central retinal artery occlusion

146

817

1.97

11.29

4.1

4.0

245.51

256.52

u/l

0.39

140

762

Rheumatic fever incl heart disease

186

1107

1.80

11.28

4.5

3.9

289.20

255.20

u/l

1.37

178

1040

Other and unspecified injuries of lower leg

337

2291

1.53

11.27

3.7

4.3

222.94

247.44

u/l

2.78

320

2170

Open wound of wrist and hand

2246

19194

1.18

11.27

4.0

4.5

237.74

241.36

u/l

0.52

2104

18268

Other factor of the environment

366

2.48

11.21

4.1

4.3

214.99

245.74

u/l

2.12

346

Other disorders of conjunctiva

745

5783

1.33

11.20

4.5

4.2

248.63

243.82

u/l

0.45

718

5476

Chondropathies

725

5594

1.33

11.15

3.9

4.5

234.02

240.30

u/l

0.73

687

5313

Psychotic depression

293

1941

1.57

11.09

2.9

4.9

222.21

252.29

u/l

3.35

277

1853

Exposure to other and unspecified inanimate mechanical forces

323

2188

1.54

11.07

4.1

4.3

233.85

242.89

u/l

0.56

307

2075

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

373

2598

1.49

11.06

3.4

2.8

261.49

239.52

u/l

1.23

357

2399

Gilbert syndrome

210

3.03

11.00

5.6

4.5

205.38

235.01

u/l

2.35

204

Extrapyramidal and movement disorders

2019

17352

1.19

10.99

3.1

4.1

234.16

246.72

u/l

3.89

1855

16330

Suggestive for eosinophilic asthma

473

3446

1.43

10.97

3.6

4.5

222.01

246.62

u/l

6.25

445

3255

Left hemicolectomy

152

868

1.92

10.96

3.4

4.1

247.43

256.08

u/l

0.19

143

821

Ingrowing nail

261

1695

1.61

10.95

4.7

4.3

234.60

240.99

u/l

0.39

244

1606

Ovarian dysfunction

275

1797

1.58

10.92

3.5

3.7

224.08

230.62

u/l

0.31

256

1699

Background retinopathy and retinal vascular changes

128

692

2.02

10.92

3.1

3.9

231.52

256.79

u/l

1.09

122

651

Embolic stroke with flimmer

151

856

1.90

10.91

3.1

3.7

252.46

246.52

u/l

0.27

138

795

Hyperaldosteronism

159

918

1.88

10.90

2.6

4.3

234.90

252.08

u/l

0.79

143

869

Blood alcohol or alcohol intoxication level

129

695

1.99

10.88

2.7

4.3

226.18

239.12

u/l

0.86

122

663

Disorders of psychological development

459

3063

1.42

10.87

4.9

4.5

244.70

243.13

u/l

0.07

439

2915

Lesion of radial nerve

196

1194

1.74

10.85

2.8

4.3

247.22

241.27

u/l

0.11

176

1123

Thyroiditis

329

2248

1.52

10.81

3.7

4.1

231.17

247.29

u/l

1.23

312

2125

Congenital iodine-deficiency syndrome/hypothyroidism

168

986

1.83

10.76

3.6

3.8

265.89

255.97

u/l

0.25

149

927

Carcinoma in situ of breast, intraductal

300

2008

1.55

10.75

4.4

3.0

256.25

236.57

u/l

0.95

280

1855

Trigger finger

681

5241

1.34

10.73

3.7

4.6

240.08

244.08

u/l

0.23

646

4970

Cerebral palsy

375

2.36

10.73

2.7

4.6

352.60

272.49

u/l

0.45

362

Adhesive capsulitis of shoulder

853

6759

1.30

10.72

4.0

4.6

233.99

245.99

u/l

2.02

808

6393

Abdominal aortic aneurysm (AAA)

606

4565

1.36

10.71

3.1

3.9

243.93

246.13

u/l

0.16

564

4261

Other disorders of patella

760

5923

1.31

10.70

3.7

4.7

240.70

240.32

u/l

0.02

704

5635

Hyphaema and other vascular disorders of iris and ciliary body

118

626

2.07

10.66

3.5

4.1

235.69

261.23

u/l

0.94

113

594

Benign neoplasm: Skin of eyelid, including canthus

793

6243

1.31

10.66

4.1

238.28

245.66

u/l

1.01

743

5876

Antenatal screening

758

3281

1.32

10.65

3.3

3.8

230.34

228.80

u/l

0.06

733

3116

Disorders of refraction and accommodation

1179

9635

1.24

10.60

4.5

4.4

239.21

240.30

u/l

0.08

1124

9154

Benign neoplasm of middle ear and respiratory system

422

3038

1.45

10.59

3.6

4.3

249.56

245.41

u/l

0.19

403

2869

Other specified disorders of muscle

154

885

1.86

10.56

4.1

4.5

235.12

241.09

u/l

0.23

147

845

Dislocation of lens

462

2.25

10.53

2.5

3.8

259.77

263.39

u/l

0.06

437

Acute bronchiolitis

245

1412

1.61

10.50

7.1

5.4

240.26

263.55

u/l

1.31

234

1353

Benign neoplasm: Parotid gland

416

2994

1.45

10.49

4.0

4.2

232.87

246.75

u/l

1.48

400

2836

Unspecified/other endometriosis

347

2399

1.49

10.46

2.9

3.8

213.32

233.27

u/l

3.53

327

2254

Monoplegia

464

2.24

10.44

7.3

4.2

253.51

242.26

u/l

0.26

442

Artificial joint re-operation

381

2711

1.48

10.42

3.2

4.1

238.82

247.95

u/l

0.87

358

2542

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS